{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    },
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "25d40f625dbe4f978a02a6b2a7210ae5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_6b365cc4096544d3b9bbd6f9c614597d",
              "IPY_MODEL_afd072d3dd184979b0ac9263ff9eee53",
              "IPY_MODEL_3d87856ef0cc4c1299855a1cd3c14c1b"
            ],
            "layout": "IPY_MODEL_5b3c33a919bf42adb78a9f221fbe2df2"
          }
        },
        "6b365cc4096544d3b9bbd6f9c614597d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f097c078eecc4c7195646b5feb4ff144",
            "placeholder": "​",
            "style": "IPY_MODEL_2079ba12f15d468ca36b789f948e0764",
            "value": "Truncating train dataset: 100%"
          }
        },
        "afd072d3dd184979b0ac9263ff9eee53": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_60d863e06e1d47a9b4e28d9d3506a8e2",
            "max": 500,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_10987c118565476f89e9980d1f55758d",
            "value": 500
          }
        },
        "3d87856ef0cc4c1299855a1cd3c14c1b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d0cb6eaaa6234bee85e6161e1ba01627",
            "placeholder": "​",
            "style": "IPY_MODEL_810fc824c86a479cba21530bf71f1147",
            "value": " 500/500 [00:00&lt;00:00, 5318.25 examples/s]"
          }
        },
        "5b3c33a919bf42adb78a9f221fbe2df2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f097c078eecc4c7195646b5feb4ff144": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2079ba12f15d468ca36b789f948e0764": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "60d863e06e1d47a9b4e28d9d3506a8e2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "10987c118565476f89e9980d1f55758d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d0cb6eaaa6234bee85e6161e1ba01627": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "810fc824c86a479cba21530bf71f1147": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "465a1294db034eb29cf73c72600b9781": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_708a852b7e4a45fdb2435cd8d1219a40",
              "IPY_MODEL_5a9388bf0f3c4fb8a42f8b7a8142e51f",
              "IPY_MODEL_bddb529520b64c7a8f331106e96c2d27"
            ],
            "layout": "IPY_MODEL_a4322f2a7c86424fb1be469ff68f359c"
          }
        },
        "708a852b7e4a45fdb2435cd8d1219a40": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_cfaef5a62425448dad9a2094fc98c0e9",
            "placeholder": "​",
            "style": "IPY_MODEL_b1be7fcb8387492480b95c759e841e23",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "5a9388bf0f3c4fb8a42f8b7a8142e51f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_813057db43a84b5b9c0575cab0d28eec",
            "max": 3071,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_ec873db6f387427487595da5dd8ba974",
            "value": 3071
          }
        },
        "bddb529520b64c7a8f331106e96c2d27": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3e61f59ff6f24310b15a60c38f280d04",
            "placeholder": "​",
            "style": "IPY_MODEL_e65abbed4c8e4e7cac1618bc04e812ee",
            "value": " 3.07k/3.07k [00:00&lt;00:00, 93.4kB/s]"
          }
        },
        "a4322f2a7c86424fb1be469ff68f359c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "cfaef5a62425448dad9a2094fc98c0e9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b1be7fcb8387492480b95c759e841e23": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "813057db43a84b5b9c0575cab0d28eec": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ec873db6f387427487595da5dd8ba974": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "3e61f59ff6f24310b15a60c38f280d04": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e65abbed4c8e4e7cac1618bc04e812ee": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "617476bf14964a2aa5038a93bad4c005": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_34cbf956ac154db3b0a340c193970439",
              "IPY_MODEL_89ef2cc0d69041e1992d834e21315cb3",
              "IPY_MODEL_d4fe78d67ef14b5281836c52d37b69b5"
            ],
            "layout": "IPY_MODEL_f21d2c1ad118433abaa6545b4056db0d"
          }
        },
        "34cbf956ac154db3b0a340c193970439": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_dbb3e11968e74432a00ced93059266ba",
            "placeholder": "​",
            "style": "IPY_MODEL_bf830e67a85b48fe991dc361c8c4a870",
            "value": "tokenizer.json: 100%"
          }
        },
        "89ef2cc0d69041e1992d834e21315cb3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e2d0e29e1854422baf5e7acb9c5b4023",
            "max": 9084480,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_7f923d649c1b4e92b5a6500c6d2906a5",
            "value": 9084480
          }
        },
        "d4fe78d67ef14b5281836c52d37b69b5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_779567d439844215b0ad30b4ea4876b9",
            "placeholder": "​",
            "style": "IPY_MODEL_345adf6aad1445798d5a4822d7357b7a",
            "value": " 9.08M/9.08M [00:00&lt;00:00, 15.7MB/s]"
          }
        },
        "f21d2c1ad118433abaa6545b4056db0d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dbb3e11968e74432a00ced93059266ba": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "bf830e67a85b48fe991dc361c8c4a870": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e2d0e29e1854422baf5e7acb9c5b4023": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7f923d649c1b4e92b5a6500c6d2906a5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "779567d439844215b0ad30b4ea4876b9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "345adf6aad1445798d5a4822d7357b7a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "99738d8077ac43ea9449a59ef57eeb96": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "VBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "VBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "VBoxView",
            "box_style": "",
            "children": [],
            "layout": "IPY_MODEL_6ea9b405f77347229e8629de41db2b30"
          }
        },
        "ea4ea81e41164c0b8b011112f0d9645f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ab7efa9867c846be9f9e14cb74cf5b42",
            "placeholder": "​",
            "style": "IPY_MODEL_afefde691db246e48d2a4fbb5e8f9b3a",
            "value": "<center> <img\nsrc=https://huggingface.co/front/assets/huggingface_logo-noborder.svg\nalt='Hugging Face'> <br> Copy a token from <a\nhref=\"https://huggingface.co/settings/tokens\" target=\"_blank\">your Hugging Face\ntokens page</a> and paste it below. <br> Immediately click login after copying\nyour token or it might be stored in plain text in this notebook file. </center>"
          }
        },
        "fbf2ce06dc2d4783a9ab23fd97af8cd7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "PasswordModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "PasswordModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "PasswordView",
            "continuous_update": true,
            "description": "Token:",
            "description_tooltip": null,
            "disabled": false,
            "layout": "IPY_MODEL_2059fd91052b43fda01efa132d0a0445",
            "placeholder": "​",
            "style": "IPY_MODEL_1f7d2f21a57045999b54937ca1c06efc",
            "value": ""
          }
        },
        "4b07613e1a5a42bbba45d110a10b794e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "CheckboxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "CheckboxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "CheckboxView",
            "description": "Add token as git credential?",
            "description_tooltip": null,
            "disabled": false,
            "indent": true,
            "layout": "IPY_MODEL_edb87c184ebc4219ae45a9b3110431ed",
            "style": "IPY_MODEL_942f9ca9ec714026a8b1847d050b1a5e",
            "value": true
          }
        },
        "af4e498cc0b043d6aa1bb5a991a878f8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ButtonModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ButtonModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ButtonView",
            "button_style": "",
            "description": "Login",
            "disabled": false,
            "icon": "",
            "layout": "IPY_MODEL_e2554819d2984ec1b327c11b4b45456c",
            "style": "IPY_MODEL_4f5ecfd0462c433f86f669882955c3cc",
            "tooltip": ""
          }
        },
        "e2c3c16960f64da894f9c4e6a67ae356": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f16734c4ae1d4c5b98695524e1c357df",
            "placeholder": "​",
            "style": "IPY_MODEL_b6394b08100744f3be37f1695f1d1aa1",
            "value": "\n<b>Pro Tip:</b> If you don't already have one, you can create a dedicated\n'notebooks' token with 'write' access, that you can then easily reuse for all\nnotebooks. </center>"
          }
        },
        "6ea9b405f77347229e8629de41db2b30": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": "center",
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": "flex",
            "flex": null,
            "flex_flow": "column",
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "50%"
          }
        },
        "ab7efa9867c846be9f9e14cb74cf5b42": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "afefde691db246e48d2a4fbb5e8f9b3a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2059fd91052b43fda01efa132d0a0445": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1f7d2f21a57045999b54937ca1c06efc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "edb87c184ebc4219ae45a9b3110431ed": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "942f9ca9ec714026a8b1847d050b1a5e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e2554819d2984ec1b327c11b4b45456c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4f5ecfd0462c433f86f669882955c3cc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ButtonStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ButtonStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "button_color": null,
            "font_weight": ""
          }
        },
        "f16734c4ae1d4c5b98695524e1c357df": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b6394b08100744f3be37f1695f1d1aa1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f0cb1a56992542eb8728432a19b90bc6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d689c0414fe04ec191e93b0444409e0e",
            "placeholder": "​",
            "style": "IPY_MODEL_e4046926828e48e3adfac6869ad7aa92",
            "value": "Connecting..."
          }
        },
        "d689c0414fe04ec191e93b0444409e0e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e4046926828e48e3adfac6869ad7aa92": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "4d12ca37e8de428eb4156703563ff051": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_403705c60380480b8d563e3fa6a2d842",
              "IPY_MODEL_cc53cde2c26c4ae1a9def1bcdf3e58a6",
              "IPY_MODEL_b99f44b1b60940819924cfa590930296"
            ],
            "layout": "IPY_MODEL_ed34293e647b4217a6c7bb904a47ec1b"
          }
        },
        "403705c60380480b8d563e3fa6a2d842": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5f5d5b48352346148b4225effe923fdb",
            "placeholder": "​",
            "style": "IPY_MODEL_16081339a40047ebbda048f1936c48d1",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "cc53cde2c26c4ae1a9def1bcdf3e58a6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_cf5051ec2ea940ab98194717546797e0",
            "max": 55351,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_5d98c32ae5074111aeecc92e53521e76",
            "value": 55351
          }
        },
        "b99f44b1b60940819924cfa590930296": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5d9e28713d4b4fe9ab4dd33d4a13450e",
            "placeholder": "​",
            "style": "IPY_MODEL_782735b0036f4b78914061828fd3cefc",
            "value": " 55.4k/55.4k [00:00&lt;00:00, 3.48MB/s]"
          }
        },
        "ed34293e647b4217a6c7bb904a47ec1b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5f5d5b48352346148b4225effe923fdb": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "16081339a40047ebbda048f1936c48d1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "cf5051ec2ea940ab98194717546797e0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5d98c32ae5074111aeecc92e53521e76": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5d9e28713d4b4fe9ab4dd33d4a13450e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "782735b0036f4b78914061828fd3cefc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2de9c53fe58243169cf9be6772a7c6fa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_3865fa4ea8744cf892881e742f814aea",
              "IPY_MODEL_bcf3f4b17cf141f38126759392c7a7ea",
              "IPY_MODEL_4750ae15951248898961a7a98303aa1b"
            ],
            "layout": "IPY_MODEL_344df6c9224d4def9fbc5fa93d3c164d"
          }
        },
        "3865fa4ea8744cf892881e742f814aea": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_56994727030c4222aeb9a13e36bfe08d",
            "placeholder": "​",
            "style": "IPY_MODEL_5aa2785937b74b029c98790ebd2fcb9e",
            "value": "tokenizer.json: 100%"
          }
        },
        "bcf3f4b17cf141f38126759392c7a7ea": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e0b4952ea6e3460aa6748703caf5271d",
            "max": 9085657,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_ba0b6512b3084666a18d3a1f2eea981d",
            "value": 9085657
          }
        },
        "4750ae15951248898961a7a98303aa1b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d30ff64e6a09419382c8ec50ea8aa45b",
            "placeholder": "​",
            "style": "IPY_MODEL_d4a583f692ad4093aa343a94e37a3f27",
            "value": " 9.09M/9.09M [00:00&lt;00:00, 25.7MB/s]"
          }
        },
        "344df6c9224d4def9fbc5fa93d3c164d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "56994727030c4222aeb9a13e36bfe08d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5aa2785937b74b029c98790ebd2fcb9e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e0b4952ea6e3460aa6748703caf5271d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ba0b6512b3084666a18d3a1f2eea981d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d30ff64e6a09419382c8ec50ea8aa45b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d4a583f692ad4093aa343a94e37a3f27": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e107a4f43f5c4cda8efced1143475f53": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_c7126aacc5714f549241261ace73a52c",
              "IPY_MODEL_39801b0a1fc4404a99e04e33e6b96441",
              "IPY_MODEL_21a5335c6ee7480ab8e62e5b802a2c9f"
            ],
            "layout": "IPY_MODEL_d1bb7c4029ce486caaee91dc8fc76abe"
          }
        },
        "c7126aacc5714f549241261ace73a52c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f7b4db4ec93642f5ac08c3ff20576cc1",
            "placeholder": "​",
            "style": "IPY_MODEL_1c31d8ef3e1041219965a4971c71c4a5",
            "value": "special_tokens_map.json: 100%"
          }
        },
        "39801b0a1fc4404a99e04e33e6b96441": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e0697b2a547849b3a4d300e93adbfc05",
            "max": 296,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_3c80e807f8d9409ebbb908ca4b7d25cc",
            "value": 296
          }
        },
        "21a5335c6ee7480ab8e62e5b802a2c9f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d1e23316a5bc4e8796f7b8291a6424d4",
            "placeholder": "​",
            "style": "IPY_MODEL_c7f364f8e192477e8ef54c3e1166866a",
            "value": " 296/296 [00:00&lt;00:00, 17.5kB/s]"
          }
        },
        "d1bb7c4029ce486caaee91dc8fc76abe": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f7b4db4ec93642f5ac08c3ff20576cc1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "1c31d8ef3e1041219965a4971c71c4a5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e0697b2a547849b3a4d300e93adbfc05": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3c80e807f8d9409ebbb908ca4b7d25cc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d1e23316a5bc4e8796f7b8291a6424d4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c7f364f8e192477e8ef54c3e1166866a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "35b5bde01867489c8639f5425b1fc4e3": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_5325c46ce1114a9cadbdff3b4eba8e1e",
              "IPY_MODEL_5b01d8d6dae3439a906b41d3c63a9dda",
              "IPY_MODEL_c838a44d2e6141029d293f10728d80b2"
            ],
            "layout": "IPY_MODEL_e75317ba160e4d11b89e5036e74f9ebc"
          }
        },
        "5325c46ce1114a9cadbdff3b4eba8e1e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_e64799106bcd4f95bf501f0fd9952613",
            "placeholder": "​",
            "style": "IPY_MODEL_9aa62d20e5094f57ba1561467c5cfaee",
            "value": "Map: 100%"
          }
        },
        "5b01d8d6dae3439a906b41d3c63a9dda": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_91922e731f5c40aea16148b5ac39ddbe",
            "max": 500,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_26eeb5890c6c4ba8a94269a8f62f93c7",
            "value": 500
          }
        },
        "c838a44d2e6141029d293f10728d80b2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_afc5f4e29900417690658eaeadfefe2e",
            "placeholder": "​",
            "style": "IPY_MODEL_d9640a5d0b374019bc01b9e2746e6148",
            "value": " 500/500 [00:21&lt;00:00, 31.43 examples/s]"
          }
        },
        "e75317ba160e4d11b89e5036e74f9ebc": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "e64799106bcd4f95bf501f0fd9952613": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9aa62d20e5094f57ba1561467c5cfaee": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "91922e731f5c40aea16148b5ac39ddbe": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "26eeb5890c6c4ba8a94269a8f62f93c7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "afc5f4e29900417690658eaeadfefe2e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d9640a5d0b374019bc01b9e2746e6148": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2a84afa083e247458ded7d2d1b7bbdcf": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_ba555c6279824533a9e06a94f753e3bc",
              "IPY_MODEL_e80a0d27beb043f3be8e28e24440588d",
              "IPY_MODEL_2ccce53cd2b84bc1b164a9483ca22fd8"
            ],
            "layout": "IPY_MODEL_4e251e3805204980a4315bb75b51d7ea"
          }
        },
        "ba555c6279824533a9e06a94f753e3bc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_240edf9d11b644b99a33c1a1a37400dd",
            "placeholder": "​",
            "style": "IPY_MODEL_f3045f7bd48e49ff8abbeba93edeea25",
            "value": "model.safetensors.index.json: 100%"
          }
        },
        "e80a0d27beb043f3be8e28e24440588d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_da99aea7d2d34da8934a9022eebb9346",
            "max": 24240,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_704391c96bf4490fa5b0ff1efd3d1bd2",
            "value": 24240
          }
        },
        "2ccce53cd2b84bc1b164a9483ca22fd8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_24ea06865d1f4188ac6ea27d762d50e6",
            "placeholder": "​",
            "style": "IPY_MODEL_896a7c0d2c1c40c8b0d85cef8b4ae7e2",
            "value": " 24.2k/24.2k [00:00&lt;00:00, 601kB/s]"
          }
        },
        "4e251e3805204980a4315bb75b51d7ea": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "240edf9d11b644b99a33c1a1a37400dd": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f3045f7bd48e49ff8abbeba93edeea25": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "da99aea7d2d34da8934a9022eebb9346": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "704391c96bf4490fa5b0ff1efd3d1bd2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "24ea06865d1f4188ac6ea27d762d50e6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "896a7c0d2c1c40c8b0d85cef8b4ae7e2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "aea11a88ca164d38bd41624afa3f3263": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_63842a5c138c4441a3b29632e8fca09d",
              "IPY_MODEL_33b4f57a8ca1403e8e38d106746e90db",
              "IPY_MODEL_3032ac75f07045c6a2360f63b9eec81e"
            ],
            "layout": "IPY_MODEL_c1b456fdef87425b82c5d3fc845cf9e1"
          }
        },
        "63842a5c138c4441a3b29632e8fca09d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7090ca9d99aa468fb4f0191c2b14b09d",
            "placeholder": "​",
            "style": "IPY_MODEL_4161a240d070484b8ad55fd01535c0e9",
            "value": "Fetching 2 files: 100%"
          }
        },
        "33b4f57a8ca1403e8e38d106746e90db": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0c154d9110a947c7932ef15ff6e3380f",
            "max": 2,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_2c7180ab842a4562842f3ebc15ed9932",
            "value": 2
          }
        },
        "3032ac75f07045c6a2360f63b9eec81e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_d7eab4416e5c4b4e80c537cf5f47311a",
            "placeholder": "​",
            "style": "IPY_MODEL_12a9a010972d4f798270ad33d6b89c5b",
            "value": " 2/2 [02:31&lt;00:00, 151.07s/it]"
          }
        },
        "c1b456fdef87425b82c5d3fc845cf9e1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7090ca9d99aa468fb4f0191c2b14b09d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4161a240d070484b8ad55fd01535c0e9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0c154d9110a947c7932ef15ff6e3380f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2c7180ab842a4562842f3ebc15ed9932": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "d7eab4416e5c4b4e80c537cf5f47311a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "12a9a010972d4f798270ad33d6b89c5b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "696cbe32be89465ba8525cdadcd519d7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_4264deb7410545bcbada15928ccd2979",
              "IPY_MODEL_c5cc128a103b4c73b604004b3e878d52",
              "IPY_MODEL_528ab88045d24fe896b39c59f495e06e"
            ],
            "layout": "IPY_MODEL_9e00166a77ba4845b5e75aaddc31d2e5"
          }
        },
        "4264deb7410545bcbada15928ccd2979": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_13a18e4da18f4dcb8829e2ffde114b9b",
            "placeholder": "​",
            "style": "IPY_MODEL_4a22ea9829aa40dd91e9645846127d43",
            "value": "model-00001-of-000002.safetensors: 100%"
          }
        },
        "c5cc128a103b4c73b604004b3e878d52": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2891a90c5c824bf3af4d846dccf9b376",
            "max": 8667826246,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_205d6207593343b68ec7bd50df745d1a",
            "value": 8667826246
          }
        },
        "528ab88045d24fe896b39c59f495e06e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_292a2f9a6f854dfaa5545d9d9414ee20",
            "placeholder": "​",
            "style": "IPY_MODEL_3f7db5e9b68f4374ac63658b4f2bdd24",
            "value": " 8.67G/8.67G [02:30&lt;00:00, 131MB/s]"
          }
        },
        "9e00166a77ba4845b5e75aaddc31d2e5": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "13a18e4da18f4dcb8829e2ffde114b9b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4a22ea9829aa40dd91e9645846127d43": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "2891a90c5c824bf3af4d846dccf9b376": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "205d6207593343b68ec7bd50df745d1a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "292a2f9a6f854dfaa5545d9d9414ee20": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3f7db5e9b68f4374ac63658b4f2bdd24": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "79dc28185a3543899b36417ceb2aa521": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_b82e58e83ac645c795040a872ff4e513",
              "IPY_MODEL_a000327b45d440208867b22c155f7da1",
              "IPY_MODEL_190ca58635d1441ca1af375a61a645e5"
            ],
            "layout": "IPY_MODEL_daf8b09d093447b7a911050c37bae72f"
          }
        },
        "b82e58e83ac645c795040a872ff4e513": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3c639b0da59d442788c75ad720969d4f",
            "placeholder": "​",
            "style": "IPY_MODEL_afb50bc5bd9d4f86b841f08b09fda31d",
            "value": "model-00002-of-000002.safetensors: 100%"
          }
        },
        "a000327b45d440208867b22c155f7da1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7430ff654ba44fe98f5d48a6fc72e7e1",
            "max": 7392730108,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_8e4f07611cfa417cbd69db378d08db7c",
            "value": 7392730108
          }
        },
        "190ca58635d1441ca1af375a61a645e5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ec01598cbe574538ae67b9eec4cb01f3",
            "placeholder": "​",
            "style": "IPY_MODEL_edf144e7a6a2406883589a498d1bb0ce",
            "value": " 7.39G/7.39G [02:09&lt;00:00, 95.5MB/s]"
          }
        },
        "daf8b09d093447b7a911050c37bae72f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3c639b0da59d442788c75ad720969d4f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "afb50bc5bd9d4f86b841f08b09fda31d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "7430ff654ba44fe98f5d48a6fc72e7e1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8e4f07611cfa417cbd69db378d08db7c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "ec01598cbe574538ae67b9eec4cb01f3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "edf144e7a6a2406883589a498d1bb0ce": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "50e3faccc8b142a69844c15bc3376037": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_1d5f86564d014171a0522f4b81ec57e6",
              "IPY_MODEL_13906a1d284a4afea9785397d69ee445",
              "IPY_MODEL_439e1db0102747d5a686d53afee4c51c"
            ],
            "layout": "IPY_MODEL_b96f7ef3dfc745418f86a67c5915fdba"
          }
        },
        "1d5f86564d014171a0522f4b81ec57e6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_784ef22c55494cc89cdb715ec5d0ce55",
            "placeholder": "​",
            "style": "IPY_MODEL_4c8a48a893e644d9889b15f8e88833a6",
            "value": "Loading checkpoint shards: 100%"
          }
        },
        "13906a1d284a4afea9785397d69ee445": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f7bd3222e17e47d98343d7adc2445b01",
            "max": 2,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_cc83e26f390b4f84b8e2d51a28a43e0b",
            "value": 2
          }
        },
        "439e1db0102747d5a686d53afee4c51c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_fa8ebcfcd7ce4935a5c63518758d69c6",
            "placeholder": "​",
            "style": "IPY_MODEL_3f8f167c54cd4463a03106cf6dd43483",
            "value": " 2/2 [00:01&lt;00:00,  2.00it/s]"
          }
        },
        "b96f7ef3dfc745418f86a67c5915fdba": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "784ef22c55494cc89cdb715ec5d0ce55": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4c8a48a893e644d9889b15f8e88833a6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "f7bd3222e17e47d98343d7adc2445b01": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "cc83e26f390b4f84b8e2d51a28a43e0b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "fa8ebcfcd7ce4935a5c63518758d69c6": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3f8f167c54cd4463a03106cf6dd43483": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "37a2dbbd1033466fb59a791414c00ecd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_d6ef039d40ef404baabd218a35c59f47",
              "IPY_MODEL_89f435bc17de4b8c94633a59d08b2618",
              "IPY_MODEL_1dfe47ee12374719be9de93fd0f563ac"
            ],
            "layout": "IPY_MODEL_856bc0c76f774db6b0942c5dbddd6c6d"
          }
        },
        "d6ef039d40ef404baabd218a35c59f47": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6f7fa182ce3f4fbcb6211a3e666b3233",
            "placeholder": "​",
            "style": "IPY_MODEL_697022776aaa4d2eb2a22a8bba95c378",
            "value": "generation_config.json: 100%"
          }
        },
        "89f435bc17de4b8c94633a59d08b2618": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b7b1f28efa6c465aa535261828bbab2a",
            "max": 181,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_f9e2a5f74104435582ebfb8d449f1d48",
            "value": 181
          }
        },
        "1dfe47ee12374719be9de93fd0f563ac": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_53509d36683f4cb19e59ed79888a9e8b",
            "placeholder": "​",
            "style": "IPY_MODEL_5e8bbb13d7be40be8e43613e67e0763e",
            "value": " 181/181 [00:00&lt;00:00, 13.6kB/s]"
          }
        },
        "856bc0c76f774db6b0942c5dbddd6c6d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6f7fa182ce3f4fbcb6211a3e666b3233": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "697022776aaa4d2eb2a22a8bba95c378": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "b7b1f28efa6c465aa535261828bbab2a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "f9e2a5f74104435582ebfb8d449f1d48": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "53509d36683f4cb19e59ed79888a9e8b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5e8bbb13d7be40be8e43613e67e0763e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "661cb7bf9bfc4d60aa2541ab95987edc": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "VBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "VBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "VBoxView",
            "box_style": "",
            "children": [],
            "layout": "IPY_MODEL_1b4147371e374df2bbe7db60d00d9a9c"
          }
        },
        "6471f8f988bd4c5f8cc8b7760656ea9d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ea066d5b756f4e8cb75c82706a19728f",
            "placeholder": "​",
            "style": "IPY_MODEL_0050a0acdf68464aad55725ccd7e5d50",
            "value": "<center> <img\nsrc=https://huggingface.co/front/assets/huggingface_logo-noborder.svg\nalt='Hugging Face'> <br> Copy a token from <a\nhref=\"https://huggingface.co/settings/tokens\" target=\"_blank\">your Hugging Face\ntokens page</a> and paste it below. <br> Immediately click login after copying\nyour token or it might be stored in plain text in this notebook file. </center>"
          }
        },
        "9cf16c240b294d8e8bda2a08b45983ff": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "PasswordModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "PasswordModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "PasswordView",
            "continuous_update": true,
            "description": "Token:",
            "description_tooltip": null,
            "disabled": false,
            "layout": "IPY_MODEL_113e2a63308b4edd8c71645546d0c650",
            "placeholder": "​",
            "style": "IPY_MODEL_c1f8b768a6ac4272844dc6d58c40a1d6",
            "value": ""
          }
        },
        "27f6a38ab5854760930c6b8ee8bf2e2b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "CheckboxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "CheckboxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "CheckboxView",
            "description": "Add token as git credential?",
            "description_tooltip": null,
            "disabled": false,
            "indent": true,
            "layout": "IPY_MODEL_de18b40d5ff4406589d6f26702b1731f",
            "style": "IPY_MODEL_390967cb1bbc477a9847698f8bdb7c04",
            "value": true
          }
        },
        "d6c8682406a3488ba5cd8ae27d737646": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ButtonModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ButtonModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ButtonView",
            "button_style": "",
            "description": "Login",
            "disabled": false,
            "icon": "",
            "layout": "IPY_MODEL_1f1e89a488f542f7bb462552be6b56a7",
            "style": "IPY_MODEL_171ea308278b4031b909e32ada0b06ac",
            "tooltip": ""
          }
        },
        "a922c6a00c0f4caba23767e692dd0f6c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_6853b9387d7c4c1f9428487b4cdadb50",
            "placeholder": "​",
            "style": "IPY_MODEL_6a45caee4dab458090af818d0f16294e",
            "value": "\n<b>Pro Tip:</b> If you don't already have one, you can create a dedicated\n'notebooks' token with 'write' access, that you can then easily reuse for all\nnotebooks. </center>"
          }
        },
        "1b4147371e374df2bbe7db60d00d9a9c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": "center",
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": "flex",
            "flex": null,
            "flex_flow": "column",
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "50%"
          }
        },
        "ea066d5b756f4e8cb75c82706a19728f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0050a0acdf68464aad55725ccd7e5d50": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "113e2a63308b4edd8c71645546d0c650": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c1f8b768a6ac4272844dc6d58c40a1d6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "de18b40d5ff4406589d6f26702b1731f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "390967cb1bbc477a9847698f8bdb7c04": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "1f1e89a488f542f7bb462552be6b56a7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "171ea308278b4031b909e32ada0b06ac": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ButtonStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ButtonStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "button_color": null,
            "font_weight": ""
          }
        },
        "6853b9387d7c4c1f9428487b4cdadb50": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6a45caee4dab458090af818d0f16294e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "df10fdb6a9c34233b8fec13f1d8ff0a7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_49d30b301bc643d2b73636c2ebbee8f1",
            "placeholder": "​",
            "style": "IPY_MODEL_10e70edc06e246e09e8b509a0ee8938c",
            "value": "Connecting..."
          }
        },
        "49d30b301bc643d2b73636c2ebbee8f1": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "10e70edc06e246e09e8b509a0ee8938c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "6c7633f034a5427bbb8fb99906376135": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_ecdad2813c1a485a8a8eb757f568231d",
              "IPY_MODEL_8169b570a6ca49d3b13446cf2473d41e",
              "IPY_MODEL_a99c7ca0406e423385a2ba2bfa8af4c4"
            ],
            "layout": "IPY_MODEL_5dd0bef7e6ef48ae9764e1c4b5c0d937"
          }
        },
        "ecdad2813c1a485a8a8eb757f568231d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5fe94338137c46c287f0290ced244b4c",
            "placeholder": "​",
            "style": "IPY_MODEL_af0fce60b48944149976a6eca2558958",
            "value": "tokenizer_config.json: 100%"
          }
        },
        "8169b570a6ca49d3b13446cf2473d41e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_73bdac672adf4dcf939f7ca5d5b77737",
            "max": 55351,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_b37ab3da6d2c4c0c9072ce4d181e7a60",
            "value": 55351
          }
        },
        "a99c7ca0406e423385a2ba2bfa8af4c4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_f8b062c5e47d447fa388c07b8e9d3ee4",
            "placeholder": "​",
            "style": "IPY_MODEL_10e40d4309504b25bc03ddaa740fea17",
            "value": " 55.4k/55.4k [00:00&lt;00:00, 4.56MB/s]"
          }
        },
        "5dd0bef7e6ef48ae9764e1c4b5c0d937": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5fe94338137c46c287f0290ced244b4c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "af0fce60b48944149976a6eca2558958": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "73bdac672adf4dcf939f7ca5d5b77737": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "b37ab3da6d2c4c0c9072ce4d181e7a60": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "f8b062c5e47d447fa388c07b8e9d3ee4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "10e40d4309504b25bc03ddaa740fea17": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "efb8bbaaafc44c33970334123551dc29": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_3c738bc6bd51486fa14b2e64636c9b9a",
              "IPY_MODEL_af506c5aaa304a79b43c049f23eb53d6",
              "IPY_MODEL_3a6eeb5790434081b3a2c72142126e17"
            ],
            "layout": "IPY_MODEL_58115e023a6349b885ae57184a27f444"
          }
        },
        "3c738bc6bd51486fa14b2e64636c9b9a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_75b987bcb29640caa59ba7573702f68e",
            "placeholder": "​",
            "style": "IPY_MODEL_ff8855c78c71404283a75188ad69e071",
            "value": "tokenizer.json: 100%"
          }
        },
        "af506c5aaa304a79b43c049f23eb53d6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_06953861ec2b4bacb96b0e35e0a57f0b",
            "max": 9085657,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_5a4ef5d74b45449eaff3768b54f40445",
            "value": 9085657
          }
        },
        "3a6eeb5790434081b3a2c72142126e17": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_b9d1d5afc56d44448fc43f9e044fad19",
            "placeholder": "​",
            "style": "IPY_MODEL_44c024bdacb443ca82ad02436cf39ade",
            "value": " 9.09M/9.09M [00:00&lt;00:00, 34.2MB/s]"
          }
        },
        "58115e023a6349b885ae57184a27f444": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "75b987bcb29640caa59ba7573702f68e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "ff8855c78c71404283a75188ad69e071": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "06953861ec2b4bacb96b0e35e0a57f0b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "5a4ef5d74b45449eaff3768b54f40445": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "b9d1d5afc56d44448fc43f9e044fad19": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "44c024bdacb443ca82ad02436cf39ade": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "836719a5d51f492a8d35000ab621cfaa": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_d925231868bb4d83addd6517d0c78838",
              "IPY_MODEL_25b42175fd1c459ca700ad139428621b",
              "IPY_MODEL_bd8f8b41121a4662b41011eb51824de9"
            ],
            "layout": "IPY_MODEL_40c237fd1b5a43918dd091fae7c5a3c0"
          }
        },
        "d925231868bb4d83addd6517d0c78838": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0e044a12ca854d5ea18a3412a2320a17",
            "placeholder": "​",
            "style": "IPY_MODEL_6c10a282b52b476ab5bc4353219659a2",
            "value": "special_tokens_map.json: 100%"
          }
        },
        "25b42175fd1c459ca700ad139428621b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_8c6b366bf74840ce8ebb2162524d40b4",
            "max": 296,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_4211fc6bcc5f4d6ab4d0c977e1ed0e0e",
            "value": 296
          }
        },
        "bd8f8b41121a4662b41011eb51824de9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2f829651500448979b2329105bea146c",
            "placeholder": "​",
            "style": "IPY_MODEL_79a2c838447d42b98c47f063ee9b2e78",
            "value": " 296/296 [00:00&lt;00:00, 19.0kB/s]"
          }
        },
        "40c237fd1b5a43918dd091fae7c5a3c0": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0e044a12ca854d5ea18a3412a2320a17": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6c10a282b52b476ab5bc4353219659a2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "8c6b366bf74840ce8ebb2162524d40b4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4211fc6bcc5f4d6ab4d0c977e1ed0e0e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "2f829651500448979b2329105bea146c": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "79a2c838447d42b98c47f063ee9b2e78": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_9HCHbgWdLWN"
      },
      "outputs": [],
      "source": [
        "%%capture\n",
        "# ! pip install trl\n",
        "! pip install datasets\n",
        "! pip install rdkit\n",
        "# ! pip install peft\n",
        "# ! pip install git+https://github.com/bitsandbytes-foundation/bitsandbytes.git\n",
        "# ! pip install bitsandbytes==0.45.1"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from datasets import load_dataset , Dataset\n",
        "# from trl import SFTConfig, SFTTrainer\n",
        "import pandas as pd"
      ],
      "metadata": {
        "id": "DRfnhi9YPoee"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## building sft dataset manual"
      ],
      "metadata": {
        "id": "SDcCZbqzXPbI"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "df = pd.read_csv(\"/content/drive/MyDrive/Papers/Original_Papers/Llm_drug_prediction/Code/reasoning_data_api/test_reason.csv\")\n",
        "dset = Dataset.from_pandas(df)"
      ],
      "metadata": {
        "id": "oJigHkjkQN4g"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample = df.head()"
      ],
      "metadata": {
        "id": "AZgV2A_QluVn"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# from rdkit import Chem\n",
        "# from rdkit.Chem import Descriptors, Draw, AllChem, Lipinski, Crippen, rdMolDescriptors\n",
        "# from rdkit.Chem import rdDepictor\n",
        "# import pandas as pd\n",
        "\n",
        "# def get_molecule_properties(smiles):\n",
        "#     \"\"\"\n",
        "#     Compute molecular properties and analyses for a given SMILES string.\n",
        "\n",
        "#     Args:\n",
        "#         smiles (str): SMILES string of the molecule.\n",
        "\n",
        "#     Returns:\n",
        "#         dict: A dictionary containing all computed properties and analyses.\n",
        "#     \"\"\"\n",
        "#     # Initialize the molecule\n",
        "#     molecule = Chem.MolFromSmiles(smiles)\n",
        "#     if molecule is None:\n",
        "#         raise ValueError(\"Invalid SMILES string provided.\")\n",
        "\n",
        "#     # Dictionary to store all properties\n",
        "#     properties = {}\n",
        "\n",
        "\n",
        "#     properties[\"Molecular_Weight\"] = Descriptors.MolWt(molecule)\n",
        "#     properties[\"LogP\"] = Crippen.MolLogP(molecule)\n",
        "#     properties[\"Molecular_Refractivity\"] = Crippen.MolMR(molecule)\n",
        "#     properties[\"TPSA\"] = Descriptors.TPSA(molecule)\n",
        "#     properties[\"Hydrogen_Bond_Donors\"] = Lipinski.NumHDonors(molecule)\n",
        "#     properties[\"Hydrogen_Bond_Acceptors\"] = Lipinski.NumHAcceptors(molecule)\n",
        "#     properties[\"Rotatable_Bonds\"] = Lipinski.NumRotatableBonds(molecule)\n",
        "#     properties[\"Chiral_Centers\"] = Chem.FindMolChiralCenters(molecule)\n",
        "\n",
        "#     return properties\n",
        "\n",
        "from rdkit import Chem\n",
        "from rdkit.Chem import Descriptors, Draw, AllChem, Lipinski, Crippen, rdMolDescriptors, FilterCatalog\n",
        "from rdkit.Chem.FilterCatalog import FilterCatalogParams\n",
        "from rdkit.Chem import rdDepictor\n",
        "import pandas as pd\n",
        "\n",
        "def get_molecule_properties(smiles):\n",
        "    \"\"\"\n",
        "    Compute molecular properties and analyses for a given SMILES string, including structural alerts (PAINS/Brenk).\n",
        "\n",
        "    Args:\n",
        "        smiles (str): SMILES string of the molecule.\n",
        "\n",
        "    Returns:\n",
        "        dict: A dictionary containing all computed properties and analyses.\n",
        "    \"\"\"\n",
        "    # Initialize the molecule\n",
        "    molecule = Chem.MolFromSmiles(smiles)\n",
        "    if molecule is None:\n",
        "        raise ValueError(\"Invalid SMILES string provided.\")\n",
        "\n",
        "    # Dictionary to store all properties\n",
        "    properties = {}\n",
        "\n",
        "    # Basic descriptors\n",
        "    properties[\"Molecular Weight\"] = Descriptors.MolWt(molecule)\n",
        "    properties[\"LogP\"] = Crippen.MolLogP(molecule)\n",
        "    properties[\"Molecular Refractivity\"] = Crippen.MolMR(molecule)\n",
        "    properties[\"TPSA\"] = Descriptors.TPSA(molecule)\n",
        "    properties[\"Hydrogen Bond_Donors\"] = Lipinski.NumHDonors(molecule)\n",
        "    properties[\"Hydrogen_Bond Acceptors\"] = Lipinski.NumHAcceptors(molecule)\n",
        "    properties[\"Rotatable Bonds\"] = Lipinski.NumRotatableBonds(molecule)\n",
        "    properties[\"Chiral Centers\"] = len(Chem.FindMolChiralCenters(molecule))  # Count instead of list\n",
        "    properties[\"Total Atoms\"] = molecule.GetNumAtoms()  # Added total number of atoms\n",
        "\n",
        "    properties[\"Total Atoms\"] = molecule.GetNumAtoms()\n",
        "    properties[\"Heavy Atoms\"] = molecule.GetNumHeavyAtoms()\n",
        "    properties[\"Total Bonds\"] = molecule.GetNumBonds()\n",
        "    properties[\"Formal Charge\"] = Chem.rdmolops.GetFormalCharge(molecule)\n",
        "    properties[\"Total Rings\"] = molecule.GetRingInfo().NumRings()\n",
        "\n",
        "    # Structural alerts (PAINS/Brenk)\n",
        "    params = FilterCatalogParams()\n",
        "    params.AddCatalog(FilterCatalogParams.FilterCatalogs.PAINS)\n",
        "    params.AddCatalog(FilterCatalogParams.FilterCatalogs.BRENK)\n",
        "    catalog = FilterCatalog.FilterCatalog(params)\n",
        "\n",
        "    # Get all matches\n",
        "    matches = catalog.GetMatches(molecule)\n",
        "    if matches:\n",
        "        properties[\"Structural Alerts\"] = [entry.GetDescription() for entry in matches]\n",
        "    else:\n",
        "        properties[\"Structural Alerts\"] = \"None\"\n",
        "\n",
        "    # ========================\n",
        "    # NEW: Ring Composition Analysis\n",
        "    # ========================\n",
        "    ri = molecule.GetRingInfo()\n",
        "    aromatic_rings = 0\n",
        "    aliphatic_rings = 0\n",
        "\n",
        "    for ring in ri.AtomRings():\n",
        "        is_aromatic = True\n",
        "        for atom_idx in ring:\n",
        "            if not molecule.GetAtomWithIdx(atom_idx).GetIsAromatic():\n",
        "                is_aromatic = False\n",
        "                break\n",
        "        if is_aromatic:\n",
        "            aromatic_rings += 1\n",
        "        else:\n",
        "            aliphatic_rings += 1\n",
        "\n",
        "\n",
        "    properties[\"Aromatic Rings\"] = aromatic_rings\n",
        "    properties[\"Aliphatic Rings\"] = aliphatic_rings\n",
        "    # properties[\"Ring_Score\"] = (\n",
        "    #     \"Optimal\" if aromatic_rings == 2 and aliphatic_rings == 1\n",
        "    #     else \"Suboptimal\"\n",
        "    # )\n",
        "    return properties"
      ],
      "metadata": {
        "id": "MPRNGkYzS-4D",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "bd5461c0-ab29-4290-f252-13bff6360d02"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<frozen importlib._bootstrap>:241: RuntimeWarning: to-Python converter for boost::shared_ptr<RDKit::FilterHierarchyMatcher> already registered; second conversion method ignored.\n",
            "<frozen importlib._bootstrap>:241: RuntimeWarning: to-Python converter for boost::shared_ptr<RDKit::FilterCatalogEntry> already registered; second conversion method ignored.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample['status'] = df_sample['labels'].map({1: 'Approved', 0 :'Not Approved'})"
      ],
      "metadata": {
        "id": "Dc0_3mFsTBKM",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "d077fee0-4ecf-4980-8c9f-a2cf3081f2a7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-6-a2d5da308825>:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample['status'] = df_sample['labels'].map({1: 'Approved', 0 :'Not Approved'})\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"rdkit_info\"] = df_sample[\"SMILES\"].apply(lambda x: get_molecule_properties(x))"
      ],
      "metadata": {
        "id": "SdRBSRcFTEYb",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "3b936e8c-d3ee-47f1-a2c5-d1b2b3966974"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-7-54682dfed210>:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample[\"rdkit_info\"] = df_sample[\"SMILES\"].apply(lambda x: get_molecule_properties(x))\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"rdkit_info\"][0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "dIcKBCgKSmrR",
        "outputId": "a5ad6c43-55c5-44e9-c5b1-875fdc7ef474"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'Molecular Weight': 324.39900000000006,\n",
              " 'LogP': 3.812980000000003,\n",
              " 'Molecular Refractivity': 90.91400000000006,\n",
              " 'TPSA': 36.26,\n",
              " 'Hydrogen Bond_Donors': 0,\n",
              " 'Hydrogen_Bond Acceptors': 3,\n",
              " 'Rotatable Bonds': 5,\n",
              " 'Chiral Centers': 0,\n",
              " 'Total Atoms': 24,\n",
              " 'Heavy Atoms': 24,\n",
              " 'Total Bonds': 26,\n",
              " 'Formal Charge': 0,\n",
              " 'Total Rings': 3,\n",
              " 'Structural Alerts': 'None',\n",
              " 'Aromatic Rings': 2,\n",
              " 'Aliphatic Rings': 1}"
            ]
          },
          "metadata": {},
          "execution_count": 110
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "sys_prompt4 =\"\"\"\n",
        "You are a **chemist specializing in drug discovery and molecular modeling**, tasked with analyzing chemical compounds for drug-likeness and viability. Your assessment considers:\n",
        "\n",
        "1. **Drug-Likeness Rules**:\n",
        "   - **Lipinski’s Rule of Five** (MW, LogP, H-bond donors/acceptors).\n",
        "   - **Veber’s Rule** (PSA, rotatable bonds).\n",
        "   - **Ghose, Egan, and Rule of Three** (lead-like properties).\n",
        "   - **PAINS & Brenk Filters** (toxic/assay-interfering structures).\n",
        "\n",
        "2. **ADMET Profiling**:\n",
        "   - **Absorption** (solubility, permeability).\n",
        "   - **Distribution** (Vd, plasma protein binding).\n",
        "   - **Metabolism** (CYP450 interactions, stability).\n",
        "   - **Excretion** (renal, biliary clearance).\n",
        "   - **Toxicity** (hepatotoxicity, cardiotoxicity, Ames test).\n",
        "\n",
        "3. **Information From similar and dissimilar  drugs**\n",
        "\n",
        "\n",
        "Your goal is to determine the compound’s potential as a drug candidate by integrating these computational and experimental criteria. and predict it will be approved or not\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "7PXo3MeHTy1f"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sys_prompt5 = \"\"\"\n",
        "You are a **chemist specializing in drug discovery and molecular modeling**. your task is to predict wheather the compound will be approved or not.\n",
        "you should consider the following criteria:\n",
        "\n",
        "\n",
        "1. Drug-Likeness Rules(Weight: 30%):\n",
        "\n",
        "Assign 1 point per passed rule (e.g., Lipinski, Veber, Ghose).\n",
        "Normalize to total applicable rules (e.g., 8/12 rules passed = 0.67×30=20.1).\n",
        "\n",
        "2. Structural Alerts\n",
        "PAINS/Brenk Filters:\n",
        "\n",
        "No alerts: +10.\n",
        "\n",
        "Alerts present: -10.\n",
        "\n",
        "4. Model Similarity & Bias Adjustment (Weight: 40%):\n",
        "Adjusted Similarity Score=(Avg. Approved Sim×Precision−Avg. Unapproved Sim×(1 - Precision))\n",
        "\n",
        "5. Toxicity & Pharmacokinetics (Weight: 20%)\n",
        "Approved Similar Drugs:\n",
        "\n",
        "If ≥3/5 have low/acceptable toxicity: +15.\n",
        "\n",
        "Missing data assumed neutral (no penalty).\n",
        "\n",
        "Unapproved Similar Drugs:\n",
        "\n",
        "If ≥3/5 have high toxicity/unknown: +5.\n",
        "\n",
        "\n",
        "\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "P14Qs2nkQZa-"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sys_prompt6 = \"\"\"\n",
        "You are a **chemist specializing in drug discovery and molecular modeling**. your task is to predict wheather the compound will be approved or not.\n",
        "\n",
        "you should consider the following criteria:\n",
        "1. Drug-Likeness Rules:\n",
        "   - Lipinski’s Rule of Five (MW, LogP, H-bond donors/acceptors).\n",
        "   - Veber’s Rule (PSA, rotatable bonds).\n",
        "   - Ghose\n",
        "   - Egan\n",
        "\n",
        "    Assign 1 point per passed rule\n",
        "    Normalize to total applicable rules (e.g., 1/5 rules passed =0.20).\n",
        "\n",
        "\n",
        "2. ADMET Profiling:\n",
        "   - Absorption (solubility, permeability).\n",
        "   - Distribution (Vd, plasma protein binding).\n",
        "   - Metabolism (CYP450 interactions, stability).\n",
        "   - Excretion (renal, biliary clearance).\n",
        "   - Toxicity (hepatotoxicity, cardiotoxicity, Ames test).\n",
        "- PAINS & Brenk Filters (toxic/assay-interfering structures).\n",
        "\n",
        "\n",
        "3. Structural Alerts:\n",
        "    PAINS/Brenk Filters\n",
        "\n",
        "4. Model Similarity & Bias Adjustment:\n",
        "Adjusted Similarity Score=(Avg. Approved Sim×Precision−Avg. Unapproved Sim×(1 - Precision))\n",
        "\n",
        "5. Toxicity & Pharmacokinetics\n",
        "\n",
        "\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "r1AB8toYYkiF"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "sys_prompt7 = \"\"\"\n",
        "You are a **chemist specializing in drug discovery and molecular modeling**. your task is to predict wheather the compound will be approved or not.\n",
        "you should consider the following criteria:\n",
        "the total sum of scoring is 100. analysis the following information and return the score.\n",
        "1. **Drug-Likeness Rules**:\n",
        "   - **Lipinski’s Rule of Five** (MW, LogP, H-bond donors/acceptors).\n",
        "   - **Veber’s Rule** (PSA, rotatable bonds).\n",
        "   - **Ghose, Egan, and Rule of Three** (lead-like properties).\n",
        "   - **PAINS & Brenk Filters** (toxic/assay-interfering structures).\n",
        "\n",
        "2. **ADMET Profiling**:\n",
        "   - **Absorption** (solubility, permeability).\n",
        "   - **Distribution** (Vd, plasma protein binding).\n",
        "   - **Metabolism** (CYP450 interactions, stability).\n",
        "   - **Excretion** (renal, biliary clearance).\n",
        "   - **Toxicity** (hepatotoxicity, cardiotoxicity, Ames test).\n",
        "\n",
        "3. Structural AlertsP\n",
        "4. Model Similarity & Bias Adjustment\n",
        "5. Toxicity & Pharmacokinetics\n",
        "\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "sYU_3Y3OnNfr"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "## I should review step by step and check again."
      ],
      "metadata": {
        "id": "IkPCL0AdWwN2"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "########################################################################################################################\n",
        "########################################################################################################################\n",
        "########################################################################################################################\n",
        "\n",
        "\n",
        "n = 0\n",
        "\n",
        "\n",
        "\n",
        "########################################################################################################################\n",
        "########################################################################################################################\n",
        "########################################################################################################################"
      ],
      "metadata": {
        "id": "NSoWYxXTQZYo"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def get_first_prompt(list_of_most_approved_info_for_n_similar , list_of_most_nonapproved_info_for_n_similar,rdkit_info , sys_prompt):\n",
        "    prompt = f\"\"\"\n",
        "    {sys_prompt}\n",
        "\n",
        "    I have developed a model that can predict the drug likelibility of compound X.\n",
        "    to predict that I have trained a classifier on a dataset of approved and unapproved drugs. the model performance is {{'F1 score': 0.80,\n",
        "    'Accuracy': 0.69,\n",
        "    'Precision': 0.68,\n",
        "    'Recall': 0.975,\n",
        "    'AUC': 0.68,\n",
        "    'Specificity': 0.20}}\n",
        "    This model outputs two lists:\n",
        "    1. The five most similar approved small molecules (with their properties and similarity scores).\n",
        "    2. The five most similar non-approved small molecules (with their properties and similarity scores).\n",
        "\n",
        "    Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.\n",
        "\n",
        "    - RDKit Analysis of Compound X:\n",
        "    {rdkit_info}df[\"SMILES\"]\n",
        "\n",
        "    Using the provided data:\n",
        "    - Approved molecules (with similarity scores): {list_of_most_approved_info_for_n_similar}\n",
        "    - Non-approved molecules (with similarity scores): {list_of_most_nonapproved_info_for_n_similar}\n",
        "    \"\"\"\n",
        "    return prompt"
      ],
      "metadata": {
        "id": "MqPGF9l2HwVI"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"1st_prompt\"] = df_sample.apply(lambda x : get_first_prompt(x[\"list_of_most_approved_info_for_n_similar\"],x[\"list_of_most_nonapproved_info_for_n_similar\"], x[\"rdkit_info\"], sys_prompt6) ,axis = 1)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "F2T5F4-SJCMp",
        "outputId": "68d9f3c2-7ef1-4dfd-afce-474c1706ec89"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-15-077d09632c3a>:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample[\"1st_prompt\"] = df_sample.apply(lambda x : get_first_prompt(x[\"list_of_most_approved_info_for_n_similar\"],x[\"list_of_most_nonapproved_info_for_n_similar\"], x[\"rdkit_info\"], sys_prompt6) ,axis = 1)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 486
        },
        "id": "rBQ6wI6mRBh3",
        "outputId": "7b355c41-74ef-468c-ad95-f601aca233cb"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                              SMILES  labels  \\\n",
              "0            CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21       1   \n",
              "1  CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H...       1   \n",
              "2  CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c...       1   \n",
              "3                            CCCCCCCCCCCCCCCCCCCCCCO       1   \n",
              "4                            CC(C)(CO)C(O)C(=O)NCCCO       0   \n",
              "\n",
              "                                               Dicts  \\\n",
              "0  {'most_app':                                  ...   \n",
              "1  {'most_app':                                  ...   \n",
              "2  {'most_app':                                  ...   \n",
              "3  {'most_app':                                  ...   \n",
              "4  {'most_app':                                  ...   \n",
              "\n",
              "            list_of_most_approved_info_for_n_similar  \\\n",
              "0  [{'name': 'Escitalopram', 'similarity score': ...   \n",
              "1  [{'name': None, 'similarity score': 0.96003526...   \n",
              "2  [{'name': 'Atorvastatin', 'similarity score': ...   \n",
              "3  [{'name': 'Salmeterol', 'similarity score': 0....   \n",
              "4  [{'name': 'Dexpanthenol', 'similarity score': ...   \n",
              "\n",
              "         list_of_most_nonapproved_info_for_n_similar        status  \\\n",
              "0  [{'name': 'Cebranopadol', 'similarity score': ...      Approved   \n",
              "1  [{'name': None, 'similarity score': 0.83061236...      Approved   \n",
              "2  [{'name': 'Ritobegron', 'similarity score': 0....      Approved   \n",
              "3  [{'name': 'Ethanolamine oleate', 'similarity s...      Approved   \n",
              "4  [{'name': 'Duvoglustat', 'similarity score': 0...  Not Approved   \n",
              "\n",
              "                                          rdkit_info  \\\n",
              "0  {'Molecular Weight': 324.39900000000006, 'LogP...   \n",
              "1  {'Molecular Weight': 2296.970999999999, 'LogP'...   \n",
              "2  {'Molecular Weight': 392.49900000000014, 'LogP...   \n",
              "3  {'Molecular Weight': 326.60900000000004, 'LogP...   \n",
              "4  {'Molecular Weight': 205.25399999999996, 'LogP...   \n",
              "\n",
              "                                          1st_prompt  \n",
              "0  \\n    \\nYou are a **chemist specializing in dr...  \n",
              "1  \\n    \\nYou are a **chemist specializing in dr...  \n",
              "2  \\n    \\nYou are a **chemist specializing in dr...  \n",
              "3  \\n    \\nYou are a **chemist specializing in dr...  \n",
              "4  \\n    \\nYou are a **chemist specializing in dr...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-733dd6a9-cfec-40ca-b3ec-62776664f540\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>SMILES</th>\n",
              "      <th>labels</th>\n",
              "      <th>Dicts</th>\n",
              "      <th>list_of_most_approved_info_for_n_similar</th>\n",
              "      <th>list_of_most_nonapproved_info_for_n_similar</th>\n",
              "      <th>status</th>\n",
              "      <th>rdkit_info</th>\n",
              "      <th>1st_prompt</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Escitalopram', 'similarity score': ...</td>\n",
              "      <td>[{'name': 'Cebranopadol', 'similarity score': ...</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular Weight': 324.39900000000006, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H...</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': None, 'similarity score': 0.96003526...</td>\n",
              "      <td>[{'name': None, 'similarity score': 0.83061236...</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular Weight': 2296.970999999999, 'LogP'...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c...</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Atorvastatin', 'similarity score': ...</td>\n",
              "      <td>[{'name': 'Ritobegron', 'similarity score': 0....</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular Weight': 392.49900000000014, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>CCCCCCCCCCCCCCCCCCCCCCO</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Salmeterol', 'similarity score': 0....</td>\n",
              "      <td>[{'name': 'Ethanolamine oleate', 'similarity s...</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular Weight': 326.60900000000004, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>CC(C)(CO)C(O)C(=O)NCCCO</td>\n",
              "      <td>0</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Dexpanthenol', 'similarity score': ...</td>\n",
              "      <td>[{'name': 'Duvoglustat', 'similarity score': 0...</td>\n",
              "      <td>Not Approved</td>\n",
              "      <td>{'Molecular Weight': 205.25399999999996, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-733dd6a9-cfec-40ca-b3ec-62776664f540')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-733dd6a9-cfec-40ca-b3ec-62776664f540 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-733dd6a9-cfec-40ca-b3ec-62776664f540');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-ca5d2ed2-4e3d-45a9-9e74-d0cd0994d080\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-ca5d2ed2-4e3d-45a9-9e74-d0cd0994d080')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-ca5d2ed2-4e3d-45a9-9e74-d0cd0994d080 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df_sample",
              "summary": "{\n  \"name\": \"df_sample\",\n  \"rows\": 5,\n  \"fields\": [\n    {\n      \"column\": \"SMILES\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O\",\n          \"CC(C)(CO)C(O)C(=O)NCCCO\",\n          \"CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"labels\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 0,\n        \"min\": 0,\n        \"max\": 1,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          0,\n          1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Dicts\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"{'most_app':                                                  SMILES  labels       sim\\n1586  CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C...       1  0.960035\\n353   CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C...       1  0.953127\\n1959  CCC(C)CCCCC(=O)N(C)[C@@H](CCN)C(=O)N[C@@H](CN[...       1  0.952627\\n80    CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[...       1  0.949965\\n486   CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)...       1  0.842993, 'most_nonapp':                                                  SMILES  labels       sim\\n1265  CCCCCCCC(=O)OC[C@H](NC(=O)CNC(=O)[C@@H](N)CCCN...       0  0.830612\\n2181  CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]...       0  0.823622\\n2102  CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23...       0  0.804892\\n1873  CCCCCCC(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2...       0  0.795840\\n2221  CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H...       0  0.793728}\",\n          \"{'most_app':                                             SMILES  labels       sim\\n437                   CC(C)(CO)[C@@H](O)C(=O)NCCCO       1  0.958293\\n821       CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO       1  0.887804\\n2103        N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O       1  0.886478\\n669   N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O       1  0.882193\\n1294  CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2       1  0.878921, 'most_nonapp':                                                  SMILES  labels       sim\\n1882                OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O       0  0.866367\\n1044                 OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O       0  0.866367\\n911               Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O       0  0.865844\\n674   OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)...       0  0.864764\\n117                                  OCc1c[nH]c2ccccc12       0  0.861736}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"list_of_most_approved_info_for_n_similar\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"[{'name': None, 'similarity score': 0.9600352644920349, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.953127384185791, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.952626645565033, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.9499645233154297, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Bacitracin', 'similarity score': 0.8429930210113525, 'approval groups': ['approved', 'vet_approved'], 'average mass': 1422.693, 'half life': 'Data regarding the half life of bacitracin in humans is not readily available.[A181997]', 'toxicity': 'The oral LD<sub>50</sub> of bacitracin in rats is >2000mg/kg.[L7775]\\\\r\\\\n\\\\r\\\\nSpecific data regarding bacitracin overdoses is not readily available.[T662] An overdose of bacitracin may lead to nephrotoxicity[A181997] and patients should be treated with supportive measures.', 'indication': 'Bacitracin is indicated in topical formulations for acute and chronic localized skin infections.[A181997] Occasionally, it is also used intramuscularly for infantile streptococcal pneumonia and empyema.[A181997] Bacitracin is also formulated as an ointment with neomycin and polymyxin B for over the counter use.[A181997,L7769] A bacitracin ointment formulated with neomycin and polymyxin B along with hydrocortisone is indicated for the treatment of corticosteroid responsive dermatoses with secondary infection.[L7772]', 'pharmacodynamics': 'Bacitracin is a mixture of polypeptides that prevent the formation of the bacterial cell wall and oxidatively cleave DNA.[A954] It has a short duration of action as it must be given every 3 to 4 hours topically.[L7769,L7772] Bacitracin is nephrotoxic when given intramuscularly and may lead to renal failure.[A181997]', 'mechanism of action': 'Bacitracin binds to a divalent metal ion such as Mn(II), Co(II), Ni(II), Cu(II), or Zn(II).[A954] These complexes bind C<sub>55</sub>-isoprenyl pyrophosphate, preventing the hydrolysis of a lipid dolichol pyrophosphate, which finally inhibits cell wall synthesis.[A954] Bacitracin metal complexes also bind and oxidatively cleave DNA.[A954]', 'metabolism': 'Data regarding the metabolism of bacitracin in humans is not readily available.[A181997] Because bacitracin is a protein it is expected to be metabolized into smaller polypeptides and amino acids.[A182009] However, the structure of bacitracin may afford it some protection from the action of proteases.[A954]', 'descriptions': 'Bacitracin is a combination of at least 9 bacitracins.[A955,A181952] 60-80% of commercially prepared bacitracin is bacitracin A.[A181952] The bacillus that produces bacitracin was first isolated from a knee scrape in 1945 from the knee wound of a child named Margaret Tracy.[A181952]\\\\r\\\\n\\\\r\\\\nBacitracin was granted FDA approval on 29 July 1948.[A181997,L7748]'}]\",\n          \"[{'name': 'Dexpanthenol', 'similarity score': 0.958292543888092, 'approval groups': ['approved'], 'average mass': 205.2515, 'half life': 'Half life have not been reported', 'toxicity': 'Mouse LD50 : 9gm/kg (Intraperitoneal)\\\\r\\\\nMouse: LD50 7gm/kg (Intravenous)\\\\r\\\\nMouse: LD50 15gm/kg (Oral)\\\\r\\\\nRabbit LD50 4gm/kg (Oral)', 'indication': 'Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.\\\\r\\\\n\\\\r\\\\nTopical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy). ', 'pharmacodynamics': 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'mechanism of action': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373].  \\\\r\\\\n\\\\r\\\\nDermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n', 'metabolism': 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.', 'descriptions': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373]. \\\\r\\\\n\\\\r\\\\nDue to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n\\\\r\\\\nDexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as [DB11204]. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.'}, {'name': 'Miglustat', 'similarity score': 0.8878036737442017, 'approval groups': ['approved'], 'average mass': 219.278, 'half life': 'The effective half-life of miglustat is approximately 6 to 7 hours.', 'toxicity': 'Miglustat has been administered at doses of up to 3000 mg/day (approximately 10 times the recommended starting dose administered to Gaucher patients) for up to six months in Human Immunodeficiency Virus (HIV)-positive patients. Adverse events observed in the HIV studies included granulocytopenia, dizziness, and paresthesia. Leukopenia and neutropenia have also been observed in a similar group of patients receiving 800 mg/day or above.', 'indication': \\\"For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C). \\\", 'pharmacodynamics': \\\"Miglustat, an N-alkylated imino sugar, is a synthetic analogue of D-glucose. Miglustat is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for catalyzing the formation of glucosylceramide (glucocerebroside). Glucosylceramide is a substrate for the endogenous glucocerebrosidase, an enzyme that is deficient in Gaucher's disease. The accumulation of glucosylceramide due to the absence of glucocerebrosidase results in the storage of this material in the lysosomes of tissue macrophages, leading to widespread pathology due to infiltration of lipid-engorged macrophages in the viscera, lymph nodes, and bone marrow. This results in secondary hematologic consequences including sever anemia and thrombocytopenia, in addition to the characteristic progressive hepatosplenomegaly, as well as skeletal complications including osteonecrosis and osteopenia with secondary pathological fractures.\\\", 'mechanism of action': 'Miglustat functions as a competitive and reversible inhibitor of the enzyme glucosylceramide synthase, the initial enzyme in a series of reactions which results in the synthesis of most glycosphingolipids. The goal of treatment with miglustat is to reduce the rate of glycosphingolipid biosynthesis so that the amount of glycosphingolipid substrate is reduced to a level which allows the residual activity of the deficient glucocerebrosidase enzyme to be more effective (substrate reduction therapy), reducing the accumulation of glucocerebroside in macrophages. In vitro and in vivo studies have shown that miglustat can reduce the synthesis of glucosylceramide-based glycosphingolipids. In clinical trials, miglustat improved liver and spleen volume, as well as hemoglobin concentration and platelet count. Inhibition of glycosphingolipid synthesis has also shown to reduce intracellular lipid storage, improve fluid-phase endosomal uptake and normalize lipid transport in peripheral blood B lymphocytes of NP-C patients, which results in a decrease in the potentially neurotoxic accumulation of gnagliosides G<sub>M2</sub> and G<sub>M3</sub>, lactosylceramide and glucosylceramide, possibly preventing further neuronal damage. Other studies have also suggested that miglustat may indirectly modulate intracellular calcium homeostasis through its effects on glucosylceramide levels, and evidence has shown that an initiating factor in the pathogenesis of NP-C may be impaired calcium homeostasis related to sphingosine storage. Therefore, the effect that miglustat exerts on intracellular calcium levels may influence an important underlying pathogenic mechanism of NP-C.', 'metabolism': 'There is no evidence that miglustat is metabolized in humans.', 'descriptions': 'Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. Miglustat was first developed as an anti-HIV agent in the 1990s. However, clinical experience with miglustat showed that therapeutic levels of the drug could not be achieved in patients without a high incidence of adverse effect.'}, {'name': 'Glucosamine', 'similarity score': 0.8864784836769104, 'approval groups': ['approved', 'investigational'], 'average mass': 179.1711, 'half life': 'The estimated half-life for glucosamine is 15 hours after an oral dose.[A232279] After a bolus intravenous injection of 1005 mg crystalline glucosamine sulfate, the parent drug has an apparent half life of 1.11 hours.[A232274]', 'toxicity': 'The oral LD50 of glucosamine in rats is >5000 mg/kg.[L32684] Symptoms of an overdose with glucosamine may include nausea, vomiting, abdominal pain, and diarrhea (common side effects of this drug). Severe and life-threatening hypersensitivity reactions to glucosamine may occur in patients with a shellfish allergy or asthma.[L32774]', 'indication': 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'pharmacodynamics': 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'mechanism of action': 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-\\u03baB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'metabolism': 'Glucosamine undergoes metabolism in the liver.[A232274] Metabolism information for glucosamine is limited in the literature.', 'descriptions': 'Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation.[A232289] Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional benefits to nonsteroidal anti-inflammatory drugs treating the painful symptoms of OA. Glucosamine is commonly used over the counter as a treatment for arthritic joint pain, although its acceptance as a medical therapy varies due to contradictory and findings with unclear clinical significance during clinical trials.[A231894,A232289] It is currently not approved as a prescription product by the FDA, but is widely available over the counter.'}, {'name': None, 'similarity score': 0.8821925520896912, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Nadolol', 'similarity score': 0.8789207935333252, 'approval groups': ['approved'], 'average mass': 309.4006, 'half life': 'The half life of nadolol is 20 to 24 hours.[L7922,L7925]', 'toxicity': 'The oral LD<sub>50</sub> in mice is 4500mg/kg.[L7934]\\\\r\\\\n\\\\r\\\\nPatients experiencing an overdose may present with bradycardia, cardiac failure, hypotension, and bronchospasm.[L7922,L7925] An overdose may be treated with atropine for bradycardia, digitalis and diuretics for cardiac failure, vasopressors for hypotension, and beta-2 stimulants for bronchospasms, as well as gastric lavage and hemodialysis.[L7922,L7925]', 'indication': 'Nadolol is indicated to treat angina pectoris and hypertension.[L7922] Another product formulated with [bendroflumethiazide] is indicated to treat hypertension.[L7925]', 'pharmacodynamics': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] It has a long duration of action as it is usually taken once daily and a wide therapeutic index as patients start at doses of 40mg daily but may be increased to doses as high as 240mg daily.[L7922,L7925] Patients taking nadolol should not aburptly stop taking it as this may lead to exacerbation of ischemic heart disease.[L7922,L7925]', 'mechanism of action': 'Although nadolol is described as a non selective beta blocker, it does not interact with beta 3 adrenal receptors.[A182402] Antagonism of beta-1 and beta-2 adrenoceptors in the heart inhibits cyclic AMP and its signalling pathway, decreasing the strength and speed of contractions as well as the speed of relaxation and conduction.[A34177] Antagonism of beta-2 adrenoceptors in the smooth muscle cells of the vasculature inhibits their relaxation, leading to an increase in peripheral vascular resistance and reducing the risk of severe hypotension.[A34177] The increase in peripheral vascular resistance may contribute to the decrease in insulin sensitivity associated with nadolol use.[A182441] Antagonism of beta-1 adrenoceptors in the juxtaglomerular apparatus of the kidney inhibits the release of renin, and therefore angiotensin II mediated vasoconstriction, aldosterone mediated water retention, and the release of epinephrine.[A34177] Antagonism of beta-2 adrenoceptors in the liver and skeletal muscle inhibits glycogenolysis, in the lungs prevents bronchodilation, and in the pancrease inhibits insulin release.[A34177]', 'metabolism': 'Nadolol is not metabolized by the liver in humans.[A182423,L7922,L7925]', 'descriptions': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects.[A34177]\\\\r\\\\n\\\\r\\\\nNadolol was granted FDA approval on 10 December 1979.[L7922]'}]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"list_of_most_nonapproved_info_for_n_similar\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"[{'name': None, 'similarity score': 0.8306123614311218, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.8236221671104431, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Murepavadin', 'similarity score': 0.8048920631408691, 'approval groups': ['investigational'], 'average mass': 1553.837, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).'}, {'name': 'PL-3994', 'similarity score': 0.7958396673202515, 'approval groups': ['investigational'], 'average mass': 1875.21, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).'}, {'name': None, 'similarity score': 0.793728232383728, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}]\",\n          \"[{'name': 'Duvoglustat', 'similarity score': 0.8663665652275085, 'approval groups': ['investigational'], 'average mass': 163.1717, 'half life': '', 'toxicity': 'ORL-RAT LD<sub>50</sub>: &gt; 5g/kg.\\\\r\\\\n', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.'}, {'name': 'Migalastat', 'similarity score': 0.8663665652275085, 'approval groups': ['approved', 'investigational'], 'average mass': 163.1717, 'half life': 'The mean elimination half-life (t1/2) of migalastat ranges from approximately 3 to 5 hours for a single oral dose of 150 mg.[L47057] For the dose of 123 mg, the mean elimination half-life was estimated to be 4 hours.[L47036]', 'toxicity': 'The most common adverse reactions reported with migalastat (\\u2265 10%) during the 6-month placebo-controlled, double-blind phase of its Study 1 clinical studies were headache, nasopharyngitis, urinary tract infection, nausea, and pyrexia [FDA Label, F1107].\\\\r\\\\n\\\\r\\\\nIn case of overdose, general medical care is recommended [FDA Label, F1107]. Headache and dizziness were the most common adverse reactions reported at doses of migalastat of up to 1250 mg and 2000 mg, respectively [FDA Label, F1107].', 'indication': 'Migalastat is approved by the FDA for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.[L47036] \\\\r\\\\n\\\\r\\\\nThis indication is approved under accelerated approval based on a reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.[L47036]\\\\r\\\\n\\\\r\\\\nMigalastat is also approved by the EMA and Health Canada to treat the same disease, although it is approved for both adults and adolescents aged 16 years and older in Europe.[L47057,L47087]', 'pharmacodynamics': 'In general, treatment in patients with migalastat in Phase 2 pharmacodynamic trials resulted in increases in endogenous alpha-galactosidase (alpha-Gal A) activity in white blood cells, as well as in skin and kidney for the majority of patients [FDA Label, F1107]. In patients with amenable galactosidase alpha gene (GLA) mutations, globotriaosylceramide (GL-3) levels tended to decrease in the urine and in the kidney interstitial capillaries.[L47057]\\\\r\\\\n\\\\r\\\\nIn an in vitro assay (HEK-293 assay), Human Embryonic Kidney (HEK-293) cell lines were transfected with specific GLA variants (mutations) which produced mutant alpha-Gal A proteins. In the transfected cells, amenability of the GLA variants was assessed after a 5-day incubation with 10 micromol/L migalastat. A GLA variant was categorized as amenable if the resultant mutant alpha-Gal A activity (measured in the cell lysates) met two criteria: 1) it showed a relative increase of at least 20% compared to the pre-treatment alpha-Gal A activity, and 2) it showed an absolute increase of at least 3% of the wild-type (normal) alpha-Gal activity. The in vitro assay did not evaluate the trafficking of the mutant alpha-Gal A proteins into the lysosome or the dissociation of migalastat from the mutant alpha-Gal A proteins within the lysosome. Also, the in vitro assay did not test whether a GLA variant causes Fabry disease or not.[L47036] ', 'mechanism of action': 'Fabry disease is a progressive X-linked lysosomal storage disorder that affects males and females [FDA Label, F1107]. Fabry disease-causing mutations occur in the galactosidase alpha (GLA) gene and result in a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) that is required for glycosphingolipid substrate (GL-3 and lyso-Gb3) metabolism [FDA Label, F1107]. Reduced alpha-Gal A activity is, therefore, associated with the progressive accumulation of glycosphingolipid substrate in vulnerable organs and tissues, which ultimately leads to the morbidity and mortality associated with Fabry disease.[L47057]\\\\r\\\\n\\\\r\\\\nMigalastat is a pharmacological chaperone that reversibly binds to the active site of the alpha-galactosidase A (alpha-Gal A) protein (encoded by the galactosidase alpha gene, GLA), which is deficient in Fabry disease. This binding stabilizes alpha-Gal A allowing its trafficking from the endoplasmic reticulum into the lysosome where it exerts its action. In the lysosome, at a lower pH and at a higher concentration of relevant substrates, migalastat dissociates from alpha-Gal A allowing it to break down the glycosphingolipids globotriaosylceramide (GL-3) and globotriaosylsphingosine (lyso-Gb3). Certain GLA variants (mutations) causing Fabry disease result in the production of abnormally folded and less stable forms of the alpha-Gal A protein which, however, retain enzymatic activity. Those GLA variants, referred to as amenable variants, produce alpha-Gal A proteins that may be stabilized by migalastat thereby restoring their trafficking to lysosomes and their intralysosomal activity.[L47036] \\\\r\\\\n\\\\r\\\\nThe GLA mutations that are amenable and not amenable to treatment with migalastat are regularly maintained and updated on online sites that are readily accessible by healthcare providers.[L47036]   ', 'metabolism': 'Based upon in vivo data, migalastat is a substrate for uridine diphosphate glucuronosyltransferase (otherwise known as UGT or UDPGT), being a minor elimination pathway.[L47036]', 'descriptions': \\\"Fabry disease is a rare, progressive genetic disorder characterized by a defective GLA gene that causes a deficiency in the enzyme alpha-Galactosidase A (alpha-Gal A). This enzyme is responsible for breaking down glycosphingolipid substrate that, when deficient in patients with Fabry disease, builds up in the blood vessels, the kidneys, the nerves, the heart, and other organs.[L47036,L47057,L4274,L4278] In the U.S., it is estimated that more than 3,000 people are living with Fabry disease, and an estimated more than 50 percent of these diagnosed patients are currently untreated.[L4274]\\\\r\\\\n\\\\r\\\\nMigalastat (approved and sold under Amicus Therapeutics' brand name Galafold) is subsequently an oral pharmacological chaperone of alpha-Gal A for the treatment of Fabry disease in adults who have amenable GLA variants.[L47036,L47057,L4274,L4278] In these patients, migalastat works by stabilizing the body\\u2019s dysfunctional alpha-Gal A enzyme so that it can clear the accumulation of glycosphingolipid disease substrate.[L47036,L47057,L4274,L4278] Globally, it is estimated that approximately 35 to 50 percent of Fabry patients may have amenable GLA variants that are treatable with migalastat. [L4274]\\\\r\\\\n\\\\r\\\\nGiven the rarity of Fabry disease and the proportion of Fabry disease patients that could benefit from migalastat therapy, Amicus Therapeutics' brand name Galafold was approved using the Accelerated Approval pathway, under which the FDA may approve drugs for serious conditions where there is an unmet medical need and where a drug is shown to have certain effects that are reasonably likely to predict a clinical benefit to patients.[L47036,L47057,L4274,L4278] A further study is required to verify and describe the clinical benefits of Galafold, and the sponsor will be conducting a confirmatory clinical trial of Galafold in adults with Fabry disease.[L47036,L47057,L4274,L4278]\\\\r\\\\n\\\\r\\\\nAdditionally, Galafold was also granted Priority Review designation, under which the FDA\\u2019s goal is to take action on an application within six months of application filing where the agency determines that the drug if approved, would provide a significant improvement in treating, diagnosing or preventing a serious condition over available therapies.[L47036,L47057] Galafold also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.[L47036,L47057]\\\\r\\\\n\\\\r\\\\nAs of August 2018, migalastat under Amicus Therapeutics' brand name Galafold is currently approved in Australia, Canada, European Union, Israel, Japan, South Korea, Switzerland, and the United States.[L4274]\\\"}, {'name': None, 'similarity score': 0.8658441305160522, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Arbutin', 'similarity score': 0.8647643327713013, 'approval groups': ['approved'], 'average mass': 272.2512, 'half life': 'No pharmacokinetic data available. ', 'toxicity': 'In an acute oral toxicity study, the LD50-value for \\u03b2-arbutin is 9804 mg/kg bw for the mouse and 8715 mg/kg bw for the rat [F44]. Dermal LD50 value in rat and mouse was reported to be greater than 928 mg/kg bw, according to an acute dermal toxicity study [F44]. Extremely high doses may cause ringing in the ears, shortness of breath, convulsions, collapse, vomiting and delirium [F43]. Nausea and vomiting were seen individuals with sensitive stomachs following oral ingestion of 15 g of dried uva ursi leaves that contain arbutin [F43]. ', 'indication': 'Indicated for over-the-counter use for epidermal hyperpigmentation in various skin conditions, such as melasma, freckles, and senile lentigines. ', 'pharmacodynamics': 'At non-toxic concentrations, arbutin inhibited the activity of tyrosinase in cultured human keratinocytes, while having minimal effect on the expression of tyrosinase mRNA or the synthesis of the enzyme [A27248]. \\u03b1-Arbutin produced a concentration-dependent inhibition of melanin synthesis of human melanoma cells, HMV-II [A32939]. No inhibitory effect on HMV-II cell growth was seen at concentrations lower than 1.0 mM. At concentrations of 0.5 mM of arbutin, tyrosinase activity was reduced to 60% of that in non-treated cells [A32939]. The addition of arbutin blocked and inhibited \\u03b1-MSH-stimulated melanogenesis in B16 melanoma cells, brownish guinea pig, and human skin tissue [A32940]. In a pilot study of healthy male adults exposed to UV B irradiation, topical administration of arbutin inhibited UV-induced nuclear factor-kappaB activation in human keratinocytes [F43]. In mouse skin, arbutin counteracted oxidative stress induced by 12-O-tetradecanoylphorbol-13-acetate [F43].', 'mechanism of action': 'Arbutin is a hydroquinone glycoside, however the hydroquinone moiety is not solely responsible for the de-pigmentating actions of arbutin [A32942]. It acts as a competitive inhibitor of tyrosinase enzyme by acting on the L-tyrosine binding site to suppress melanogenesis and mediate its de-pigmenting actions on human skin [A27248]. Tyrosinase is an enzyme involved in the regulation of rate-limiting steps during the synthesis of melanin; it regulates the conversion of L-tyrosine into L-dopa, and subsequent conversion of L-dopa to L-dopaquinone [A27248]. Via inhibition of tyrosinase activity in a concentration-dependent manner, arbutin attenuates the production of melanin in melanocytes. While most studies suggest that arbutin has negligible effect on the tyrosinase mRNA expression, a study assessing the effect of arbutin on melanocyte differentiation inducement system using ES cells propose that arbutin may also downregulate the expression of tyrosinase in addition to its inhibitory action on the enzyme [A32938]. The contradictory findings across studies may be due to previous studies using terminally-differentiated melanocytes and melanoma cells [A32938]. ', 'metabolism': 'Arbutin is readily susceptible to hydrolysis in dilute acids to yield D-glucose and hydroquinone. It is expected that orally administered arbutin is easily hydrolyzed to free hydroquinone molecules by stomach acid [F43]. Hydroquinone is further metabolized into the main metabolites, hydroquinone glucuronide and hydroquinone sulfate [F43]. ', 'descriptions': 'Extracted from the dried leaves of bearberry plant in the genus _Arctostaphylos_ and other plants commonly in the _Ericaceae_ family, arbutin is a beta-D-glucopyranoside of [DB09526]. It is found in foods, over-the-counter drugs, and herbal dietary supplements [F43]. Most commonly, it is an active ingredient in skincare and cosmetic products as a skin-lightening agent for the prevention of melanin formation in various skin conditions that involve cutaneous hyperpigmentation or hyperactive melanocyte function [A27248]. It has also been used as an anti-infective for the urinary system as well as a diuretic [F43]. Arbutin is available in both natural and synthetic forms; it can be synthesized from acetobromglucose and [DB09526] [F43]. Arbutin is a competitive inhibitor of tyrosinase (E.C.1.14.18.1) in melanocytes [A27248], and the inhibition of melanin synthesis at non-toxic concentrations was observed _in vitro_. Arbutin was shown to be less cytotoxic to melanocytes in culture compared to [DB09526] [A32942].'}, {'name': 'Indole-3-carbinol', 'similarity score': 0.8617359399795532, 'approval groups': ['investigational'], 'average mass': 147.1739, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).'}]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"status\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"Not Approved\",\n          \"Approved\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"rdkit_info\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"1st_prompt\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\n    \\nYou are a **chemist specializing in drug discovery and molecular modeling**. your task is to predict wheather the compound will be approved or not.\\n\\nyou should consider the following criteria:\\n1. Drug-Likeness Rules:\\n   - Lipinski\\u2019s Rule of Five (MW, LogP, H-bond donors/acceptors).\\n   - Veber\\u2019s Rule (PSA, rotatable bonds).\\n   - Ghose\\n   - Egan\\n\\n    Assign 1 point per passed rule\\n    Normalize to total applicable rules (e.g., 1/5 rules passed =0.20).\\n\\n\\n2. ADMET Profiling:\\n   - Absorption (solubility, permeability).\\n   - Distribution (Vd, plasma protein binding).\\n   - Metabolism (CYP450 interactions, stability).\\n   - Excretion (renal, biliary clearance).\\n   - Toxicity (hepatotoxicity, cardiotoxicity, Ames test).\\n- PAINS & Brenk Filters (toxic/assay-interfering structures).\\n\\n\\n3. Structural Alerts:\\n    PAINS/Brenk Filters\\n\\n4. Model Similarity & Bias Adjustment:\\nAdjusted Similarity Score=(Avg. Approved Sim\\u00d7Precision\\u2212Avg. Unapproved Sim\\u00d7(1 - Precision))\\n\\n5. Toxicity & Pharmacokinetics\\n\\n\\n\\n\\n    I have developed a model that can predict the drug likelibility of compound X.\\n    to predict that I have trained a classifier on a dataset of approved and unapproved drugs. the model performance is {'F1 score': 0.80,\\n    'Accuracy': 0.69,\\n    'Precision': 0.68,\\n    'Recall': 0.975,\\n    'AUC': 0.68,\\n    'Specificity': 0.20}\\n    This model outputs two lists:\\n    1. The five most similar approved small molecules (with their properties and similarity scores).\\n    2. The five most similar non-approved small molecules (with their properties and similarity scores).\\n\\n    Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.\\n\\n    - RDKit Analysis of Compound X:\\n    {'Molecular Weight': 2296.970999999999, 'LogP': -10.32609999999995, 'Molecular Refractivity': 606.0736000000024, 'TPSA': 947.18, 'Hydrogen Bond_Donors': 36, 'Hydrogen_Bond Acceptors': 36, 'Rotatable Bonds': 59, 'Chiral Centers': 24, 'Total Atoms': 161, 'Heavy Atoms': 161, 'Total Bonds': 161, 'Formal Charge': 0, 'Total Rings': 2, 'Structural Alerts': ['Aliphatic_long_chain'], 'Aromatic Rings': 0, 'Aliphatic Rings': 2}df[\\\"SMILES\\\"]\\n\\n    Using the provided data:\\n    - Approved molecules (with similarity scores): [{'name': None, 'similarity score': 0.9600352644920349, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.953127384185791, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.952626645565033, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.9499645233154297, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Bacitracin', 'similarity score': 0.8429930210113525, 'approval groups': ['approved', 'vet_approved'], 'average mass': 1422.693, 'half life': 'Data regarding the half life of bacitracin in humans is not readily available.[A181997]', 'toxicity': 'The oral LD<sub>50</sub> of bacitracin in rats is >2000mg/kg.[L7775]\\\\r\\\\n\\\\r\\\\nSpecific data regarding bacitracin overdoses is not readily available.[T662] An overdose of bacitracin may lead to nephrotoxicity[A181997] and patients should be treated with supportive measures.', 'indication': 'Bacitracin is indicated in topical formulations for acute and chronic localized skin infections.[A181997] Occasionally, it is also used intramuscularly for infantile streptococcal pneumonia and empyema.[A181997] Bacitracin is also formulated as an ointment with neomycin and polymyxin B for over the counter use.[A181997,L7769] A bacitracin ointment formulated with neomycin and polymyxin B along with hydrocortisone is indicated for the treatment of corticosteroid responsive dermatoses with secondary infection.[L7772]', 'pharmacodynamics': 'Bacitracin is a mixture of polypeptides that prevent the formation of the bacterial cell wall and oxidatively cleave DNA.[A954] It has a short duration of action as it must be given every 3 to 4 hours topically.[L7769,L7772] Bacitracin is nephrotoxic when given intramuscularly and may lead to renal failure.[A181997]', 'mechanism of action': 'Bacitracin binds to a divalent metal ion such as Mn(II), Co(II), Ni(II), Cu(II), or Zn(II).[A954] These complexes bind C<sub>55</sub>-isoprenyl pyrophosphate, preventing the hydrolysis of a lipid dolichol pyrophosphate, which finally inhibits cell wall synthesis.[A954] Bacitracin metal complexes also bind and oxidatively cleave DNA.[A954]', 'metabolism': 'Data regarding the metabolism of bacitracin in humans is not readily available.[A181997] Because bacitracin is a protein it is expected to be metabolized into smaller polypeptides and amino acids.[A182009] However, the structure of bacitracin may afford it some protection from the action of proteases.[A954]', 'descriptions': 'Bacitracin is a combination of at least 9 bacitracins.[A955,A181952] 60-80% of commercially prepared bacitracin is bacitracin A.[A181952] The bacillus that produces bacitracin was first isolated from a knee scrape in 1945 from the knee wound of a child named Margaret Tracy.[A181952]\\\\r\\\\n\\\\r\\\\nBacitracin was granted FDA approval on 29 July 1948.[A181997,L7748]'}]\\n    - Non-approved molecules (with similarity scores): [{'name': None, 'similarity score': 0.8306123614311218, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.8236221671104431, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Murepavadin', 'similarity score': 0.8048920631408691, 'approval groups': ['investigational'], 'average mass': 1553.837, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).'}, {'name': 'PL-3994', 'similarity score': 0.7958396673202515, 'approval groups': ['investigational'], 'average mass': 1875.21, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).'}, {'name': None, 'similarity score': 0.793728232383728, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}]\\n    \",\n          \"\\n    \\nYou are a **chemist specializing in drug discovery and molecular modeling**. your task is to predict wheather the compound will be approved or not.\\n\\nyou should consider the following criteria:\\n1. Drug-Likeness Rules:\\n   - Lipinski\\u2019s Rule of Five (MW, LogP, H-bond donors/acceptors).\\n   - Veber\\u2019s Rule (PSA, rotatable bonds).\\n   - Ghose\\n   - Egan\\n\\n    Assign 1 point per passed rule\\n    Normalize to total applicable rules (e.g., 1/5 rules passed =0.20).\\n\\n\\n2. ADMET Profiling:\\n   - Absorption (solubility, permeability).\\n   - Distribution (Vd, plasma protein binding).\\n   - Metabolism (CYP450 interactions, stability).\\n   - Excretion (renal, biliary clearance).\\n   - Toxicity (hepatotoxicity, cardiotoxicity, Ames test).\\n- PAINS & Brenk Filters (toxic/assay-interfering structures).\\n\\n\\n3. Structural Alerts:\\n    PAINS/Brenk Filters\\n\\n4. Model Similarity & Bias Adjustment:\\nAdjusted Similarity Score=(Avg. Approved Sim\\u00d7Precision\\u2212Avg. Unapproved Sim\\u00d7(1 - Precision))\\n\\n5. Toxicity & Pharmacokinetics\\n\\n\\n\\n\\n    I have developed a model that can predict the drug likelibility of compound X.\\n    to predict that I have trained a classifier on a dataset of approved and unapproved drugs. the model performance is {'F1 score': 0.80,\\n    'Accuracy': 0.69,\\n    'Precision': 0.68,\\n    'Recall': 0.975,\\n    'AUC': 0.68,\\n    'Specificity': 0.20}\\n    This model outputs two lists:\\n    1. The five most similar approved small molecules (with their properties and similarity scores).\\n    2. The five most similar non-approved small molecules (with their properties and similarity scores).\\n\\n    Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.\\n\\n    - RDKit Analysis of Compound X:\\n    {'Molecular Weight': 205.25399999999996, 'LogP': -1.1355999999999997, 'Molecular Refractivity': 51.58610000000003, 'TPSA': 89.79, 'Hydrogen Bond_Donors': 4, 'Hydrogen_Bond Acceptors': 4, 'Rotatable Bonds': 6, 'Chiral Centers': 0, 'Total Atoms': 14, 'Heavy Atoms': 14, 'Total Bonds': 13, 'Formal Charge': 0, 'Total Rings': 0, 'Structural Alerts': ['Aliphatic_long_chain'], 'Aromatic Rings': 0, 'Aliphatic Rings': 0}df[\\\"SMILES\\\"]\\n\\n    Using the provided data:\\n    - Approved molecules (with similarity scores): [{'name': 'Dexpanthenol', 'similarity score': 0.958292543888092, 'approval groups': ['approved'], 'average mass': 205.2515, 'half life': 'Half life have not been reported', 'toxicity': 'Mouse LD50 : 9gm/kg (Intraperitoneal)\\\\r\\\\nMouse: LD50 7gm/kg (Intravenous)\\\\r\\\\nMouse: LD50 15gm/kg (Oral)\\\\r\\\\nRabbit LD50 4gm/kg (Oral)', 'indication': 'Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.\\\\r\\\\n\\\\r\\\\nTopical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy). ', 'pharmacodynamics': 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'mechanism of action': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373].  \\\\r\\\\n\\\\r\\\\nDermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n', 'metabolism': 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.', 'descriptions': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373]. \\\\r\\\\n\\\\r\\\\nDue to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n\\\\r\\\\nDexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as [DB11204]. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.'}, {'name': 'Miglustat', 'similarity score': 0.8878036737442017, 'approval groups': ['approved'], 'average mass': 219.278, 'half life': 'The effective half-life of miglustat is approximately 6 to 7 hours.', 'toxicity': 'Miglustat has been administered at doses of up to 3000 mg/day (approximately 10 times the recommended starting dose administered to Gaucher patients) for up to six months in Human Immunodeficiency Virus (HIV)-positive patients. Adverse events observed in the HIV studies included granulocytopenia, dizziness, and paresthesia. Leukopenia and neutropenia have also been observed in a similar group of patients receiving 800 mg/day or above.', 'indication': \\\"For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C). \\\", 'pharmacodynamics': \\\"Miglustat, an N-alkylated imino sugar, is a synthetic analogue of D-glucose. Miglustat is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for catalyzing the formation of glucosylceramide (glucocerebroside). Glucosylceramide is a substrate for the endogenous glucocerebrosidase, an enzyme that is deficient in Gaucher's disease. The accumulation of glucosylceramide due to the absence of glucocerebrosidase results in the storage of this material in the lysosomes of tissue macrophages, leading to widespread pathology due to infiltration of lipid-engorged macrophages in the viscera, lymph nodes, and bone marrow. This results in secondary hematologic consequences including sever anemia and thrombocytopenia, in addition to the characteristic progressive hepatosplenomegaly, as well as skeletal complications including osteonecrosis and osteopenia with secondary pathological fractures.\\\", 'mechanism of action': 'Miglustat functions as a competitive and reversible inhibitor of the enzyme glucosylceramide synthase, the initial enzyme in a series of reactions which results in the synthesis of most glycosphingolipids. The goal of treatment with miglustat is to reduce the rate of glycosphingolipid biosynthesis so that the amount of glycosphingolipid substrate is reduced to a level which allows the residual activity of the deficient glucocerebrosidase enzyme to be more effective (substrate reduction therapy), reducing the accumulation of glucocerebroside in macrophages. In vitro and in vivo studies have shown that miglustat can reduce the synthesis of glucosylceramide-based glycosphingolipids. In clinical trials, miglustat improved liver and spleen volume, as well as hemoglobin concentration and platelet count. Inhibition of glycosphingolipid synthesis has also shown to reduce intracellular lipid storage, improve fluid-phase endosomal uptake and normalize lipid transport in peripheral blood B lymphocytes of NP-C patients, which results in a decrease in the potentially neurotoxic accumulation of gnagliosides G<sub>M2</sub> and G<sub>M3</sub>, lactosylceramide and glucosylceramide, possibly preventing further neuronal damage. Other studies have also suggested that miglustat may indirectly modulate intracellular calcium homeostasis through its effects on glucosylceramide levels, and evidence has shown that an initiating factor in the pathogenesis of NP-C may be impaired calcium homeostasis related to sphingosine storage. Therefore, the effect that miglustat exerts on intracellular calcium levels may influence an important underlying pathogenic mechanism of NP-C.', 'metabolism': 'There is no evidence that miglustat is metabolized in humans.', 'descriptions': 'Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. Miglustat was first developed as an anti-HIV agent in the 1990s. However, clinical experience with miglustat showed that therapeutic levels of the drug could not be achieved in patients without a high incidence of adverse effect.'}, {'name': 'Glucosamine', 'similarity score': 0.8864784836769104, 'approval groups': ['approved', 'investigational'], 'average mass': 179.1711, 'half life': 'The estimated half-life for glucosamine is 15 hours after an oral dose.[A232279] After a bolus intravenous injection of 1005 mg crystalline glucosamine sulfate, the parent drug has an apparent half life of 1.11 hours.[A232274]', 'toxicity': 'The oral LD50 of glucosamine in rats is >5000 mg/kg.[L32684] Symptoms of an overdose with glucosamine may include nausea, vomiting, abdominal pain, and diarrhea (common side effects of this drug). Severe and life-threatening hypersensitivity reactions to glucosamine may occur in patients with a shellfish allergy or asthma.[L32774]', 'indication': 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'pharmacodynamics': 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'mechanism of action': 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-\\u03baB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'metabolism': 'Glucosamine undergoes metabolism in the liver.[A232274] Metabolism information for glucosamine is limited in the literature.', 'descriptions': 'Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation.[A232289] Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional benefits to nonsteroidal anti-inflammatory drugs treating the painful symptoms of OA. Glucosamine is commonly used over the counter as a treatment for arthritic joint pain, although its acceptance as a medical therapy varies due to contradictory and findings with unclear clinical significance during clinical trials.[A231894,A232289] It is currently not approved as a prescription product by the FDA, but is widely available over the counter.'}, {'name': None, 'similarity score': 0.8821925520896912, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Nadolol', 'similarity score': 0.8789207935333252, 'approval groups': ['approved'], 'average mass': 309.4006, 'half life': 'The half life of nadolol is 20 to 24 hours.[L7922,L7925]', 'toxicity': 'The oral LD<sub>50</sub> in mice is 4500mg/kg.[L7934]\\\\r\\\\n\\\\r\\\\nPatients experiencing an overdose may present with bradycardia, cardiac failure, hypotension, and bronchospasm.[L7922,L7925] An overdose may be treated with atropine for bradycardia, digitalis and diuretics for cardiac failure, vasopressors for hypotension, and beta-2 stimulants for bronchospasms, as well as gastric lavage and hemodialysis.[L7922,L7925]', 'indication': 'Nadolol is indicated to treat angina pectoris and hypertension.[L7922] Another product formulated with [bendroflumethiazide] is indicated to treat hypertension.[L7925]', 'pharmacodynamics': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] It has a long duration of action as it is usually taken once daily and a wide therapeutic index as patients start at doses of 40mg daily but may be increased to doses as high as 240mg daily.[L7922,L7925] Patients taking nadolol should not aburptly stop taking it as this may lead to exacerbation of ischemic heart disease.[L7922,L7925]', 'mechanism of action': 'Although nadolol is described as a non selective beta blocker, it does not interact with beta 3 adrenal receptors.[A182402] Antagonism of beta-1 and beta-2 adrenoceptors in the heart inhibits cyclic AMP and its signalling pathway, decreasing the strength and speed of contractions as well as the speed of relaxation and conduction.[A34177] Antagonism of beta-2 adrenoceptors in the smooth muscle cells of the vasculature inhibits their relaxation, leading to an increase in peripheral vascular resistance and reducing the risk of severe hypotension.[A34177] The increase in peripheral vascular resistance may contribute to the decrease in insulin sensitivity associated with nadolol use.[A182441] Antagonism of beta-1 adrenoceptors in the juxtaglomerular apparatus of the kidney inhibits the release of renin, and therefore angiotensin II mediated vasoconstriction, aldosterone mediated water retention, and the release of epinephrine.[A34177] Antagonism of beta-2 adrenoceptors in the liver and skeletal muscle inhibits glycogenolysis, in the lungs prevents bronchodilation, and in the pancrease inhibits insulin release.[A34177]', 'metabolism': 'Nadolol is not metabolized by the liver in humans.[A182423,L7922,L7925]', 'descriptions': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects.[A34177]\\\\r\\\\n\\\\r\\\\nNadolol was granted FDA approval on 10 December 1979.[L7922]'}]\\n    - Non-approved molecules (with similarity scores): [{'name': 'Duvoglustat', 'similarity score': 0.8663665652275085, 'approval groups': ['investigational'], 'average mass': 163.1717, 'half life': '', 'toxicity': 'ORL-RAT LD<sub>50</sub>: &gt; 5g/kg.\\\\r\\\\n', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.'}, {'name': 'Migalastat', 'similarity score': 0.8663665652275085, 'approval groups': ['approved', 'investigational'], 'average mass': 163.1717, 'half life': 'The mean elimination half-life (t1/2) of migalastat ranges from approximately 3 to 5 hours for a single oral dose of 150 mg.[L47057] For the dose of 123 mg, the mean elimination half-life was estimated to be 4 hours.[L47036]', 'toxicity': 'The most common adverse reactions reported with migalastat (\\u2265 10%) during the 6-month placebo-controlled, double-blind phase of its Study 1 clinical studies were headache, nasopharyngitis, urinary tract infection, nausea, and pyrexia [FDA Label, F1107].\\\\r\\\\n\\\\r\\\\nIn case of overdose, general medical care is recommended [FDA Label, F1107]. Headache and dizziness were the most common adverse reactions reported at doses of migalastat of up to 1250 mg and 2000 mg, respectively [FDA Label, F1107].', 'indication': 'Migalastat is approved by the FDA for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.[L47036] \\\\r\\\\n\\\\r\\\\nThis indication is approved under accelerated approval based on a reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.[L47036]\\\\r\\\\n\\\\r\\\\nMigalastat is also approved by the EMA and Health Canada to treat the same disease, although it is approved for both adults and adolescents aged 16 years and older in Europe.[L47057,L47087]', 'pharmacodynamics': 'In general, treatment in patients with migalastat in Phase 2 pharmacodynamic trials resulted in increases in endogenous alpha-galactosidase (alpha-Gal A) activity in white blood cells, as well as in skin and kidney for the majority of patients [FDA Label, F1107]. In patients with amenable galactosidase alpha gene (GLA) mutations, globotriaosylceramide (GL-3) levels tended to decrease in the urine and in the kidney interstitial capillaries.[L47057]\\\\r\\\\n\\\\r\\\\nIn an in vitro assay (HEK-293 assay), Human Embryonic Kidney (HEK-293) cell lines were transfected with specific GLA variants (mutations) which produced mutant alpha-Gal A proteins. In the transfected cells, amenability of the GLA variants was assessed after a 5-day incubation with 10 micromol/L migalastat. A GLA variant was categorized as amenable if the resultant mutant alpha-Gal A activity (measured in the cell lysates) met two criteria: 1) it showed a relative increase of at least 20% compared to the pre-treatment alpha-Gal A activity, and 2) it showed an absolute increase of at least 3% of the wild-type (normal) alpha-Gal activity. The in vitro assay did not evaluate the trafficking of the mutant alpha-Gal A proteins into the lysosome or the dissociation of migalastat from the mutant alpha-Gal A proteins within the lysosome. Also, the in vitro assay did not test whether a GLA variant causes Fabry disease or not.[L47036] ', 'mechanism of action': 'Fabry disease is a progressive X-linked lysosomal storage disorder that affects males and females [FDA Label, F1107]. Fabry disease-causing mutations occur in the galactosidase alpha (GLA) gene and result in a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) that is required for glycosphingolipid substrate (GL-3 and lyso-Gb3) metabolism [FDA Label, F1107]. Reduced alpha-Gal A activity is, therefore, associated with the progressive accumulation of glycosphingolipid substrate in vulnerable organs and tissues, which ultimately leads to the morbidity and mortality associated with Fabry disease.[L47057]\\\\r\\\\n\\\\r\\\\nMigalastat is a pharmacological chaperone that reversibly binds to the active site of the alpha-galactosidase A (alpha-Gal A) protein (encoded by the galactosidase alpha gene, GLA), which is deficient in Fabry disease. This binding stabilizes alpha-Gal A allowing its trafficking from the endoplasmic reticulum into the lysosome where it exerts its action. In the lysosome, at a lower pH and at a higher concentration of relevant substrates, migalastat dissociates from alpha-Gal A allowing it to break down the glycosphingolipids globotriaosylceramide (GL-3) and globotriaosylsphingosine (lyso-Gb3). Certain GLA variants (mutations) causing Fabry disease result in the production of abnormally folded and less stable forms of the alpha-Gal A protein which, however, retain enzymatic activity. Those GLA variants, referred to as amenable variants, produce alpha-Gal A proteins that may be stabilized by migalastat thereby restoring their trafficking to lysosomes and their intralysosomal activity.[L47036] \\\\r\\\\n\\\\r\\\\nThe GLA mutations that are amenable and not amenable to treatment with migalastat are regularly maintained and updated on online sites that are readily accessible by healthcare providers.[L47036]   ', 'metabolism': 'Based upon in vivo data, migalastat is a substrate for uridine diphosphate glucuronosyltransferase (otherwise known as UGT or UDPGT), being a minor elimination pathway.[L47036]', 'descriptions': \\\"Fabry disease is a rare, progressive genetic disorder characterized by a defective GLA gene that causes a deficiency in the enzyme alpha-Galactosidase A (alpha-Gal A). This enzyme is responsible for breaking down glycosphingolipid substrate that, when deficient in patients with Fabry disease, builds up in the blood vessels, the kidneys, the nerves, the heart, and other organs.[L47036,L47057,L4274,L4278] In the U.S., it is estimated that more than 3,000 people are living with Fabry disease, and an estimated more than 50 percent of these diagnosed patients are currently untreated.[L4274]\\\\r\\\\n\\\\r\\\\nMigalastat (approved and sold under Amicus Therapeutics' brand name Galafold) is subsequently an oral pharmacological chaperone of alpha-Gal A for the treatment of Fabry disease in adults who have amenable GLA variants.[L47036,L47057,L4274,L4278] In these patients, migalastat works by stabilizing the body\\u2019s dysfunctional alpha-Gal A enzyme so that it can clear the accumulation of glycosphingolipid disease substrate.[L47036,L47057,L4274,L4278] Globally, it is estimated that approximately 35 to 50 percent of Fabry patients may have amenable GLA variants that are treatable with migalastat. [L4274]\\\\r\\\\n\\\\r\\\\nGiven the rarity of Fabry disease and the proportion of Fabry disease patients that could benefit from migalastat therapy, Amicus Therapeutics' brand name Galafold was approved using the Accelerated Approval pathway, under which the FDA may approve drugs for serious conditions where there is an unmet medical need and where a drug is shown to have certain effects that are reasonably likely to predict a clinical benefit to patients.[L47036,L47057,L4274,L4278] A further study is required to verify and describe the clinical benefits of Galafold, and the sponsor will be conducting a confirmatory clinical trial of Galafold in adults with Fabry disease.[L47036,L47057,L4274,L4278]\\\\r\\\\n\\\\r\\\\nAdditionally, Galafold was also granted Priority Review designation, under which the FDA\\u2019s goal is to take action on an application within six months of application filing where the agency determines that the drug if approved, would provide a significant improvement in treating, diagnosing or preventing a serious condition over available therapies.[L47036,L47057] Galafold also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.[L47036,L47057]\\\\r\\\\n\\\\r\\\\nAs of August 2018, migalastat under Amicus Therapeutics' brand name Galafold is currently approved in Australia, Canada, European Union, Israel, Japan, South Korea, Switzerland, and the United States.[L4274]\\\"}, {'name': None, 'similarity score': 0.8658441305160522, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Arbutin', 'similarity score': 0.8647643327713013, 'approval groups': ['approved'], 'average mass': 272.2512, 'half life': 'No pharmacokinetic data available. ', 'toxicity': 'In an acute oral toxicity study, the LD50-value for \\u03b2-arbutin is 9804 mg/kg bw for the mouse and 8715 mg/kg bw for the rat [F44]. Dermal LD50 value in rat and mouse was reported to be greater than 928 mg/kg bw, according to an acute dermal toxicity study [F44]. Extremely high doses may cause ringing in the ears, shortness of breath, convulsions, collapse, vomiting and delirium [F43]. Nausea and vomiting were seen individuals with sensitive stomachs following oral ingestion of 15 g of dried uva ursi leaves that contain arbutin [F43]. ', 'indication': 'Indicated for over-the-counter use for epidermal hyperpigmentation in various skin conditions, such as melasma, freckles, and senile lentigines. ', 'pharmacodynamics': 'At non-toxic concentrations, arbutin inhibited the activity of tyrosinase in cultured human keratinocytes, while having minimal effect on the expression of tyrosinase mRNA or the synthesis of the enzyme [A27248]. \\u03b1-Arbutin produced a concentration-dependent inhibition of melanin synthesis of human melanoma cells, HMV-II [A32939]. No inhibitory effect on HMV-II cell growth was seen at concentrations lower than 1.0 mM. At concentrations of 0.5 mM of arbutin, tyrosinase activity was reduced to 60% of that in non-treated cells [A32939]. The addition of arbutin blocked and inhibited \\u03b1-MSH-stimulated melanogenesis in B16 melanoma cells, brownish guinea pig, and human skin tissue [A32940]. In a pilot study of healthy male adults exposed to UV B irradiation, topical administration of arbutin inhibited UV-induced nuclear factor-kappaB activation in human keratinocytes [F43]. In mouse skin, arbutin counteracted oxidative stress induced by 12-O-tetradecanoylphorbol-13-acetate [F43].', 'mechanism of action': 'Arbutin is a hydroquinone glycoside, however the hydroquinone moiety is not solely responsible for the de-pigmentating actions of arbutin [A32942]. It acts as a competitive inhibitor of tyrosinase enzyme by acting on the L-tyrosine binding site to suppress melanogenesis and mediate its de-pigmenting actions on human skin [A27248]. Tyrosinase is an enzyme involved in the regulation of rate-limiting steps during the synthesis of melanin; it regulates the conversion of L-tyrosine into L-dopa, and subsequent conversion of L-dopa to L-dopaquinone [A27248]. Via inhibition of tyrosinase activity in a concentration-dependent manner, arbutin attenuates the production of melanin in melanocytes. While most studies suggest that arbutin has negligible effect on the tyrosinase mRNA expression, a study assessing the effect of arbutin on melanocyte differentiation inducement system using ES cells propose that arbutin may also downregulate the expression of tyrosinase in addition to its inhibitory action on the enzyme [A32938]. The contradictory findings across studies may be due to previous studies using terminally-differentiated melanocytes and melanoma cells [A32938]. ', 'metabolism': 'Arbutin is readily susceptible to hydrolysis in dilute acids to yield D-glucose and hydroquinone. It is expected that orally administered arbutin is easily hydrolyzed to free hydroquinone molecules by stomach acid [F43]. Hydroquinone is further metabolized into the main metabolites, hydroquinone glucuronide and hydroquinone sulfate [F43]. ', 'descriptions': 'Extracted from the dried leaves of bearberry plant in the genus _Arctostaphylos_ and other plants commonly in the _Ericaceae_ family, arbutin is a beta-D-glucopyranoside of [DB09526]. It is found in foods, over-the-counter drugs, and herbal dietary supplements [F43]. Most commonly, it is an active ingredient in skincare and cosmetic products as a skin-lightening agent for the prevention of melanin formation in various skin conditions that involve cutaneous hyperpigmentation or hyperactive melanocyte function [A27248]. It has also been used as an anti-infective for the urinary system as well as a diuretic [F43]. Arbutin is available in both natural and synthetic forms; it can be synthesized from acetobromglucose and [DB09526] [F43]. Arbutin is a competitive inhibitor of tyrosinase (E.C.1.14.18.1) in melanocytes [A27248], and the inhibition of melanin synthesis at non-toxic concentrations was observed _in vitro_. Arbutin was shown to be less cytotoxic to melanocytes in culture compared to [DB09526] [A32942].'}, {'name': 'Indole-3-carbinol', 'similarity score': 0.8617359399795532, 'approval groups': ['investigational'], 'average mass': 147.1739, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).'}]\\n    \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"labels\"][n]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GhjJl6z5oDf5",
        "outputId": "d1f00d73-5a7c-4e35-b8d2-44e5cda13eb0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "np.int64(1)"
            ]
          },
          "metadata": {},
          "execution_count": 17
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"1st_prompt\"][n]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 122
        },
        "id": "G3i6gxW1MPT7",
        "outputId": "1becc3e5-1929-4eac-a9d4-12a2b841a6b5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'\\n    \\nYou are a **chemist specializing in drug discovery and molecular modeling**. your task is to predict wheather the compound will be approved or not.\\n\\nyou should consider the following criteria:\\n1. Drug-Likeness Rules:\\n   - Lipinski’s Rule of Five (MW, LogP, H-bond donors/acceptors).\\n   - Veber’s Rule (PSA, rotatable bonds).\\n   - Ghose\\n   - Egan\\n\\n    Assign 1 point per passed rule\\n    Normalize to total applicable rules (e.g., 1/5 rules passed =0.20).\\n\\n\\n2. ADMET Profiling:\\n   - Absorption (solubility, permeability).\\n   - Distribution (Vd, plasma protein binding).\\n   - Metabolism (CYP450 interactions, stability).\\n   - Excretion (renal, biliary clearance).\\n   - Toxicity (hepatotoxicity, cardiotoxicity, Ames test).\\n- PAINS & Brenk Filters (toxic/assay-interfering structures).\\n\\n\\n3. Structural Alerts:\\n    PAINS/Brenk Filters\\n\\n4. Model Similarity & Bias Adjustment:\\nAdjusted Similarity Score=(Avg. Approved Sim×Precision−Avg. Unapproved Sim×(1 - Precision))\\n\\n5. Toxicity & Pharmacokinetics\\n\\n\\n\\n\\n    I have developed a model that can predict the drug likelibility of compound X.\\n    to predict that I have trained a classifier on a dataset of approved and unapproved drugs. the model performance is {\\'F1 score\\': 0.80,\\n    \\'Accuracy\\': 0.69,\\n    \\'Precision\\': 0.68,\\n    \\'Recall\\': 0.975,\\n    \\'AUC\\': 0.68,\\n    \\'Specificity\\': 0.20}\\n    This model outputs two lists:\\n    1. The five most similar approved small molecules (with their properties and similarity scores).\\n    2. The five most similar non-approved small molecules (with their properties and similarity scores).\\n\\n    Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.\\n\\n    - RDKit Analysis of Compound X:\\n    {\\'Molecular Weight\\': 324.39900000000006, \\'LogP\\': 3.812980000000003, \\'Molecular Refractivity\\': 90.91400000000006, \\'TPSA\\': 36.26, \\'Hydrogen Bond_Donors\\': 0, \\'Hydrogen_Bond Acceptors\\': 3, \\'Rotatable Bonds\\': 5, \\'Chiral Centers\\': 0, \\'Total Atoms\\': 24, \\'Heavy Atoms\\': 24, \\'Total Bonds\\': 26, \\'Formal Charge\\': 0, \\'Total Rings\\': 3, \\'Structural Alerts\\': \\'None\\', \\'Aromatic Rings\\': 2, \\'Aliphatic Rings\\': 1}df[\"SMILES\"]\\n\\n    Using the provided data:\\n    - Approved molecules (with similarity scores): [{\\'name\\': \\'Escitalopram\\', \\'similarity score\\': 0.9846152067184448, \\'approval groups\\': [\\'approved\\'], \\'average mass\\': 324.3919, \\'half life\\': \"The elimination half-life of escitalopram is 27-32 hours, though this is increased by approximately 50% in the elderly and doubled in patients with reduced hepatic function.[A185420,L8513,L8516,L8522] The elimination half-life of escitalopram\\'s primary metabolite, S-desmethylcitalopram, is approximately 54 hours at steady state.[A39738]\", \\'toxicity\\': \\'Symptoms of overdose may include CNS effects (dizziness, convulsions, coma, somnolence), gastrointestinal distress (nausea, vomiting), and/or cardiac abnormalities (hypotension, tachycardia, ECG changes).[L8513,L8516,L8522] There is no specific antidote for escitalopram overdose. Management of overdose should focus on monitoring for cardiac abnormalities and changes to vital signs as well as treatment with supportive measures as indicated. As escitalopram is highly distributed into tissue following oral administration, forced diuresis, dialysis, and other methods of extracting drug from plasma are unlikely to be beneficial.\\', \\'indication\\': \\'Escitalopram is indicated for the acute and maintenance treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years old and older and for the acute treatment of generalized anxiety disorder (GAD) in adults and pediatric patients 7 years old and older.[L8513,L8513] It is additionally indicated for symptomatic relief of obsessive-compulsive disorder (OCD) in Canada.[L8516]\\', \\'pharmacodynamics\\': \\'Escitalopram belongs to a class of medications called selective serotonin re-uptake inhibitors (SSRIs). These agents cause an increase in serotonin levels in neuronal synapses by preventing the re-uptake of serotonin (5-HT) into the presynaptic terminals of serotonergic neurons.[A185420,A39738,L8513,L8516] As compared to other SSRIs, it appears to have a relatively quick onset of effect due to its potency.[A185819,A185822]\\\\r\\\\n\\\\r\\\\nSSRIs as a class have been associated with abnormal bleeding, particularly in patients receiving concomitant therapy with other medications affecting hemostasis, and with the development of serotonin syndrome. Use escitalopram with caution in patients with a higher-than-baseline risk of bleeding and in patients receiving concomitant therapy with other serotonergic drugs. Escitalopram may also cause a discontinuation syndrome with abrupt removal of the drug, and should be slowly tapered if discontinuation of therapy is warranted.[L8513,L8516,L8522]\\', \\'mechanism of action\\': \\'Escitalopram, like other selective serotonin re-uptake inhibitors, enhances serotonergic activity by binding to the orthosteric (i.e. primary) binding site on the serotonin transporter (SERT), the same site to which endogenous 5-HT binds, and thus prevents the re-uptake of serotonin into the presynaptic neuron.[A185420,A39738,A185726] Escitalopram, along with [paroxetine], is also considered an allosteric serotonin re-uptake inhibitor - it binds to a secondary allosteric site on the SERT molecule to more strongly inhibit 5-HT re-uptake. Its combination of orthosteric and allosteric activity on SERT allows for greater extracellular 5-HT levels, a faster onset of action, and greater efficacy as compared to other SSRIs. [A185825,A185726] The sustained elevation of synaptic 5-HT eventually causes desensitization of 5-HT<sub>1A</sub> auto-receptors, which normally shut down endogenous 5-HT release in the presence of excess 5-HT - this desensitization may be necessary for the full clinical effect of SSRIs and may be responsible for their typically prolonged onset of action.[A185828,A185726]\\\\r\\\\n\\\\r\\\\nEscitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects.[L8513,L8516,L8522,A185726]\\', \\'metabolism\\': \\'The metabolism of escitalopram is mainly hepatic, mediated primarily by CYP2C19 and CYP3A4 and, to a lesser extent, CYP2D6. Oxidative N-demethylation by the CYP enzyme system results in S-desmethylcitalopram (S-DCT) and S-didesmethylcitalopram (S-DDCT) - these metabolites do not contribute to the pharmacologic activity of escitalopram, and exist in the plasma in small quantities relative to the parent compound (28-31% and <5%, respectively).[L8513,L8516,L8522]\\\\r\\\\n\\\\r\\\\nThere is also some evidence that escitalopram is metabolized to a propionic acid metabolite by monoamine oxidase A and B in the brain, and that these enzymes constitute the major route of escitalopram metabolism in the brain.[A39738]\\', \\'descriptions\\': \\'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]\\'}, {\\'name\\': None, \\'similarity score\\': 0.9304230213165283, \\'approval groups\\': None, \\'average mass\\': None, \\'half life\\': None, \\'toxicity\\': None, \\'indication\\': None, \\'pharmacodynamics\\': None, \\'mechanism of action\\': None, \\'metabolism\\': None, \\'descriptions\\': None}, {\\'name\\': \\'Rotigotine\\', \\'similarity score\\': 0.9241100549697876, \\'approval groups\\': [\\'approved\\'], \\'average mass\\': 315.48, \\'half life\\': \\'After removal of the patch, plasma levels decreased with a terminal half-life of 5 to 7 hours. The pharmacokinetic profile showed a biphasic elimination with an initial half-life of 3 hours.\\', \\'toxicity\\': \\'The most likely symptoms of overdose would be those related to the pharmacodynamic profile of a dopamine agonist, including nausea, vomiting, hypotension, involuntary movements, hallucinations, confusion, convulsions, and other signs of excessive dopaminergic stimulation.\\', \\'indication\\': \"For use/treatment in neurologic disorders and parkinson\\'s disease as well as moderate-to-severe primary Restless Legs Syndrome.\", \\'pharmacodynamics\\': \"Rotigotine is an agonist at all 5 dopamine receptor subtypes (D1-D5) but binds to the D3 receptor with the highest affinity. It is also an antagonist at α-2-adrenergic receptors and an agonist at the 5HT1A receptors. Rotigotine also inhibits dopamine uptake and prolactin secretion. There is no indication of a QT/QTc prolonging effect of Neupro in doses up to 24 mg/24 hours. The effects of Neupro at doses up to 24 mg/24 hours (supratherapeutic doses) on the QT/QTc interval was evaluated in a double-blind, randomized, placebo- and positive-controlled (moxifloxacin 400 mg IV, single dose) parallel-group trial with an overall treatment period of 52 days in male and female patients with advanced-stage Parkinson\\'s disease. Assay sensitivity was confirmed by significant QTc prolongation by moxifloxacin. \", \\'mechanism of action\\': \\'Rotigotine, a member of the dopamine agonist class of drugs, is delivered continuously through the skin (transdermal) using a silicone-based patch that is replaced every 24 hours. A dopamine agonist works by activating dopamine receptors in the body, mimicking the effect of the neurotransmitter dopamine. The precise mechanism of action of rotigotine as a treatment for Restless Legs Syndrome is unknown but is thought to be related to its ability to stimulate dopamine \\', \\'metabolism\\': \\'Hepatic (CYP-mediated). Rotigotine is extensively and rapidly metabolized by conjugation and N-dealkylation. After intravenous dosing the predominant metabolites in human plasma are sulfate conjugates of rotigotine, glucuronide conjugates of rotigotine, sulfate conjugates of the N-despropyl-rotigotine and conjugates of N-desthienylethyl-rotigotine. Multiple CYP isoenzymes, sulfotransferases and two UDP-glucuronosyltransferases catalyze the metabolism of rotigotine.\\', \\'descriptions\\': \"Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinson\\'s disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours.\\\\r\\\\n\\\\r\\\\nLike other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well.\\\\r\\\\n\\\\r\\\\nRotigotine was developed by Aderis Pharmaceuticals. In 1998 Aderis licensed worldwide development and commercialization rights to Schwarz Pharma of Germany. It was approved by the European Medicines Agency in 2006 and by the FDA in 2007. However, all Neupro patches in the United States and some of Europe were recalled in 2008 due to delivery mechanism issues. Rotigotine has been authorized as a treatment for RLS since August 2008.\"}, {\\'name\\': \\'Clopidogrel\\', \\'similarity score\\': 0.9227179884910583, \\'approval groups\\': [\\'approved\\'], \\'average mass\\': 321.822, \\'half life\\': \\'That half life of clopidogrel is approximately 6 hours following a 75mg oral dose while the half life of the active metabolite is approximately 30 minutes.[L7213]\\', \\'toxicity\\': \\'A single dose of clopidogrel at 1500-2000mg/kg was lethal to mice and rats while 3000mg/kg was lethal to baboons.[L7213] Symptoms of overdose include vomiting, breathing difficulty, gastrointestinal hemorrhage, and prostration.[L7213] Clopidogrel is irreversibly bound to platelets for their lifetime, which is approximately 11 days.[L7213] Overdoses of clopidogrel can be treated with platelet transfusions to restore clotting ability.[L7213]\\', \\'indication\\': \\'Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213]\\', \\'pharmacodynamics\\': \\'Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] It has a long duration of action as it is taken once daily and a large therapeutic window as it is given in doses of 75-300mg daily.[L7213]\\', \\'mechanism of action\\': \\'Clopidogrel is activated via a 2 steps reaction to an active thiol-containing metabolite.[A180508] This active form is a platelet inhibitor that irreversibly binds to P2Y<sub>12</sub> ADP receptors on platelets.[L7213] This binding prevents ADP binding to P2Y<sub>12</sub> receptors, activation of the glycoprotein GPIIb/IIIa complex, and platelet aggregation.[L7213]\\', \\'metabolism\\': \\'85-90% of an oral dose undergoes first pass metabolism by carboxylesterase 1 in the liver to an inactive carboxylic acid metabolite.[A180535] about 2% of clopidogrel is oxidized to 2-oxoclopidogrel.[A180535] This conversion is 35.8% by CYP1A2, 19.4% by CYP2B6, and 44.9% by CYP2C19[A180535] though other studies suggest CYP3A4, CYP3A5, and CYP2C9 also contribute.[A180508] 2-oxoclopidogrel is further metabolized to the active metabolite.[A180508,A180535] This conversion is 32.9% by CYP2B6, 6.79% by CYP2C9, 20.6% by CYP2C19, and 39.8% by CYP3A4.[A180508,A180535]\\', \\'descriptions\\': \\'Clopidogrel is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke.[A180508,L7213] Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,[L7213]\\\\r\\\\n\\\\r\\\\nIt has been shown to be superior to [aspirin] in reducing cardiovascular outcomes in patients with cardiovascular disease and provides additional benefit to patients with acute coronary syndromes already taking aspirin.[A180547]\\\\r\\\\n\\\\r\\\\nClopidogrel was granted FDA approval on 17 November 1997.[L7213]\\'}, {\\'name\\': \\'Azelastine\\', \\'similarity score\\': 0.9128557443618774, \\'approval groups\\': [\\'approved\\'], \\'average mass\\': 381.898, \\'half life\\': \\'Based on intravenous and oral administration, azelastine demonstrated an elimination half-life of 22 hours.[L8240,L8270] Its primary active metabolite, desmethylazelastine, has an elimination half-life of 54 hours.[A1518]\\', \\'toxicity\\': \\'Overdosage of intranasal or ophthalmic azelastine is unlikely to result in clinically significant adverse effects aside from increased drowsiness.[L8240,L8270] If overdose does occur, employ general supportive measures. Oral ingestion of antihistamines, including non-oral formulations of azelastine, can cause serious adverse effects in children - for this reason, these products should be kept out of the reach of children. The oral LD<sub>50</sub> in rats is 580 mg/kg.[L8276]\\', \\'indication\\': \\'Intranasal azelastine is indicated for the symptomatic treatment of seasonal allergic rhinitis in patients 5 years and older and for the symptomatic treatment of vasomotor rhinitis in patients 12 years and older.[L8240] Ophthalmic azelastine solution is indicated for the treatment of itchy eyes associated with allergic conjunctivitis.[L8270]\\\\r\\\\n\\\\r\\\\nAs a 0.15% nasal spray, azelastine hydrochloride is also indicated for over-the-counter treatment of allergies in patients aged six years and older.[L34640]\\', \\'pharmacodynamics\\': \\'Azelastine antagonizes the actions of histamine, resulting in the relief of histamine-mediated allergy symptoms.[A1518,L8240,L8270] Onset of action occurs within 15 minutes with intranasal formulations and as quickly as 3 minutes with ophthalmic solutions.[A1517] Intranasal formulations have a relatively long-duration of action, with peak effects observed 4-6 hours after the initial dose and efficacy maintained over the entirety of the standard 12 hour dosing interval.[A1518]\\', \\'mechanism of action\\': \\'Azelastine is primarily a selective antagonist of histamine H1-receptors, with a lesser affinity for H2-receptors, used for the symptomatic treatment of allergies.[A1518,A1517,L8240,L8270] Histamine H1-receptors are G-protein-coupled receptors with 7 transmembrane spanning domains[A184328] that are found on nerve endings, smooth muscle cells, and glandular cells.[A687] Following allergen exposure in sensitized individuals, IgE-receptor cross-linking on mast cells results in the release of histamine, which binds to H1-receptors and contributes to typical allergic symptoms such as itching, sneezing, and congestion.[A687] \\\\r\\\\n\\\\r\\\\nThough its primary mode of action is thought to be via H1-receptor antagonism, azelastine (like other second-generation antihistamines) appears to affect other mediators of allergic symptomatology. Azelastine has mast cell-stabilizing properties that prevent the release of interleukin-6, tryptase, histamine, and TNF-alpha[A1518] from mast cells, and has been shown to reduce mediators of mast cell degranulation such as leukotrienes in the nasal lavage of patients with rhinitis,[A1517] as well as inhibiting their production and release from eosinophils (potentially via inhibition of phospholipase A<sub>2</sub> and leukotriene C<sub>4</sub> synthase).[A1518,A184373] Additionally, patients using oral azelastine were observed to have significantly reduced concentrations of substance P and bradykinin in nasal secretions[A1518], both of which may play a role in nasal itching and sneezing in patients with allergic rhinitis.\\', \\'metabolism\\': \\'Azelastine hydrochloride is oxidatively metabolized to its main, and biologically active, metabolite desmethylazelastine by the cytochrome P450 enzyme system.[L8240,L8270] Though labels for azelastine state that specific CYP enzyme involvement has not been elucidated, it has been suggested that the N-demethylation of azelastine is primarily catalyzed by CYP3A4, CYP2D6, and CYP1A2.[A38655]\\', \\'descriptions\\': \\'Azelastine, a phthalazine derivative, is an antihistamine available as an intranasal spray for the treatment of allergic and vasomotor rhinitis and as an ophthalmic solution for the treatment of allergic conjunctivitis.[L8240,L8270] It is a racemic mixture, though there is no noted difference in pharmacologic activity between enantiomers, and was first granted FDA approval in 1996.[L8240,L8270] Azelastine is also available in combination with fluticasone propionate as a nasal spray marketed under the trade name Dymista™, which is indicated for the symptomatic treatment of seasonal allergic rhinitis in patients 6 years of age and older.[L8309]\\'}]\\n    - Non-approved molecules (with similarity scores): [{\\'name\\': \\'Cebranopadol\\', \\'similarity score\\': 0.9188753366470337, \\'approval groups\\': [\\'investigational\\'], \\'average mass\\': 378.491, \\'half life\\': \\'\\', \\'toxicity\\': \\'\\', \\'indication\\': \\'\\', \\'pharmacodynamics\\': \\'\\', \\'mechanism of action\\': \\'\\', \\'metabolism\\': \\'\\', \\'descriptions\\': \\'Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.\\'}, {\\'name\\': \\'Rucaparib\\', \\'similarity score\\': 0.9010326862335205, \\'approval groups\\': [\\'approved\\', \\'investigational\\'], \\'average mass\\': 323.371, \\'half life\\': \\'The mean (coefficient of variation) terminal elimination half-life is 26 (39%) hours.[L42155]\\', \\'toxicity\\': \\'There is no information regarding the LD50 and overdose of rucaparib.\\', \\'indication\\': \\'Rucaparib is indicated for the maintenance treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)- associated recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.[L44572]\\\\r\\\\n\\\\r\\\\nUnder accelerated approval by the FDA, rucaparib is also indicated for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.[L44572]\\', \\'pharmacodynamics\\': \\'Rucaparib is an anticancer agent that exerts cytotoxic effects against cancer cells. It works by inhibiting poly (ADP-ribose) polymerase (PARP), an enzyme that plays a role in DNA repair. Rucaparib inhibits PARP-1, PARP-2, and PARP-3. It also interacts with PARP-4, PARP-10, PARP-12, PARP-15, and PARP-16, but to a lesser extent.[A18745] In mice, rucaparib accumulated and was retained in tumours, inhibiting PARP enzymes for seven days.[A249240]\\\\r\\\\n\\\\r\\\\nRucaparib decreases tumour growth in tumour cell lines with deficiencies in BRCA1/2 and other DNA repair genes.[L42155] In addition to PARP inhibition, rucaparib demonstrated PARP-independent cytotoxic mechanisms in cancer cells. When co-administered with other chemotherapeutic agents, rucaparib contributed to synergistic or additive effects _in vitro_ and _in vivo_. There is evidence that rucaparib can sensitize cancer cells to chemotherapy. Rucaparib can also cause vasodilation, which may increase tumour perfusion and enhance the accumulation of cytotoxic drugs in cancer cells.[A249240]\\', \\'mechanism of action\\': \\'PARPs play a role in DNA repair by activating DNA damage response pathways, such as base excision repair, and facilitating DNA repair. PARPs were evaluated as novel anticancer therapeutic targets after discovering that PARP-1 inhibitors reduce tumour growth in BRCA-deficient cancers.[A18745] BRCA1 and BRCA2 are tumour suppressor genes involved in various cellular processes related to cell growth and death, including DNA repair.[A249195] More specifically, BRCA1 and BRCA2 are involved in homologous recombination (HR) DNA repair. Cancer cells with a deleterious BRCA mutation are HR-deficient, resulting in unregulated and aberrant cell repair and growth.[A18745]\\\\r\\\\n\\\\r\\\\nRucaparib inhibits PARP1, PARP2, and PARP3.[L42155] Inhibiting PARP traps the enzyme on damaged DNA, halting the repair process and forming toxic PARP–DNA complexes. Alternatively, other DNA repair processes such as error-prone nonhomologous end joining (NHEJ) or alternative end-joining pathways can be initiated, leading to mutations or chromosomal change.[A31354] Further DNA damage can trigger cancer cell apoptosis and cell death.[L42155] \\\\r\\\\n\\\\r\\\\nTypically, inhibition of PARP converts single-strand breaks in DNA to double-strand breaks at replication forks. HR DNA repair pathways repair double-strand breaks; however, HR-deficient cancer cells lack this repair mechanism. Because HR-deficient cancer cells are more vulnerable to unsalvageable DNA damage, rucaparib-induced PARP inhibition leads to synthetic lethality. In this phenomenon, two non-lethal defects (HR deficiency and PARP inhibition) combine and cause cell death.[A18745,A31354]\\', \\'metabolism\\': \\'In vitro, rucaparib is primarily metabolized by CYP2D6 and, to a lesser extent, by CYP1A2 and CYP3A4. In addition to CYP-based oxidation, rucaparib also undergoes N-demethylation, N-methylation, and glucuronidation.[L42155] In one study, seven metabolites of rucaparib were identified in plasma, urine, and feces.[A249245]\\', \\'descriptions\\': \\'Rucaparib is an anticancer drug and poly (ADP-ribose) polymerase (PARP) inhibitor. PARP is an enzyme that plays an essential role in DNA repair.[A18745] Rucaparib is proposed to work in several PARP-dependent and PARP-independent mechanisms of action; however, it causes a unique effect of synthetic lethality. By targeting the genetically-mutated cancer cells that lack a DNA repair mechanism, rucaparib causes cancer cell death and reduces tumour growth.[A18745,A31354]\\\\r\\\\n\\\\r\\\\nRucaparib was granted FDA Breakthrough Therapy designation in April 2015 [A18745] and accelerated approval in December 2016.[A249240] The drug was later approved by the European Commission in May 2018.[L42185] It is currently used to treat recurrent ovarian and prostate cancer in adults.[L42155,L42185]\\'}, {\\'name\\': \\'(R)-etodolac\\', \\'similarity score\\': 0.8997461795806885, \\'approval groups\\': [\\'investigational\\'], \\'average mass\\': 287.359, \\'half life\\': \\'\\', \\'toxicity\\': \\'\\', \\'indication\\': \\'\\', \\'pharmacodynamics\\': \\'\\', \\'mechanism of action\\': \\'\\', \\'metabolism\\': \\'\\', \\'descriptions\\': \\'\\'}, {\\'name\\': \\'LB-100\\', \\'similarity score\\': 0.899722695350647, \\'approval groups\\': [\\'investigational\\'], \\'average mass\\': 268.313, \\'half life\\': \\'\\', \\'toxicity\\': \\'\\', \\'indication\\': \\'\\', \\'pharmacodynamics\\': \\'\\', \\'mechanism of action\\': \\'\\', \\'metabolism\\': \\'\\', \\'descriptions\\': \\'LB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).\\'}, {\\'name\\': \\'Cobiprostone\\', \\'similarity score\\': 0.8987033367156982, \\'approval groups\\': [\\'investigational\\'], \\'average mass\\': 404.495, \\'half life\\': \\'\\', \\'toxicity\\': \\'\\', \\'indication\\': \\'Investigated for use/treatment in cystic fibrosis.\\', \\'pharmacodynamics\\': \\'\\', \\'mechanism of action\\': \\'\\', \\'metabolism\\': \\'\\', \\'descriptions\\': \\'\\'}]\\n    '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 18
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.loc[n, \"think1\"] = \"\"\"\n",
        "Okay, let's tackle this problem step by step. The user wants to predict if compound X will be approved based on several criteria. Let's start by breaking down each part of the analysis as outlined.\n",
        "\n",
        "First, Drug-Likeness Rules. The user mentioned Lipinski’s Rule of Five, Veber’s Rule, Ghose, and Egan. I need to check each of these for compound X using the provided RDKit analysis.\n",
        "\n",
        "Looking at Lipinski's Rule:\n",
        "\n",
        "- Molecular Weight (MW) should be ≤500. Compound X has 324.4, so that's a pass.\n",
        "\n",
        "- LogP ≤5. The LogP here is 3.81, which is under 5, so another pass.\n",
        "\n",
        "- Hydrogen Bond Donors ≤5. The compound has 0, so pass.\n",
        "\n",
        "- Hydrogen Bond Acceptors ≤10. It has 3, so pass. That's 4/4 for Lipinski.\n",
        "\n",
        "Veber's Rule looks at Polar Surface Area (TPSA) ≤140 Å² and Rotatable Bonds ≤10. Compound X has TPSA of 36.26 and 5 rotatable bonds. Both pass, so that's 2 points.\n",
        "\n",
        "Ghose Filter:\n",
        "\n",
        "- MW between 160-480. 324.4 is within range.\n",
        "\n",
        "- LogP between -0.4 to 5.6. 3.81 is okay.\n",
        "\n",
        "- Molar Refractivity (MR) between 40-130. The MR here is 90.91, so pass.\n",
        "\n",
        "- Total atoms between 20-70. Compound X has 24 atoms. Pass. So 4/4 for Ghose.\n",
        "\n",
        "Egan's Rule:\n",
        "\n",
        "- LogP ≤5.1 and TPSA ≤131.6. Compound X meets both, so 2 points.\n",
        "\n",
        "Adding up all applicable rules. Wait, the user says to assign 1 point per passed rule and normalize. Let me check how many total rules there are. Lipinski has 4, Veber 2, Ghose 4, Egan 2. Total of 12 rules? Wait, actually, each rule (Lipinski, Veber, Ghose, Egan) is a set of criteria. For example, Lipinski's Rule of Five has four criteria, but passing all four counts as 1 point for Lipinski. Or is each criterion a separate point? The user says \"1 point per passed rule\". So each rule (e.g., Lipinski's) is considered a single rule, and passing all its criteria gives 1 point. But wait, no, the user might mean each individual criterion. The initial instruction says \"Assign 1 point per passed rule. Normalize to total applicable rules (e.g., 1/5 rules passed =0.20).\" Hmm, maybe each rule is a separate check. For example, Lipinski's Rule has four components (MW, LogP, H donors, H acceptors). But Lipinski's Rule is considered as a single rule where if a compound passes all four, it gets 1 point. Similarly, Veber's is two components (PSA and rotatable bonds), and passing both gives 1 point. So each of the four rules (Lipinski, Veber, Ghose, Egan) are each a single rule. But the user says \"1 point per passed rule\". So if a compound passes Lipinski's Rule (all four criteria), that's 1 point. If it passes Veber's, another 1 point. Then Ghose and Egan each 1 point if passed. But how many total applicable rules? For example, if some rules aren't applicable. But the user hasn't mentioned that. So total applicable rules would be 4 (Lipinski, Veber, Ghose, Egan). So the normalization is over 4. But in the example given, 1/5, maybe there are 5 rules? Wait, maybe the user made a typo. Let me recheck the initial instruction:\n",
        "\n",
        "\"Drug-Likeness Rules:\n",
        "\n",
        "- Lipinski’s Rule of Five (MW, LogP, H-bond donors/acceptors).\n",
        "\n",
        "- Veber’s Rule (PSA, rotatable bonds).\n",
        "\n",
        "- Ghose\n",
        "\n",
        "- Egan\n",
        "\n",
        "Assign 1 point per passed rule\n",
        "\n",
        "Normalize to total applicable rules (e.g., 1/5 rules passed =0.20).\"\n",
        "\n",
        "Wait, the example says 1/5, which would imply 5 rules, but the user listed four. Maybe Ghose and Egan each have more than one component? Let me recall the actual rules.\n",
        "\n",
        "Lipinski's Rule of Five: MW ≤500, LogP ≤5, H-donors ≤5, H-acceptors ≤10. All four must be met to pass the rule. So passing Lipinski is 1 point.\n",
        "\n",
        "Veber's Rule: PSA ≤140 Å² and rotatable bonds ≤10. Both needed for 1 point.\n",
        "\n",
        "Ghose Filter: MW 160-480, LogP -0.4–5.6, MR 40-130, total atoms 20-70. All four needed for 1 point.\n",
        "\n",
        "Egan’s Rule: LogP ≤5.88 and TPSA ≤131.6. Both needed for 1 point.\n",
        "\n",
        "So each of the four rules (Lipinski, Veber, Ghose, Egan) is a separate rule. So total applicable rules are 4. Each passed rule gives 1 point. So the normalization would be points / 4.\n",
        "\n",
        "Now, checking compound X against each:\n",
        "\n",
        "Lipinski: All four criteria met (MW 324.4, LogP 3.81, H-donors 0, H-acceptors 3). So 1 point.\n",
        "\n",
        "Veber: PSA 36.26 ≤140 and rotatable bonds 5 ≤10. Pass. 1 point.\n",
        "\n",
        "Ghose: MW 324.4 within 160-480, LogP 3.81 within -0.4–5.6, MR 90.91 within 40-130, total atoms 24 within 20-70. All pass. 1 point.\n",
        "\n",
        "Egan: LogP 3.81 ≤5.88 and TPSA 36.26 ≤131.6. Both pass. 1 point.\n",
        "\n",
        "Total points: 4/4 = 1.0. So normalized score is 1.0. That's perfect for drug-likeness.\n",
        "\n",
        "Next, ADMET Profiling. The user lists Absorption, Distribution, Metabolism, Excretion, Toxicity, PAINS/Brenk. But the data provided doesn't directly give ADMET parameters. However, the approved and non-approved molecules' info might have some clues. For example, looking at the approved similar drugs, their metabolism and toxicity profiles might be similar. But without specific ADMET data for compound X, maybe we can infer based on similarity to approved drugs. For example, if the approved drugs have good ADMET profiles and compound X is similar, it might also have good ADMET.\n",
        "\n",
        "Structural Alerts: The RDKit analysis says \"Structural Alerts: None\", so that's good. PAINS/Brenk filters are passed, so no issues there.\n",
        "\n",
        "Model Similarity & Bias Adjustment: The adjusted similarity score formula is given. Need to calculate that. The approved molecules have similarity scores, and the non-approved as well. The model's precision is 0.68.\n",
        "\n",
        "First, compute the average similarity score for approved and non-approved. The approved list has 5 entries, but some have 'None' for name. Let's check:\n",
        "\n",
        "Approved molecules:\n",
        "\n",
        "1. Escitalopram: 0.9846\n",
        "\n",
        "2. None: 0.9304 (this entry seems incomplete, but assuming it's approved? The approval groups are 'approved' for others. This one has approval groups as None. Maybe a data issue. Perhaps this entry should be excluded? Or maybe it's a mistake. Let's check the user input.\n",
        "\n",
        "Looking at the user's data for approved molecules:\n",
        "\n",
        "The first entry is Escitalopram, approval groups: ['approved'].\n",
        "\n",
        "Second entry: name None, approval groups None. Probably an error or missing data. Maybe this is a non-approved, but in the approved list. Hmm. But the user says \"approved molecules (with similarity scores)\" and lists five entries. The second one has approval groups as None, so maybe it's a mistake. Perhaps exclude that entry. So taking only the four approved with valid data: Escitalopram (0.9846), Rotigotine (0.9241), Clopidogrel (0.9227), Azelastine (0.9129). The None entry has 0.9304 but no approval info; perhaps it's non-approved but mistakenly in the approved list. Alternatively, maybe it's approved but data missing. For safety, maybe calculate the average of all five, but the second entry's approval group is None. Alternatively, maybe the user intended all five in the approved list. Let's proceed with the given data as is.\n",
        "\n",
        "Approved similarity scores: [0.9846, 0.9304, 0.9241, 0.9227, 0.9129]. Average = sum them and divide by 5.\n",
        "\n",
        "Sum: 0.9846 + 0.9304 = 1.915; +0.9241=2.8391; +0.9227=3.7618; +0.9129=4.6747. Average ≈4.6747/5 ≈0.9349.\n",
        "\n",
        "Non-approved molecules: their similarity scores are [0.9189, 0.9010, 0.8997, 0.8997, 0.8987]. Sum: 0.9189 +0.9010=1.8199; +0.8997=2.7196; +0.8997=3.6193; +0.8987=4.518. Average ≈4.518/5 ≈0.9036.\n",
        "\n",
        "Model's precision is 0.68.\n",
        "\n",
        "Adjusted Similarity Score = (Avg. Approved Sim × Precision) - (Avg. Unapproved Sim × (1 - Precision)).\n",
        "\n",
        "Plugging in:\n",
        "\n",
        "(0.9349 * 0.68) - (0.9036 * (1 - 0.68)) = 0.6357 - (0.9036 * 0.32) ≈ 0.6357 - 0.2892 ≈0.3465. So adjusted score is ~0.35.\n",
        "\n",
        "Toxicity & Pharmacokinetics: The approved drugs have known toxicity profiles. For example, Escitalopram has overdose info, but no severe structural alerts. The non-approved ones might have less favorable profiles. Since compound X has no structural alerts, that's a positive sign. Also, looking at the approved similar drugs, their toxicity is manageable, suggesting compound X might as well.\n",
        "\n",
        "Now, the model performance: The classifier has high recall (0.975) but low specificity (0.20), meaning it's good at identifying approved drugs but has many false positives. Precision is 0.68, so when it predicts approved, 68% are correct. F1 is 0.80, which is decent.\n",
        "\n",
        "Combining all factors:\n",
        "\n",
        "- Drug-likeness score is 1.0, excellent.\n",
        "\n",
        "- ADMET: Assuming similar to approved drugs, which have acceptable profiles. Structural alerts none.\n",
        "\n",
        "- Adjusted similarity score positive (0.35), favoring approved.\n",
        "\n",
        "- Model's precision is 0.68, but with high recall. However, the adjusted score might offset some bias.\n",
        "\n",
        "But how to combine these? The user wants a final prediction. The high drug-likeness, no structural alerts, and similarity to approved compounds (especially Escitalopram which is very similar) suggest a higher chance of approval. The model's adjusted score is positive but not extremely high. However, the classifier itself has a precision of 0.68, meaning 68% of its positive predictions are correct. If the model is predicting compound X as approved (since it's asking for the prediction), then with 68% precision, but considering the high similarity to approved drugs, the likelihood might be higher.\n",
        "\n",
        "But wait, the user hasn't explicitly stated the model's prediction for compound X. The model outputs similar approved and non-approved molecules, but the actual prediction would be based on those similarities. The adjusted similarity score is a way to weigh the similarity towards approved, considering the model's precision. The adjusted score is positive (0.35), which might tip towards approved.\n",
        "\n",
        "Putting it all together, despite the model's moderate precision, the strong drug-likeness, structural safety, and high similarity to approved drugs (especially the top one being almost 0.98 similar to Escitalopram) suggest that compound X has a good chance of approval. However, the non-approved similar molecules are also quite similar (scores around 0.90), which might be a concern, but the adjusted score still favors approved.\n",
        "\n",
        "Final conclusion: Likely to be approved.\n",
        "\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "Bsqao1_dLnqp",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "406addad-5e18-4383-cead-5f5ba94801be"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-20-1bca7d5f674f>:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample.loc[n, \"think1\"] = \"\"\"\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.loc[n, \"answer1\"] = \"\"\"\n",
        "Analysis of Compound X's Approval Likelihood\n",
        "1. Drug-Likeness Rules\n",
        "Compound X passes all 4 drug-likeness rules (Lipinski, Veber, Ghose, Egan) with a normalized score of 1.0 (4/4 rules passed). Key highlights:\n",
        "\n",
        "Lipinski: MW = 324.4 (<500), LogP = 3.81 (<5), H-bond donors = 0 (<5), H-bond acceptors = 3 (<10).\n",
        "\n",
        "Veber: TPSA = 36.26 Å² (<140), rotatable bonds = 5 (<10).\n",
        "\n",
        "Ghose/Egan: All parameters (MW, LogP, MR, TPSA) within acceptable ranges.\n",
        "\n",
        "Conclusion: Excellent drug-likeness profile.\n",
        "\n",
        "2. ADMET & Structural Alerts\n",
        "ADMET: No direct data, but similarity to approved drugs (e.g., escitalopram, clopidogrel) suggests favorable absorption, metabolism, and toxicity profiles.\n",
        "\n",
        "Structural Alerts: None detected (passes PAINS/Brenk filters).\n",
        "\n",
        "3. Model Similarity & Bias Adjustment\n",
        "Avg. Approved Similarity: 0.935 (high similarity to escitalopram [0.985], rotigotine, clopidogrel).\n",
        "\n",
        "Avg. Unapproved Similarity: 0.904 (closest non-approved: cebranopadol [0.919], rucaparib).\n",
        "\n",
        "Adjusted Similarity Score:\n",
        "\n",
        "(\n",
        "0.935\n",
        "×\n",
        "0.68\n",
        ")\n",
        "−\n",
        "(\n",
        "0.904\n",
        "×\n",
        "0.32\n",
        ")\n",
        "=\n",
        "0.35\n",
        "(0.935×0.68)−(0.904×0.32)=0.35\n",
        "Positive score indicates bias toward approved drugs.\n",
        "\n",
        "4. Toxicity & Pharmacokinetics\n",
        "Similarity to approved drugs (e.g., escitalopram) suggests manageable toxicity (no cardiotoxicity/hepatotoxicity alerts).\n",
        "\n",
        "Pharmacokinetic parameters (e.g., rotatable bonds = 5, TPSA = 36.26) suggest good permeability and solubility.\n",
        "\n",
        "5. Model Performance Context\n",
        "High Recall (97.5%): Model rarely misses approved drugs (low false negatives).\n",
        "\n",
        "Low Specificity (20%): High false positives, but adjusted similarity score mitigates bias.\n",
        "\n",
        "Precision (68%): 68% of predicted \"approved\" compounds are truly approved.\n",
        "\n",
        "Final Prediction\n",
        "Compound X has a high likelihood of regulatory approval due to:\n",
        "\n",
        "Perfect drug-likeness score.\n",
        "\n",
        "High structural similarity to approved drugs (e.g., escitalopram).\n",
        "\n",
        "No structural alerts or toxicity red flags.\n",
        "\n",
        "Positive adjusted similarity score (0.35) despite model bias.\n",
        "\n",
        "Recommendation: Proceed to preclinical trials with focus on CYP450 metabolism and long-term toxicity studies.\n",
        "\n",
        "\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "ow7SkvpfMzJx",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "6f6d042c-a8f3-44d7-df21-56b66f1a4151"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-22-d78c3fe3e360>:1: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample.loc[n, \"answer1\"] = \"\"\"\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def get_second_prompt(label):\n",
        "    return f\"\"\"But wait the true answer is {label}. think step by step and tell why\"\"\"\n",
        "## reevaluation\n",
        "## on the second thought\n",
        "df_sample[\"2nd_prompt\"] = df_sample.apply(lambda x : get_second_prompt(x[\"status\"]) ,axis = 1)"
      ],
      "metadata": {
        "id": "EGWHOUlZUwQt",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "83e02f53-80d3-487d-e12d-f98674aafa68"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-23-cb5606af8c1c>:5: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample[\"2nd_prompt\"] = df_sample.apply(lambda x : get_second_prompt(x[\"status\"]) ,axis = 1)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"2nd_prompt\"][n]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 36
        },
        "id": "rlgyAvxSNotg",
        "outputId": "c29dde96-845e-47a0-d87c-a3ae12abe35b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'But wait the true answer is Approved. think step by step and tell why'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 24
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.loc[n , \"think2\"]= \"\"\"\n",
        "Okay, let's try to figure out why the compound X wasn't approved even though the initial analysis suggested it might be. First, I need to recall the data provided. The user mentioned that the model listed similar approved and non-approved molecules. The approved ones like Dexpanthenol, Miglustat, Glucosamine, and Nadolol had high similarity scores. The non-approved ones included Duvoglustat, Migalastat, Arbutin, and Indole-3-carbinol.\n",
        "\n",
        "The initial analysis looked at drug-likeness rules (Lipinski, Veber) and ADMET properties, and everything seemed okay. Molecular weight, LogP, TPSA, rotatable bonds—all within acceptable ranges. Toxicity data from similar approved drugs suggested low acute toxicity. So why the rejection?\n",
        "\n",
        "Hmm, maybe the answer lies in the specifics of the non-approved molecules. Let me check those again. Migalastat is mentioned as approved but under accelerated pathways, which sometimes means there's conditional approval pending further studies. Duvoglustat is investigational, so maybe it has issues. Arbutin is approved but for topical use, which is different from systemic administration. Indole-3-carbinol is investigational, possibly with unresolved safety issues.\n",
        "\n",
        "Wait, the user said the true answer is \"Not Approved.\" So what's missing here? Maybe the ADMET profile isn't as good as thought. Let's re-examine the ADMET part. The compound has low LogP (-1.14), which is quite hydrophilic. High solubility is good, but too low LogP can mean poor membrane permeability, making oral bioavailability challenging. Even if similar approved drugs have low LogP, maybe this compound's combination of properties leads to poor absorption despite passing the rules.\n",
        "\n",
        "Another angle: the similar non-approved drugs. If the compound is structurally closer to non-approved ones with issues, that's a red flag. For example, Migalastat's approval is under accelerated pathways with ongoing trials. If compound X's mechanism or metabolism mirrors a drug that later showed toxicity in confirmatory trials, that could be a problem.\n",
        "\n",
        "Also, looking at the approved analogs: Dexpanthenol is used topically or as a supplement. Miglustat is for a rare disease (Gaucher) with specific indications. If compound X is intended for a broader use, the safety profile might not hold up. The high similarity to Dexpanthenol might not translate to efficacy in a different therapeutic area.\n",
        "\n",
        "Toxicity data: The LD50 values from Dexpanthenol are high, but maybe compound X has off-target effects not captured in acute toxicity. Chronic toxicity or specific organ toxicity (like hepatotoxicity) could be a concern. The initial analysis didn't mention CYP interactions or detailed metabolism beyond what's in similar drugs. If compound X has unique metabolites that are toxic, that's a risk.\n",
        "\n",
        "Pharmacodynamics and mechanism of action: If the approved analogs work through well-understood mechanisms but compound X's MoA is novel or less understood, regulators might be cautious. The non-approved analogs might have mechanisms that failed in clinical trials, and similarity to those could be a negative.\n",
        "\n",
        "Another point: The presence of 4 hydrogen bond donors and acceptors. While within Lipinski's limits, this might lead to high polarity, affecting passive diffusion. Even if TPSA is under 140, the specific arrangement could hinder absorption.\n",
        "\n",
        "Also, the rotatable bonds (6) are at the higher end of Veber's criteria. This might increase molecular flexibility, potentially leading to poor bioavailability or rapid metabolism. Approved drugs with similar counts might have optimized structures that compound X lacks.\n",
        "\n",
        "Looking at the non-approved list, Arbutin is approved but for topical use. If compound X is intended for systemic use, the safety profile from topical applications doesn't guarantee safety orally or intravenously. Similarly, Indole-3-carbinol is investigational, possibly due to insufficient efficacy or safety concerns.\n",
        "\n",
        "Regulatory agencies also look at therapeutic need. If compound X is similar to existing drugs but doesn't offer significant advantages (e.g., better efficacy, fewer side effects), approval might be denied. The market might already be saturated with similar molecules.\n",
        "\n",
        "Lastly, maybe the model's similarity scores aren't the whole story. Structural similarity doesn't always translate to similar pharmacokinetics or dynamics. Subtle differences in the structure could lead to unexpected issues in clinical trials, like drug interactions or immune responses not seen in analogs.\n",
        "\n",
        "Putting it all together, despite passing initial drug-likeness and ADMET checks, compound X's high similarity to drugs with limited use (topical, rare diseases) or non-approved molecules, combined with potential bioavailability issues and lack of therapeutic innovation, likely led to its rejection.\n",
        "\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "w0BlmW5gOFQv"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.loc[n , \"answer2\"]= \"\"\"\n",
        "1. Critical Drug-Likeness and ADMET Red Flags\n",
        "Lipinski/VEBER Rule Limitations\n",
        "Low LogP (-1.14): Extremely hydrophilic, suggesting poor membrane permeability despite good solubility. While Lipinski’s rules are met, passive absorption for systemic delivery may fail (e.g., analogs like Dexpanthenol are used topically or in niche indications, not orally).\n",
        "\n",
        "High Rotatable Bonds (6): At the upper limit of Veber’s criteria, increasing metabolic instability and reducing bioavailability compared to optimized drugs like Miglustat.\n",
        "\n",
        "ADMET Weaknesses\n",
        "Absorption: Low LogP and moderate TPSA (89.79) indicate poor oral bioavailability. Approved analogs (e.g., Dexpanthenol) bypass this via non-oral routes (injection/topical).\n",
        "\n",
        "Toxicity Gaps:\n",
        "\n",
        "No Ames test data for mutagenicity. Structural similarity to non-mutagens is not definitive.\n",
        "\n",
        "Chronic toxicity risks (e.g., hepatotoxicity) are unaddressed. Non-approved analogs like Duvoglustat/Indole-3-carbinol highlight unresolved safety concerns.\n",
        "\n",
        "2. Structural Similarity to High-Risk Analogs\n",
        "Non-Approved Molecules\n",
        "Migalastat (0.866 similarity): Approved under accelerated pathways with ongoing confirmatory trials. Compound X’s similarity raises questions about long-term safety validation.\n",
        "\n",
        "Arbutin (0.865 similarity): Approved only for topical use. Systemic administration of Compound X may inherit unstudied risks (e.g., hydroquinone release).\n",
        "\n",
        "Duvoglustat/Indole-3-carbinol: Investigational status implies efficacy/safety failures in trials (e.g., anti-HIV activity abandoned due to toxicity).\n",
        "\n",
        "Approved Molecules with Niche Use\n",
        "Dexpanthenol: Topical/epithelial use only. Systemic efficacy unproven.\n",
        "\n",
        "Miglustat: Targets rare diseases (Gaucher/Niemann-Pick). Broad indications for Compound X may require stricter safety thresholds.\n",
        "\n",
        "3. Lack of Therapeutic Differentiation\n",
        "Mechanistic Redundancy: Overlaps with existing drugs (e.g., Glucosamine for joint health) without novel targets or improved efficacy.\n",
        "\n",
        "No Market Need: Similar to Nadolol (beta-blocker), which is no longer first-line due to newer selective agents.\n",
        "\n",
        "4. Hidden Metabolic/Toxicological Risks\n",
        "Metabolism: Unlike Miglustat (minimal hepatic metabolism), Compound X’s undefined metabolic pathway risks toxic metabolite formation.\n",
        "\n",
        "CYP450 Interactions: No data on enzyme inhibition/induction, critical for chronic use.\n",
        "\n",
        "Conclusion: Key Reasons for Rejection\n",
        "Poor Oral Bioavailability: Hydrophilicity and rotatable bonds limit systemic absorption.\n",
        "\n",
        "Structural Links to Non-Approved/High-Risk Drugs: Migalastat’s conditional approval and Arbutin’s topical-only use signal unaddressed risks.\n",
        "\n",
        "Lack of Therapeutic Innovation: Redundant mechanism without safety/efficacy advantages.\n",
        "\n",
        "Incomplete Toxicity Profile: Missing mutagenicity and chronic toxicity data.\n",
        "\n",
        "Final Verdict: Regulatory agencies prioritize risk-benefit balance. Compound X’s similarity to niche-use drugs, unresolved ADMET gaps, and lack of differentiation outweigh its drug-like properties. Not Approved.\n",
        "\n",
        "Recommendation: Redesign for improved permeability (e.g., prodrug) or pursue topical indications with rigorous chronic toxicity studies.\"\"\""
      ],
      "metadata": {
        "id": "ZZg9LNvNOTSm"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "## add posible routs(oral/topical):\n",
        "\n",
        "def get_third_prompt(label):\n",
        "    return  f\"\"\"\n",
        "    write your thinking in the following format\n",
        "    {{\"status(Approved/NonApproved)\": {label},\n",
        "    \"score(0=notapproved to 10=approved): \"\n",
        "    \"reason_to_be_approved\":\n",
        "    \"reason_to_be_notapproved\"   }}\n",
        "    \"\"\"\n",
        "df_sample[\"3rd_prompt\"] = df_sample.apply(lambda x : get_third_prompt(x[\"status\"]) ,axis = 1)"
      ],
      "metadata": {
        "id": "-VttoC3zWdif",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "f8747b48-a991-4bc9-b015-a2a890aee988"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "<ipython-input-132-b21bfb3cac8b>:11: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame.\n",
            "Try using .loc[row_indexer,col_indexer] = value instead\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  df_sample[\"3rd_prompt\"] = df_sample.apply(lambda x : get_third_prompt(x[\"status\"]) ,axis = 1)\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample[\"3rd_prompt\"][n]"
      ],
      "metadata": {
        "id": "Y4_eiAMAmQek",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 54
        },
        "outputId": "362bc667-74d3-4ed1-dd67-2dd7d7b5ed3f"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'\\n    write your thinking in the following format\\n    {\"status(Approved/NonApproved)\": Not Approved,\\n    \"score(0=notapproved to 10=approved): \"\\n    \"reason_to_be_approved\":\\n    \"reason_to_be_notapproved\"   }\\n    '"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 133
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.loc[n , \"think3\"]= \"\"\"\n",
        "Alright, the user wants me to format the previous analysis into a specific JSON structure. Let me start by recalling the conclusion from the last response: Compound X was deemed Not Approved.\n",
        "\n",
        "First, I need to assign a score. The original analysis mentioned strengths like meeting drug-likeness rules and similarity to approved drugs, but significant weaknesses in bioavailability and toxicity. Considering the balance, a score around 3.5/10 seems appropriate—low but not the absolute lowest.\n",
        "\n",
        "For \"reason_to_be_approved\", I should list the positives: adherence to Lipinski's and Veber's rules, similarity to safe approved drugs like Dexpanthenol, and low acute toxicity. These are valid points that could support approval under certain conditions.\n",
        "\n",
        "Now, \"reason_to_be_notapproved\" requires detailing the critical flaws. Poor oral bioavailability due to low LogP and high rotatable bonds is a key issue. Structural similarity to non-approved or topically used drugs like Arbutin and Migalastat (with their own risks) raises red flags. Lack of data on chronic toxicity and CYP interactions, plus no therapeutic innovation compared to existing drugs, are major hurdles. The market need isn't addressed, making approval unlikely.\n",
        "\n",
        "I need to ensure the JSON syntax is correct, with proper commas and quotes. Also, the score should be a float. Let me double-check each key and value to match the required format.\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "g75ZAIC8WjXb"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.loc[n , \"anwer3\"] = \"\"\"\n",
        "{\n",
        "    \"status(Approved/NonApproved)\": \"Not Approved\",\n",
        "    \"score(0=notapproved to 10=approved)\": 3.5,\n",
        "    \"reason_to_be_approved\": \"Compound X meets key drug-likeness rules (Lipinski/Veber), aligns structurally with safe approved drugs (e.g., Dexpanthenol, Miglustat), and shows low acute toxicity in analogs.\",\n",
        "    \"reason_to_be_notapproved\": \"1. **Poor oral bioavailability**: Extremely low LogP (-1.14) and high rotatable bonds (6) limit systemic absorption. 2. **Structural similarity to non-approved/topical drugs**: Migalastat (accelerated approval with unresolved safety) and Arbutin (topical-only use) suggest unaddressed systemic risks. 3. **Incomplete toxicity profile**: No Ames test or chronic toxicity data. 4. **No therapeutic differentiation**: Overlaps with existing drugs (e.g., Glucosamine) without novel mechanisms. 5. **Metabolic uncertainty**: Undefined CYP450 interactions and potential toxic metabolites.\"\n",
        "}\n",
        "\"\"\""
      ],
      "metadata": {
        "id": "vX_G-0s7WjDt"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_sample.to_csv(\"/content/drive/MyDrive/Papers/Original_Papers/Llm_drug_prediction/Code/reasoning_data_api/for_sft.csv\" , index = False)"
      ],
      "metadata": {
        "id": "RSSmjzh7SHPZ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "## training sft"
      ],
      "metadata": {
        "id": "PKyv_WfvXLeH"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "df_sft = pd.read_csv(\"/content/drive/MyDrive/Papers/Original_Papers/Llm_drug_prediction/Code/reasoning_data_api/for_sft.csv\" )"
      ],
      "metadata": {
        "id": "lkaBnV4lXTcq"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "df_sft"
      ],
      "metadata": {
        "id": "h9n8ZC3H5CyI",
        "outputId": "fc4f9f21-5868-4023-bcab-8e7fc466f5b9",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 711
        }
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                                              SMILES  labels  \\\n",
              "0            CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21       1   \n",
              "1  CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H...       1   \n",
              "2  CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c...       1   \n",
              "3                            CCCCCCCCCCCCCCCCCCCCCCO       1   \n",
              "4                            CC(C)(CO)C(O)C(=O)NCCCO       0   \n",
              "\n",
              "                                               Dicts  \\\n",
              "0  {'most_app':                                  ...   \n",
              "1  {'most_app':                                  ...   \n",
              "2  {'most_app':                                  ...   \n",
              "3  {'most_app':                                  ...   \n",
              "4  {'most_app':                                  ...   \n",
              "\n",
              "            list_of_most_approved_info_for_n_similar  \\\n",
              "0  [{'name': 'Escitalopram', 'similarity score': ...   \n",
              "1  [{'name': None, 'similarity score': 0.96003526...   \n",
              "2  [{'name': 'Atorvastatin', 'similarity score': ...   \n",
              "3  [{'name': 'Salmeterol', 'similarity score': 0....   \n",
              "4  [{'name': 'Dexpanthenol', 'similarity score': ...   \n",
              "\n",
              "         list_of_most_nonapproved_info_for_n_similar        status  \\\n",
              "0  [{'name': 'Cebranopadol', 'similarity score': ...      Approved   \n",
              "1  [{'name': None, 'similarity score': 0.83061236...      Approved   \n",
              "2  [{'name': 'Ritobegron', 'similarity score': 0....      Approved   \n",
              "3  [{'name': 'Ethanolamine oleate', 'similarity s...      Approved   \n",
              "4  [{'name': 'Duvoglustat', 'similarity score': 0...  Not Approved   \n",
              "\n",
              "                                          rdkit_info  \\\n",
              "0  {'Molecular_Weight': 324.39900000000006, 'LogP...   \n",
              "1  {'Molecular_Weight': 2296.970999999999, 'LogP'...   \n",
              "2  {'Molecular_Weight': 392.49900000000014, 'LogP...   \n",
              "3  {'Molecular_Weight': 326.60900000000004, 'LogP...   \n",
              "4  {'Molecular_Weight': 205.25399999999996, 'LogP...   \n",
              "\n",
              "                                          1st_prompt  \\\n",
              "0  \\n    \\nYou are a **chemist specializing in dr...   \n",
              "1  \\n    \\nYou are a **chemist specializing in dr...   \n",
              "2  \\n    \\nYou are a **chemist specializing in dr...   \n",
              "3  \\n    \\nYou are a **chemist specializing in dr...   \n",
              "4  \\n    \\nYou are a **chemist specializing in dr...   \n",
              "\n",
              "                                              think1  \\\n",
              "0  \\nOkay, let's tackle this analysis. The user w...   \n",
              "1  \\nOkay, let's start by looking at the data pro...   \n",
              "2  \\nOkay, let's start by looking at Compound X's...   \n",
              "3  \\nOkay, let's try to figure out whether compou...   \n",
              "4  \\nOkay, let me start by looking at the data pr...   \n",
              "\n",
              "                                             answer1  \\\n",
              "0  \\nBased on the analysis of Compound X's proper...   \n",
              "1  \\nAnalysis of Compound X's Drug Approval Poten...   \n",
              "2  \\nAnalysis of Compound X's Likelihood for Regu...   \n",
              "3  \\nAnalysis of Compound X's Drug Approval Likel...   \n",
              "4  \\nAnalysis of Compound X for Regulatory Approv...   \n",
              "\n",
              "                                          2nd_prompt  \\\n",
              "0  But wait the true answer is Approved. think st...   \n",
              "1  But wait the true answer is Approved. think st...   \n",
              "2  But wait the true answer is Approved. think st...   \n",
              "3  But wait the true answer is Approved. think st...   \n",
              "4  But wait the true answer is Not Approved. thin...   \n",
              "\n",
              "                                              think2  \\\n",
              "0  \\nOkay, let's see. The user previously asked f...   \n",
              "1                                                NaN   \n",
              "2  \\nOkay, so the user initially provided a detai...   \n",
              "3  \\nOkay, the user previously thought the compou...   \n",
              "4  \\nOkay, let's try to figure out why the compou...   \n",
              "\n",
              "                                             answer2  \\\n",
              "0  \\nStep-by-Step Explanation for Regulatory Appr...   \n",
              "1  \\nRevised Analysis: Why Compound X Could Be Ap...   \n",
              "2  \\n1. High Structural Similarity to Atorvastati...   \n",
              "3  \\n1. Drug-Likeness Rules Are Guidelines, Not A...   \n",
              "4  \\n1. Critical Drug-Likeness and ADMET Red Flag...   \n",
              "\n",
              "                                          3rd_prompt  \\\n",
              "0  \\n    write your thinking in the following for...   \n",
              "1  \\n    write your thinking in the following for...   \n",
              "2  \\n    write your thinking in the following for...   \n",
              "3  \\n    write your thinking in the following for...   \n",
              "4  \\n    write your thinking in the following for...   \n",
              "\n",
              "                                              think3  \\\n",
              "0  \\nOkay, let's tackle this step by step. The us...   \n",
              "1  \\nOkay, let's tackle this. The user wants the ...   \n",
              "2  \\nAlright, let's tackle this query step by ste...   \n",
              "3  \\nOkay, let's tackle this. The user wants me t...   \n",
              "4  \\nAlright, the user wants me to format the pre...   \n",
              "\n",
              "                                              anwer3  \n",
              "0  \\n{\\n    \"status(Approved/NonApproved)\": \"Appr...  \n",
              "1  \\n{\\n    \"status(Approved/NonApproved)\": \"Appr...  \n",
              "2  \\n{\\n    \"status(Approved/NonApproved)\": \"Appr...  \n",
              "3  \\n{\\n    \"status(Approved/NonApproved)\": \"Appr...  \n",
              "4  \\n{\\n    \"status(Approved/NonApproved)\": \"Not ...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-8b82f78f-f364-45ee-ab71-9d60117c98ef\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>SMILES</th>\n",
              "      <th>labels</th>\n",
              "      <th>Dicts</th>\n",
              "      <th>list_of_most_approved_info_for_n_similar</th>\n",
              "      <th>list_of_most_nonapproved_info_for_n_similar</th>\n",
              "      <th>status</th>\n",
              "      <th>rdkit_info</th>\n",
              "      <th>1st_prompt</th>\n",
              "      <th>think1</th>\n",
              "      <th>answer1</th>\n",
              "      <th>2nd_prompt</th>\n",
              "      <th>think2</th>\n",
              "      <th>answer2</th>\n",
              "      <th>3rd_prompt</th>\n",
              "      <th>think3</th>\n",
              "      <th>anwer3</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Escitalopram', 'similarity score': ...</td>\n",
              "      <td>[{'name': 'Cebranopadol', 'similarity score': ...</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular_Weight': 324.39900000000006, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "      <td>\\nOkay, let's tackle this analysis. The user w...</td>\n",
              "      <td>\\nBased on the analysis of Compound X's proper...</td>\n",
              "      <td>But wait the true answer is Approved. think st...</td>\n",
              "      <td>\\nOkay, let's see. The user previously asked f...</td>\n",
              "      <td>\\nStep-by-Step Explanation for Regulatory Appr...</td>\n",
              "      <td>\\n    write your thinking in the following for...</td>\n",
              "      <td>\\nOkay, let's tackle this step by step. The us...</td>\n",
              "      <td>\\n{\\n    \"status(Approved/NonApproved)\": \"Appr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H...</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': None, 'similarity score': 0.96003526...</td>\n",
              "      <td>[{'name': None, 'similarity score': 0.83061236...</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular_Weight': 2296.970999999999, 'LogP'...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "      <td>\\nOkay, let's start by looking at the data pro...</td>\n",
              "      <td>\\nAnalysis of Compound X's Drug Approval Poten...</td>\n",
              "      <td>But wait the true answer is Approved. think st...</td>\n",
              "      <td>NaN</td>\n",
              "      <td>\\nRevised Analysis: Why Compound X Could Be Ap...</td>\n",
              "      <td>\\n    write your thinking in the following for...</td>\n",
              "      <td>\\nOkay, let's tackle this. The user wants the ...</td>\n",
              "      <td>\\n{\\n    \"status(Approved/NonApproved)\": \"Appr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c...</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Atorvastatin', 'similarity score': ...</td>\n",
              "      <td>[{'name': 'Ritobegron', 'similarity score': 0....</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular_Weight': 392.49900000000014, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "      <td>\\nOkay, let's start by looking at Compound X's...</td>\n",
              "      <td>\\nAnalysis of Compound X's Likelihood for Regu...</td>\n",
              "      <td>But wait the true answer is Approved. think st...</td>\n",
              "      <td>\\nOkay, so the user initially provided a detai...</td>\n",
              "      <td>\\n1. High Structural Similarity to Atorvastati...</td>\n",
              "      <td>\\n    write your thinking in the following for...</td>\n",
              "      <td>\\nAlright, let's tackle this query step by ste...</td>\n",
              "      <td>\\n{\\n    \"status(Approved/NonApproved)\": \"Appr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>CCCCCCCCCCCCCCCCCCCCCCO</td>\n",
              "      <td>1</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Salmeterol', 'similarity score': 0....</td>\n",
              "      <td>[{'name': 'Ethanolamine oleate', 'similarity s...</td>\n",
              "      <td>Approved</td>\n",
              "      <td>{'Molecular_Weight': 326.60900000000004, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "      <td>\\nOkay, let's try to figure out whether compou...</td>\n",
              "      <td>\\nAnalysis of Compound X's Drug Approval Likel...</td>\n",
              "      <td>But wait the true answer is Approved. think st...</td>\n",
              "      <td>\\nOkay, the user previously thought the compou...</td>\n",
              "      <td>\\n1. Drug-Likeness Rules Are Guidelines, Not A...</td>\n",
              "      <td>\\n    write your thinking in the following for...</td>\n",
              "      <td>\\nOkay, let's tackle this. The user wants me t...</td>\n",
              "      <td>\\n{\\n    \"status(Approved/NonApproved)\": \"Appr...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>CC(C)(CO)C(O)C(=O)NCCCO</td>\n",
              "      <td>0</td>\n",
              "      <td>{'most_app':                                  ...</td>\n",
              "      <td>[{'name': 'Dexpanthenol', 'similarity score': ...</td>\n",
              "      <td>[{'name': 'Duvoglustat', 'similarity score': 0...</td>\n",
              "      <td>Not Approved</td>\n",
              "      <td>{'Molecular_Weight': 205.25399999999996, 'LogP...</td>\n",
              "      <td>\\n    \\nYou are a **chemist specializing in dr...</td>\n",
              "      <td>\\nOkay, let me start by looking at the data pr...</td>\n",
              "      <td>\\nAnalysis of Compound X for Regulatory Approv...</td>\n",
              "      <td>But wait the true answer is Not Approved. thin...</td>\n",
              "      <td>\\nOkay, let's try to figure out why the compou...</td>\n",
              "      <td>\\n1. Critical Drug-Likeness and ADMET Red Flag...</td>\n",
              "      <td>\\n    write your thinking in the following for...</td>\n",
              "      <td>\\nAlright, the user wants me to format the pre...</td>\n",
              "      <td>\\n{\\n    \"status(Approved/NonApproved)\": \"Not ...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-8b82f78f-f364-45ee-ab71-9d60117c98ef')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-8b82f78f-f364-45ee-ab71-9d60117c98ef button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-8b82f78f-f364-45ee-ab71-9d60117c98ef');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-5ebb07cf-bca6-48f5-b4ef-bce2ad83fbdd\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-5ebb07cf-bca6-48f5-b4ef-bce2ad83fbdd')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-5ebb07cf-bca6-48f5-b4ef-bce2ad83fbdd button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_e087b45c-40db-4a2f-b18b-17ba0c3322a3\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df_sft')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_e087b45c-40db-4a2f-b18b-17ba0c3322a3 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('df_sft');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df_sft",
              "summary": "{\n  \"name\": \"df_sft\",\n  \"rows\": 5,\n  \"fields\": [\n    {\n      \"column\": \"SMILES\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O\",\n          \"CC(C)(CO)C(O)C(=O)NCCCO\",\n          \"CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"labels\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 0,\n        \"min\": 0,\n        \"max\": 1,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          0,\n          1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Dicts\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"{'most_app':                                                  SMILES  labels       sim\\n1586  CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C...       1  0.960035\\n353   CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C...       1  0.953127\\n1959  CCC(C)CCCCC(=O)N(C)[C@@H](CCN)C(=O)N[C@@H](CN[...       1  0.952627\\n80    CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[...       1  0.949965\\n486   CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)...       1  0.842993, 'most_nonapp':                                                  SMILES  labels       sim\\n1265  CCCCCCCC(=O)OC[C@H](NC(=O)CNC(=O)[C@@H](N)CCCN...       0  0.830612\\n2181  CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H]...       0  0.823622\\n2102  CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23...       0  0.804892\\n1873  CCCCCCC(=O)N[C@@H]1CSSC[C@@H](C(=O)N[C@@H](Cc2...       0  0.795840\\n2221  CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H...       0  0.793728}\",\n          \"{'most_app':                                             SMILES  labels       sim\\n437                   CC(C)(CO)[C@@H](O)C(=O)NCCCO       1  0.958293\\n821       CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO       1  0.887804\\n2103        N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O       1  0.886478\\n669   N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O       1  0.882193\\n1294  CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2       1  0.878921, 'most_nonapp':                                                  SMILES  labels       sim\\n1882                OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O       0  0.866367\\n1044                 OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O       0  0.866367\\n911               Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O       0  0.865844\\n674   OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)...       0  0.864764\\n117                                  OCc1c[nH]c2ccccc12       0  0.861736}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"list_of_most_approved_info_for_n_similar\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"[{'name': None, 'similarity score': 0.9600352644920349, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.953127384185791, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.952626645565033, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.9499645233154297, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Bacitracin', 'similarity score': 0.8429930210113525, 'approval groups': ['approved', 'vet_approved'], 'average mass': 1422.693, 'half life': 'Data regarding the half life of bacitracin in humans is not readily available.[A181997]', 'toxicity': 'The oral LD<sub>50</sub> of bacitracin in rats is >2000mg/kg.[L7775]\\\\r\\\\n\\\\r\\\\nSpecific data regarding bacitracin overdoses is not readily available.[T662] An overdose of bacitracin may lead to nephrotoxicity[A181997] and patients should be treated with supportive measures.', 'indication': 'Bacitracin is indicated in topical formulations for acute and chronic localized skin infections.[A181997] Occasionally, it is also used intramuscularly for infantile streptococcal pneumonia and empyema.[A181997] Bacitracin is also formulated as an ointment with neomycin and polymyxin B for over the counter use.[A181997,L7769] A bacitracin ointment formulated with neomycin and polymyxin B along with hydrocortisone is indicated for the treatment of corticosteroid responsive dermatoses with secondary infection.[L7772]', 'pharmacodynamics': 'Bacitracin is a mixture of polypeptides that prevent the formation of the bacterial cell wall and oxidatively cleave DNA.[A954] It has a short duration of action as it must be given every 3 to 4 hours topically.[L7769,L7772] Bacitracin is nephrotoxic when given intramuscularly and may lead to renal failure.[A181997]', 'mechanism of action': 'Bacitracin binds to a divalent metal ion such as Mn(II), Co(II), Ni(II), Cu(II), or Zn(II).[A954] These complexes bind C<sub>55</sub>-isoprenyl pyrophosphate, preventing the hydrolysis of a lipid dolichol pyrophosphate, which finally inhibits cell wall synthesis.[A954] Bacitracin metal complexes also bind and oxidatively cleave DNA.[A954]', 'metabolism': 'Data regarding the metabolism of bacitracin in humans is not readily available.[A181997] Because bacitracin is a protein it is expected to be metabolized into smaller polypeptides and amino acids.[A182009] However, the structure of bacitracin may afford it some protection from the action of proteases.[A954]', 'descriptions': 'Bacitracin is a combination of at least 9 bacitracins.[A955,A181952] 60-80% of commercially prepared bacitracin is bacitracin A.[A181952] The bacillus that produces bacitracin was first isolated from a knee scrape in 1945 from the knee wound of a child named Margaret Tracy.[A181952]\\\\r\\\\n\\\\r\\\\nBacitracin was granted FDA approval on 29 July 1948.[A181997,L7748]'}]\",\n          \"[{'name': 'Dexpanthenol', 'similarity score': 0.958292543888092, 'approval groups': ['approved'], 'average mass': 205.2515, 'half life': 'Half life have not been reported', 'toxicity': 'Mouse LD50 : 9gm/kg (Intraperitoneal)\\\\r\\\\nMouse: LD50 7gm/kg (Intravenous)\\\\r\\\\nMouse: LD50 15gm/kg (Oral)\\\\r\\\\nRabbit LD50 4gm/kg (Oral)', 'indication': 'Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.\\\\r\\\\n\\\\r\\\\nTopical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy). ', 'pharmacodynamics': 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'mechanism of action': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373].  \\\\r\\\\n\\\\r\\\\nDermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n', 'metabolism': 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.', 'descriptions': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373]. \\\\r\\\\n\\\\r\\\\nDue to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n\\\\r\\\\nDexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as [DB11204]. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.'}, {'name': 'Miglustat', 'similarity score': 0.8878036737442017, 'approval groups': ['approved'], 'average mass': 219.278, 'half life': 'The effective half-life of miglustat is approximately 6 to 7 hours.', 'toxicity': 'Miglustat has been administered at doses of up to 3000 mg/day (approximately 10 times the recommended starting dose administered to Gaucher patients) for up to six months in Human Immunodeficiency Virus (HIV)-positive patients. Adverse events observed in the HIV studies included granulocytopenia, dizziness, and paresthesia. Leukopenia and neutropenia have also been observed in a similar group of patients receiving 800 mg/day or above.', 'indication': \\\"For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C). \\\", 'pharmacodynamics': \\\"Miglustat, an N-alkylated imino sugar, is a synthetic analogue of D-glucose. Miglustat is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for catalyzing the formation of glucosylceramide (glucocerebroside). Glucosylceramide is a substrate for the endogenous glucocerebrosidase, an enzyme that is deficient in Gaucher's disease. The accumulation of glucosylceramide due to the absence of glucocerebrosidase results in the storage of this material in the lysosomes of tissue macrophages, leading to widespread pathology due to infiltration of lipid-engorged macrophages in the viscera, lymph nodes, and bone marrow. This results in secondary hematologic consequences including sever anemia and thrombocytopenia, in addition to the characteristic progressive hepatosplenomegaly, as well as skeletal complications including osteonecrosis and osteopenia with secondary pathological fractures.\\\", 'mechanism of action': 'Miglustat functions as a competitive and reversible inhibitor of the enzyme glucosylceramide synthase, the initial enzyme in a series of reactions which results in the synthesis of most glycosphingolipids. The goal of treatment with miglustat is to reduce the rate of glycosphingolipid biosynthesis so that the amount of glycosphingolipid substrate is reduced to a level which allows the residual activity of the deficient glucocerebrosidase enzyme to be more effective (substrate reduction therapy), reducing the accumulation of glucocerebroside in macrophages. In vitro and in vivo studies have shown that miglustat can reduce the synthesis of glucosylceramide-based glycosphingolipids. In clinical trials, miglustat improved liver and spleen volume, as well as hemoglobin concentration and platelet count. Inhibition of glycosphingolipid synthesis has also shown to reduce intracellular lipid storage, improve fluid-phase endosomal uptake and normalize lipid transport in peripheral blood B lymphocytes of NP-C patients, which results in a decrease in the potentially neurotoxic accumulation of gnagliosides G<sub>M2</sub> and G<sub>M3</sub>, lactosylceramide and glucosylceramide, possibly preventing further neuronal damage. Other studies have also suggested that miglustat may indirectly modulate intracellular calcium homeostasis through its effects on glucosylceramide levels, and evidence has shown that an initiating factor in the pathogenesis of NP-C may be impaired calcium homeostasis related to sphingosine storage. Therefore, the effect that miglustat exerts on intracellular calcium levels may influence an important underlying pathogenic mechanism of NP-C.', 'metabolism': 'There is no evidence that miglustat is metabolized in humans.', 'descriptions': 'Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. Miglustat was first developed as an anti-HIV agent in the 1990s. However, clinical experience with miglustat showed that therapeutic levels of the drug could not be achieved in patients without a high incidence of adverse effect.'}, {'name': 'Glucosamine', 'similarity score': 0.8864784836769104, 'approval groups': ['approved', 'investigational'], 'average mass': 179.1711, 'half life': 'The estimated half-life for glucosamine is 15 hours after an oral dose.[A232279] After a bolus intravenous injection of 1005 mg crystalline glucosamine sulfate, the parent drug has an apparent half life of 1.11 hours.[A232274]', 'toxicity': 'The oral LD50 of glucosamine in rats is >5000 mg/kg.[L32684] Symptoms of an overdose with glucosamine may include nausea, vomiting, abdominal pain, and diarrhea (common side effects of this drug). Severe and life-threatening hypersensitivity reactions to glucosamine may occur in patients with a shellfish allergy or asthma.[L32774]', 'indication': 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'pharmacodynamics': 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'mechanism of action': 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-\\u03baB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'metabolism': 'Glucosamine undergoes metabolism in the liver.[A232274] Metabolism information for glucosamine is limited in the literature.', 'descriptions': 'Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation.[A232289] Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional benefits to nonsteroidal anti-inflammatory drugs treating the painful symptoms of OA. Glucosamine is commonly used over the counter as a treatment for arthritic joint pain, although its acceptance as a medical therapy varies due to contradictory and findings with unclear clinical significance during clinical trials.[A231894,A232289] It is currently not approved as a prescription product by the FDA, but is widely available over the counter.'}, {'name': None, 'similarity score': 0.8821925520896912, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Nadolol', 'similarity score': 0.8789207935333252, 'approval groups': ['approved'], 'average mass': 309.4006, 'half life': 'The half life of nadolol is 20 to 24 hours.[L7922,L7925]', 'toxicity': 'The oral LD<sub>50</sub> in mice is 4500mg/kg.[L7934]\\\\r\\\\n\\\\r\\\\nPatients experiencing an overdose may present with bradycardia, cardiac failure, hypotension, and bronchospasm.[L7922,L7925] An overdose may be treated with atropine for bradycardia, digitalis and diuretics for cardiac failure, vasopressors for hypotension, and beta-2 stimulants for bronchospasms, as well as gastric lavage and hemodialysis.[L7922,L7925]', 'indication': 'Nadolol is indicated to treat angina pectoris and hypertension.[L7922] Another product formulated with [bendroflumethiazide] is indicated to treat hypertension.[L7925]', 'pharmacodynamics': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] It has a long duration of action as it is usually taken once daily and a wide therapeutic index as patients start at doses of 40mg daily but may be increased to doses as high as 240mg daily.[L7922,L7925] Patients taking nadolol should not aburptly stop taking it as this may lead to exacerbation of ischemic heart disease.[L7922,L7925]', 'mechanism of action': 'Although nadolol is described as a non selective beta blocker, it does not interact with beta 3 adrenal receptors.[A182402] Antagonism of beta-1 and beta-2 adrenoceptors in the heart inhibits cyclic AMP and its signalling pathway, decreasing the strength and speed of contractions as well as the speed of relaxation and conduction.[A34177] Antagonism of beta-2 adrenoceptors in the smooth muscle cells of the vasculature inhibits their relaxation, leading to an increase in peripheral vascular resistance and reducing the risk of severe hypotension.[A34177] The increase in peripheral vascular resistance may contribute to the decrease in insulin sensitivity associated with nadolol use.[A182441] Antagonism of beta-1 adrenoceptors in the juxtaglomerular apparatus of the kidney inhibits the release of renin, and therefore angiotensin II mediated vasoconstriction, aldosterone mediated water retention, and the release of epinephrine.[A34177] Antagonism of beta-2 adrenoceptors in the liver and skeletal muscle inhibits glycogenolysis, in the lungs prevents bronchodilation, and in the pancrease inhibits insulin release.[A34177]', 'metabolism': 'Nadolol is not metabolized by the liver in humans.[A182423,L7922,L7925]', 'descriptions': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects.[A34177]\\\\r\\\\n\\\\r\\\\nNadolol was granted FDA approval on 10 December 1979.[L7922]'}]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"list_of_most_nonapproved_info_for_n_similar\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"[{'name': None, 'similarity score': 0.8306123614311218, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.8236221671104431, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Murepavadin', 'similarity score': 0.8048920631408691, 'approval groups': ['investigational'], 'average mass': 1553.837, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).'}, {'name': 'PL-3994', 'similarity score': 0.7958396673202515, 'approval groups': ['investigational'], 'average mass': 1875.21, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).'}, {'name': None, 'similarity score': 0.793728232383728, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}]\",\n          \"[{'name': 'Duvoglustat', 'similarity score': 0.8663665652275085, 'approval groups': ['investigational'], 'average mass': 163.1717, 'half life': '', 'toxicity': 'ORL-RAT LD<sub>50</sub>: &gt; 5g/kg.\\\\r\\\\n', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.'}, {'name': 'Migalastat', 'similarity score': 0.8663665652275085, 'approval groups': ['approved', 'investigational'], 'average mass': 163.1717, 'half life': 'The mean elimination half-life (t1/2) of migalastat ranges from approximately 3 to 5 hours for a single oral dose of 150 mg.[L47057] For the dose of 123 mg, the mean elimination half-life was estimated to be 4 hours.[L47036]', 'toxicity': 'The most common adverse reactions reported with migalastat (\\u2265 10%) during the 6-month placebo-controlled, double-blind phase of its Study 1 clinical studies were headache, nasopharyngitis, urinary tract infection, nausea, and pyrexia [FDA Label, F1107].\\\\r\\\\n\\\\r\\\\nIn case of overdose, general medical care is recommended [FDA Label, F1107]. Headache and dizziness were the most common adverse reactions reported at doses of migalastat of up to 1250 mg and 2000 mg, respectively [FDA Label, F1107].', 'indication': 'Migalastat is approved by the FDA for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.[L47036] \\\\r\\\\n\\\\r\\\\nThis indication is approved under accelerated approval based on a reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.[L47036]\\\\r\\\\n\\\\r\\\\nMigalastat is also approved by the EMA and Health Canada to treat the same disease, although it is approved for both adults and adolescents aged 16 years and older in Europe.[L47057,L47087]', 'pharmacodynamics': 'In general, treatment in patients with migalastat in Phase 2 pharmacodynamic trials resulted in increases in endogenous alpha-galactosidase (alpha-Gal A) activity in white blood cells, as well as in skin and kidney for the majority of patients [FDA Label, F1107]. In patients with amenable galactosidase alpha gene (GLA) mutations, globotriaosylceramide (GL-3) levels tended to decrease in the urine and in the kidney interstitial capillaries.[L47057]\\\\r\\\\n\\\\r\\\\nIn an in vitro assay (HEK-293 assay), Human Embryonic Kidney (HEK-293) cell lines were transfected with specific GLA variants (mutations) which produced mutant alpha-Gal A proteins. In the transfected cells, amenability of the GLA variants was assessed after a 5-day incubation with 10 micromol/L migalastat. A GLA variant was categorized as amenable if the resultant mutant alpha-Gal A activity (measured in the cell lysates) met two criteria: 1) it showed a relative increase of at least 20% compared to the pre-treatment alpha-Gal A activity, and 2) it showed an absolute increase of at least 3% of the wild-type (normal) alpha-Gal activity. The in vitro assay did not evaluate the trafficking of the mutant alpha-Gal A proteins into the lysosome or the dissociation of migalastat from the mutant alpha-Gal A proteins within the lysosome. Also, the in vitro assay did not test whether a GLA variant causes Fabry disease or not.[L47036] ', 'mechanism of action': 'Fabry disease is a progressive X-linked lysosomal storage disorder that affects males and females [FDA Label, F1107]. Fabry disease-causing mutations occur in the galactosidase alpha (GLA) gene and result in a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) that is required for glycosphingolipid substrate (GL-3 and lyso-Gb3) metabolism [FDA Label, F1107]. Reduced alpha-Gal A activity is, therefore, associated with the progressive accumulation of glycosphingolipid substrate in vulnerable organs and tissues, which ultimately leads to the morbidity and mortality associated with Fabry disease.[L47057]\\\\r\\\\n\\\\r\\\\nMigalastat is a pharmacological chaperone that reversibly binds to the active site of the alpha-galactosidase A (alpha-Gal A) protein (encoded by the galactosidase alpha gene, GLA), which is deficient in Fabry disease. This binding stabilizes alpha-Gal A allowing its trafficking from the endoplasmic reticulum into the lysosome where it exerts its action. In the lysosome, at a lower pH and at a higher concentration of relevant substrates, migalastat dissociates from alpha-Gal A allowing it to break down the glycosphingolipids globotriaosylceramide (GL-3) and globotriaosylsphingosine (lyso-Gb3). Certain GLA variants (mutations) causing Fabry disease result in the production of abnormally folded and less stable forms of the alpha-Gal A protein which, however, retain enzymatic activity. Those GLA variants, referred to as amenable variants, produce alpha-Gal A proteins that may be stabilized by migalastat thereby restoring their trafficking to lysosomes and their intralysosomal activity.[L47036] \\\\r\\\\n\\\\r\\\\nThe GLA mutations that are amenable and not amenable to treatment with migalastat are regularly maintained and updated on online sites that are readily accessible by healthcare providers.[L47036]   ', 'metabolism': 'Based upon in vivo data, migalastat is a substrate for uridine diphosphate glucuronosyltransferase (otherwise known as UGT or UDPGT), being a minor elimination pathway.[L47036]', 'descriptions': \\\"Fabry disease is a rare, progressive genetic disorder characterized by a defective GLA gene that causes a deficiency in the enzyme alpha-Galactosidase A (alpha-Gal A). This enzyme is responsible for breaking down glycosphingolipid substrate that, when deficient in patients with Fabry disease, builds up in the blood vessels, the kidneys, the nerves, the heart, and other organs.[L47036,L47057,L4274,L4278] In the U.S., it is estimated that more than 3,000 people are living with Fabry disease, and an estimated more than 50 percent of these diagnosed patients are currently untreated.[L4274]\\\\r\\\\n\\\\r\\\\nMigalastat (approved and sold under Amicus Therapeutics' brand name Galafold) is subsequently an oral pharmacological chaperone of alpha-Gal A for the treatment of Fabry disease in adults who have amenable GLA variants.[L47036,L47057,L4274,L4278] In these patients, migalastat works by stabilizing the body\\u2019s dysfunctional alpha-Gal A enzyme so that it can clear the accumulation of glycosphingolipid disease substrate.[L47036,L47057,L4274,L4278] Globally, it is estimated that approximately 35 to 50 percent of Fabry patients may have amenable GLA variants that are treatable with migalastat. [L4274]\\\\r\\\\n\\\\r\\\\nGiven the rarity of Fabry disease and the proportion of Fabry disease patients that could benefit from migalastat therapy, Amicus Therapeutics' brand name Galafold was approved using the Accelerated Approval pathway, under which the FDA may approve drugs for serious conditions where there is an unmet medical need and where a drug is shown to have certain effects that are reasonably likely to predict a clinical benefit to patients.[L47036,L47057,L4274,L4278] A further study is required to verify and describe the clinical benefits of Galafold, and the sponsor will be conducting a confirmatory clinical trial of Galafold in adults with Fabry disease.[L47036,L47057,L4274,L4278]\\\\r\\\\n\\\\r\\\\nAdditionally, Galafold was also granted Priority Review designation, under which the FDA\\u2019s goal is to take action on an application within six months of application filing where the agency determines that the drug if approved, would provide a significant improvement in treating, diagnosing or preventing a serious condition over available therapies.[L47036,L47057] Galafold also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.[L47036,L47057]\\\\r\\\\n\\\\r\\\\nAs of August 2018, migalastat under Amicus Therapeutics' brand name Galafold is currently approved in Australia, Canada, European Union, Israel, Japan, South Korea, Switzerland, and the United States.[L4274]\\\"}, {'name': None, 'similarity score': 0.8658441305160522, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Arbutin', 'similarity score': 0.8647643327713013, 'approval groups': ['approved'], 'average mass': 272.2512, 'half life': 'No pharmacokinetic data available. ', 'toxicity': 'In an acute oral toxicity study, the LD50-value for \\u03b2-arbutin is 9804 mg/kg bw for the mouse and 8715 mg/kg bw for the rat [F44]. Dermal LD50 value in rat and mouse was reported to be greater than 928 mg/kg bw, according to an acute dermal toxicity study [F44]. Extremely high doses may cause ringing in the ears, shortness of breath, convulsions, collapse, vomiting and delirium [F43]. Nausea and vomiting were seen individuals with sensitive stomachs following oral ingestion of 15 g of dried uva ursi leaves that contain arbutin [F43]. ', 'indication': 'Indicated for over-the-counter use for epidermal hyperpigmentation in various skin conditions, such as melasma, freckles, and senile lentigines. ', 'pharmacodynamics': 'At non-toxic concentrations, arbutin inhibited the activity of tyrosinase in cultured human keratinocytes, while having minimal effect on the expression of tyrosinase mRNA or the synthesis of the enzyme [A27248]. \\u03b1-Arbutin produced a concentration-dependent inhibition of melanin synthesis of human melanoma cells, HMV-II [A32939]. No inhibitory effect on HMV-II cell growth was seen at concentrations lower than 1.0 mM. At concentrations of 0.5 mM of arbutin, tyrosinase activity was reduced to 60% of that in non-treated cells [A32939]. The addition of arbutin blocked and inhibited \\u03b1-MSH-stimulated melanogenesis in B16 melanoma cells, brownish guinea pig, and human skin tissue [A32940]. In a pilot study of healthy male adults exposed to UV B irradiation, topical administration of arbutin inhibited UV-induced nuclear factor-kappaB activation in human keratinocytes [F43]. In mouse skin, arbutin counteracted oxidative stress induced by 12-O-tetradecanoylphorbol-13-acetate [F43].', 'mechanism of action': 'Arbutin is a hydroquinone glycoside, however the hydroquinone moiety is not solely responsible for the de-pigmentating actions of arbutin [A32942]. It acts as a competitive inhibitor of tyrosinase enzyme by acting on the L-tyrosine binding site to suppress melanogenesis and mediate its de-pigmenting actions on human skin [A27248]. Tyrosinase is an enzyme involved in the regulation of rate-limiting steps during the synthesis of melanin; it regulates the conversion of L-tyrosine into L-dopa, and subsequent conversion of L-dopa to L-dopaquinone [A27248]. Via inhibition of tyrosinase activity in a concentration-dependent manner, arbutin attenuates the production of melanin in melanocytes. While most studies suggest that arbutin has negligible effect on the tyrosinase mRNA expression, a study assessing the effect of arbutin on melanocyte differentiation inducement system using ES cells propose that arbutin may also downregulate the expression of tyrosinase in addition to its inhibitory action on the enzyme [A32938]. The contradictory findings across studies may be due to previous studies using terminally-differentiated melanocytes and melanoma cells [A32938]. ', 'metabolism': 'Arbutin is readily susceptible to hydrolysis in dilute acids to yield D-glucose and hydroquinone. It is expected that orally administered arbutin is easily hydrolyzed to free hydroquinone molecules by stomach acid [F43]. Hydroquinone is further metabolized into the main metabolites, hydroquinone glucuronide and hydroquinone sulfate [F43]. ', 'descriptions': 'Extracted from the dried leaves of bearberry plant in the genus _Arctostaphylos_ and other plants commonly in the _Ericaceae_ family, arbutin is a beta-D-glucopyranoside of [DB09526]. It is found in foods, over-the-counter drugs, and herbal dietary supplements [F43]. Most commonly, it is an active ingredient in skincare and cosmetic products as a skin-lightening agent for the prevention of melanin formation in various skin conditions that involve cutaneous hyperpigmentation or hyperactive melanocyte function [A27248]. It has also been used as an anti-infective for the urinary system as well as a diuretic [F43]. Arbutin is available in both natural and synthetic forms; it can be synthesized from acetobromglucose and [DB09526] [F43]. Arbutin is a competitive inhibitor of tyrosinase (E.C.1.14.18.1) in melanocytes [A27248], and the inhibition of melanin synthesis at non-toxic concentrations was observed _in vitro_. Arbutin was shown to be less cytotoxic to melanocytes in culture compared to [DB09526] [A32942].'}, {'name': 'Indole-3-carbinol', 'similarity score': 0.8617359399795532, 'approval groups': ['investigational'], 'average mass': 147.1739, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).'}]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"status\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"Not Approved\",\n          \"Approved\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"rdkit_info\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"{'Molecular_Weight': 2296.970999999999, 'LogP': -10.32609999999995, 'Molecular_Refractivity': 606.0736000000024, 'TPSA': 947.18, 'Hydrogen_Bond_Donors': 36, 'Hydrogen_Bond_Acceptors': 36, 'Rotatable_Bonds': 59, 'Chiral_Centers': [(10, 'S'), (17, 'S'), (20, 'S'), (27, 'S'), (33, 'S'), (34, 'R'), (40, 'S'), (47, 'S'), (54, 'S'), (62, 'R'), (70, 'S'), (77, 'R'), (91, 'S'), (98, 'S'), (101, 'S'), (108, 'S'), (114, 'S'), (115, 'R'), (121, 'S'), (128, 'S'), (135, 'S'), (143, 'R'), (151, 'S'), (158, 'R')]}\",\n          \"{'Molecular_Weight': 205.25399999999996, 'LogP': -1.1355999999999997, 'Molecular_Refractivity': 51.58610000000003, 'TPSA': 89.79, 'Hydrogen_Bond_Donors': 4, 'Hydrogen_Bond_Acceptors': 4, 'Rotatable_Bonds': 6, 'Chiral_Centers': []}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"1st_prompt\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\n    \\nYou are a **chemist specializing in drug discovery and molecular modeling**, tasked with analyzing chemical compounds for drug-likeness and viability. Your assessment considers:\\n\\n1. **Drug-Likeness Rules**:\\n   - **Lipinski\\u2019s Rule of Five** (MW, LogP, H-bond donors/acceptors).\\n   - **Veber\\u2019s Rule** (PSA, rotatable bonds).\\n   - **Ghose, Egan, and Rule of Three** (lead-like properties).\\n   - **PAINS & Brenk Filters** (toxic/assay-interfering structures).\\n\\n2. **ADMET Profiling**:\\n   - **Absorption** (solubility, permeability).\\n   - **Distribution** (Vd, plasma protein binding).\\n   - **Metabolism** (CYP450 interactions, stability).\\n   - **Excretion** (renal, biliary clearance).\\n   - **Toxicity** (hepatotoxicity, cardiotoxicity, Ames test).\\n\\n3. **Information From similar and dissimilar  drugs**\\n\\n\\nYour goal is to determine the compound\\u2019s potential as a drug candidate by integrating these computational and experimental criteria. and predict it will be approved or not\\n\\n\\n    I have developed a model that can predict the drug likelibility of compound X.\\n    This model outputs two lists:\\n    1. The five most similar approved small molecules (with their properties and similarity scores).\\n    2. The five most similar non-approved small molecules (with their properties and similarity scores).\\n\\n    Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.\\n\\n    - RDKit Analysis of Compound X:\\n    {'Molecular_Weight': 2296.970999999999, 'LogP': -10.32609999999995, 'Molecular_Refractivity': 606.0736000000024, 'TPSA': 947.18, 'Hydrogen_Bond_Donors': 36, 'Hydrogen_Bond_Acceptors': 36, 'Rotatable_Bonds': 59, 'Chiral_Centers': [(10, 'S'), (17, 'S'), (20, 'S'), (27, 'S'), (33, 'S'), (34, 'R'), (40, 'S'), (47, 'S'), (54, 'S'), (62, 'R'), (70, 'S'), (77, 'R'), (91, 'S'), (98, 'S'), (101, 'S'), (108, 'S'), (114, 'S'), (115, 'R'), (121, 'S'), (128, 'S'), (135, 'S'), (143, 'R'), (151, 'S'), (158, 'R')]}df[\\\"SMILES\\\"]\\n\\n    Using the provided data:\\n    - Approved molecules (with similarity scores): [{'name': None, 'similarity score': 0.9600352644920349, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.953127384185791, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.952626645565033, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.9499645233154297, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Bacitracin', 'similarity score': 0.8429930210113525, 'approval groups': ['approved', 'vet_approved'], 'average mass': 1422.693, 'half life': 'Data regarding the half life of bacitracin in humans is not readily available.[A181997]', 'toxicity': 'The oral LD<sub>50</sub> of bacitracin in rats is >2000mg/kg.[L7775]\\\\r\\\\n\\\\r\\\\nSpecific data regarding bacitracin overdoses is not readily available.[T662] An overdose of bacitracin may lead to nephrotoxicity[A181997] and patients should be treated with supportive measures.', 'indication': 'Bacitracin is indicated in topical formulations for acute and chronic localized skin infections.[A181997] Occasionally, it is also used intramuscularly for infantile streptococcal pneumonia and empyema.[A181997] Bacitracin is also formulated as an ointment with neomycin and polymyxin B for over the counter use.[A181997,L7769] A bacitracin ointment formulated with neomycin and polymyxin B along with hydrocortisone is indicated for the treatment of corticosteroid responsive dermatoses with secondary infection.[L7772]', 'pharmacodynamics': 'Bacitracin is a mixture of polypeptides that prevent the formation of the bacterial cell wall and oxidatively cleave DNA.[A954] It has a short duration of action as it must be given every 3 to 4 hours topically.[L7769,L7772] Bacitracin is nephrotoxic when given intramuscularly and may lead to renal failure.[A181997]', 'mechanism of action': 'Bacitracin binds to a divalent metal ion such as Mn(II), Co(II), Ni(II), Cu(II), or Zn(II).[A954] These complexes bind C<sub>55</sub>-isoprenyl pyrophosphate, preventing the hydrolysis of a lipid dolichol pyrophosphate, which finally inhibits cell wall synthesis.[A954] Bacitracin metal complexes also bind and oxidatively cleave DNA.[A954]', 'metabolism': 'Data regarding the metabolism of bacitracin in humans is not readily available.[A181997] Because bacitracin is a protein it is expected to be metabolized into smaller polypeptides and amino acids.[A182009] However, the structure of bacitracin may afford it some protection from the action of proteases.[A954]', 'descriptions': 'Bacitracin is a combination of at least 9 bacitracins.[A955,A181952] 60-80% of commercially prepared bacitracin is bacitracin A.[A181952] The bacillus that produces bacitracin was first isolated from a knee scrape in 1945 from the knee wound of a child named Margaret Tracy.[A181952]\\\\r\\\\n\\\\r\\\\nBacitracin was granted FDA approval on 29 July 1948.[A181997,L7748]'}]\\n    - Non-approved molecules (with similarity scores): [{'name': None, 'similarity score': 0.8306123614311218, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': None, 'similarity score': 0.8236221671104431, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Murepavadin', 'similarity score': 0.8048920631408691, 'approval groups': ['investigational'], 'average mass': 1553.837, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).'}, {'name': 'PL-3994', 'similarity score': 0.7958396673202515, 'approval groups': ['investigational'], 'average mass': 1875.21, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).'}, {'name': None, 'similarity score': 0.793728232383728, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}]\\n    \",\n          \"\\n    \\nYou are a **chemist specializing in drug discovery and molecular modeling**, tasked with analyzing chemical compounds for drug-likeness and viability. Your assessment considers:\\n\\n1. **Drug-Likeness Rules**:\\n   - **Lipinski\\u2019s Rule of Five** (MW, LogP, H-bond donors/acceptors).\\n   - **Veber\\u2019s Rule** (PSA, rotatable bonds).\\n   - **Ghose, Egan, and Rule of Three** (lead-like properties).\\n   - **PAINS & Brenk Filters** (toxic/assay-interfering structures).\\n\\n2. **ADMET Profiling**:\\n   - **Absorption** (solubility, permeability).\\n   - **Distribution** (Vd, plasma protein binding).\\n   - **Metabolism** (CYP450 interactions, stability).\\n   - **Excretion** (renal, biliary clearance).\\n   - **Toxicity** (hepatotoxicity, cardiotoxicity, Ames test).\\n\\n3. **Information From similar and dissimilar  drugs**\\n\\n\\nYour goal is to determine the compound\\u2019s potential as a drug candidate by integrating these computational and experimental criteria. and predict it will be approved or not\\n\\n\\n    I have developed a model that can predict the drug likelibility of compound X.\\n    This model outputs two lists:\\n    1. The five most similar approved small molecules (with their properties and similarity scores).\\n    2. The five most similar non-approved small molecules (with their properties and similarity scores).\\n\\n    Your task is to analyze the likelihood of compound X receiving regulatory approval based on its similarity to known molecules.\\n\\n    - RDKit Analysis of Compound X:\\n    {'Molecular_Weight': 205.25399999999996, 'LogP': -1.1355999999999997, 'Molecular_Refractivity': 51.58610000000003, 'TPSA': 89.79, 'Hydrogen_Bond_Donors': 4, 'Hydrogen_Bond_Acceptors': 4, 'Rotatable_Bonds': 6, 'Chiral_Centers': []}df[\\\"SMILES\\\"]\\n\\n    Using the provided data:\\n    - Approved molecules (with similarity scores): [{'name': 'Dexpanthenol', 'similarity score': 0.958292543888092, 'approval groups': ['approved'], 'average mass': 205.2515, 'half life': 'Half life have not been reported', 'toxicity': 'Mouse LD50 : 9gm/kg (Intraperitoneal)\\\\r\\\\nMouse: LD50 7gm/kg (Intravenous)\\\\r\\\\nMouse: LD50 15gm/kg (Oral)\\\\r\\\\nRabbit LD50 4gm/kg (Oral)', 'indication': 'Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus.\\\\r\\\\n\\\\r\\\\nTopical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy). ', 'pharmacodynamics': 'Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus. ', 'mechanism of action': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373].  \\\\r\\\\n\\\\r\\\\nDermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n', 'metabolism': 'Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.', 'descriptions': 'Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium[A32373]. \\\\r\\\\n\\\\r\\\\nDue to its good penetration and high local concentrations, dexpanthanol is used in many topical products, such as ointments and lotions for treatment of dermatological conditions to relieve itching or promote healing. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].\\\\r\\\\n\\\\r\\\\nDexpanthenol is also available as a racemic mixture containing both the dextrorotatory form (dexpanthenol) and the levorotatory form (levopanthenol) as [DB11204]. While pantothenic acid is optically active, only the dextrorotatory form (dexpanthenol) is biologically active.'}, {'name': 'Miglustat', 'similarity score': 0.8878036737442017, 'approval groups': ['approved'], 'average mass': 219.278, 'half life': 'The effective half-life of miglustat is approximately 6 to 7 hours.', 'toxicity': 'Miglustat has been administered at doses of up to 3000 mg/day (approximately 10 times the recommended starting dose administered to Gaucher patients) for up to six months in Human Immunodeficiency Virus (HIV)-positive patients. Adverse events observed in the HIV studies included granulocytopenia, dizziness, and paresthesia. Leukopenia and neutropenia have also been observed in a similar group of patients receiving 800 mg/day or above.', 'indication': \\\"For the treatment of adult patients with mild to moderate type 1 (nonneuropathic) Gaucher's disease for whom enzyme replacement therapy is not a therapeutic option (e.g. due to constraints such as allergy, hypersensitivity, or poor venous access). Now approved in some countries for the treatment of progressive neurological symptoms in adult and pediatric patients with Niemann-Pick disease type C (NP-C). \\\", 'pharmacodynamics': \\\"Miglustat, an N-alkylated imino sugar, is a synthetic analogue of D-glucose. Miglustat is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for catalyzing the formation of glucosylceramide (glucocerebroside). Glucosylceramide is a substrate for the endogenous glucocerebrosidase, an enzyme that is deficient in Gaucher's disease. The accumulation of glucosylceramide due to the absence of glucocerebrosidase results in the storage of this material in the lysosomes of tissue macrophages, leading to widespread pathology due to infiltration of lipid-engorged macrophages in the viscera, lymph nodes, and bone marrow. This results in secondary hematologic consequences including sever anemia and thrombocytopenia, in addition to the characteristic progressive hepatosplenomegaly, as well as skeletal complications including osteonecrosis and osteopenia with secondary pathological fractures.\\\", 'mechanism of action': 'Miglustat functions as a competitive and reversible inhibitor of the enzyme glucosylceramide synthase, the initial enzyme in a series of reactions which results in the synthesis of most glycosphingolipids. The goal of treatment with miglustat is to reduce the rate of glycosphingolipid biosynthesis so that the amount of glycosphingolipid substrate is reduced to a level which allows the residual activity of the deficient glucocerebrosidase enzyme to be more effective (substrate reduction therapy), reducing the accumulation of glucocerebroside in macrophages. In vitro and in vivo studies have shown that miglustat can reduce the synthesis of glucosylceramide-based glycosphingolipids. In clinical trials, miglustat improved liver and spleen volume, as well as hemoglobin concentration and platelet count. Inhibition of glycosphingolipid synthesis has also shown to reduce intracellular lipid storage, improve fluid-phase endosomal uptake and normalize lipid transport in peripheral blood B lymphocytes of NP-C patients, which results in a decrease in the potentially neurotoxic accumulation of gnagliosides G<sub>M2</sub> and G<sub>M3</sub>, lactosylceramide and glucosylceramide, possibly preventing further neuronal damage. Other studies have also suggested that miglustat may indirectly modulate intracellular calcium homeostasis through its effects on glucosylceramide levels, and evidence has shown that an initiating factor in the pathogenesis of NP-C may be impaired calcium homeostasis related to sphingosine storage. Therefore, the effect that miglustat exerts on intracellular calcium levels may influence an important underlying pathogenic mechanism of NP-C.', 'metabolism': 'There is no evidence that miglustat is metabolized in humans.', 'descriptions': 'Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. Miglustat was first developed as an anti-HIV agent in the 1990s. However, clinical experience with miglustat showed that therapeutic levels of the drug could not be achieved in patients without a high incidence of adverse effect.'}, {'name': 'Glucosamine', 'similarity score': 0.8864784836769104, 'approval groups': ['approved', 'investigational'], 'average mass': 179.1711, 'half life': 'The estimated half-life for glucosamine is 15 hours after an oral dose.[A232279] After a bolus intravenous injection of 1005 mg crystalline glucosamine sulfate, the parent drug has an apparent half life of 1.11 hours.[A232274]', 'toxicity': 'The oral LD50 of glucosamine in rats is >5000 mg/kg.[L32684] Symptoms of an overdose with glucosamine may include nausea, vomiting, abdominal pain, and diarrhea (common side effects of this drug). Severe and life-threatening hypersensitivity reactions to glucosamine may occur in patients with a shellfish allergy or asthma.[L32774]', 'indication': 'Glucosamine is generally used over the counter in the symptomatic treatment of osteoarthritis and joint pain,[A2352] frequently combined with chondroitin sulfate and/or ibuprofen.[L32699]', 'pharmacodynamics': 'The administration of glucosamine, in theory, provides a building block towards the synthesis of glycosaminoglycans, slowing the progression of osteoarthritis and relieving symptoms of joint pain. Studies to this date examining the efficacy of glucosamine sulfate have been inconclusive. Glycosaminoglycans contribute to joint cartilage elasticity, strength, and flexibility.[A232144] A systematic review of various studies and guidelines determined that modest improvements were reported for joint pain and function in patients taking glucosamine. A consistent joint space narrowing was observed, but with an unclear clinical significance.[A231894]', 'mechanism of action': 'The mechanism of action of glucosamine in joint health is unclear,[A231894] however there are several possible mechanisms that contribute to its therapeutic effects. Because glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage,[A232289] glucosamine supplements may help to rebuild cartilage and treat the symptoms of arthritis.  Some in vitro studies show evidence that glucosamine reduces inflammation via inhibition of interferon gamma[A12619,A12616,A12621]  and Nuclear factor kappa B subunit 65 (NF-\\u03baB p65),[A12616,A232284] improving the symptoms of arthritis and joint pain. Clinical relevance is unknown at this time.', 'metabolism': 'Glucosamine undergoes metabolism in the liver.[A232274] Metabolism information for glucosamine is limited in the literature.', 'descriptions': 'Osteoarthritis (OA) is a progressive and degenerative joint disease marked by loss of cartilage, bone changes, and synovial membrane inflammation.[A232289] Treatment with chondroprotective drugs, such as glucosamine sulfate may offer additional benefits to nonsteroidal anti-inflammatory drugs treating the painful symptoms of OA. Glucosamine is commonly used over the counter as a treatment for arthritic joint pain, although its acceptance as a medical therapy varies due to contradictory and findings with unclear clinical significance during clinical trials.[A231894,A232289] It is currently not approved as a prescription product by the FDA, but is widely available over the counter.'}, {'name': None, 'similarity score': 0.8821925520896912, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Nadolol', 'similarity score': 0.8789207935333252, 'approval groups': ['approved'], 'average mass': 309.4006, 'half life': 'The half life of nadolol is 20 to 24 hours.[L7922,L7925]', 'toxicity': 'The oral LD<sub>50</sub> in mice is 4500mg/kg.[L7934]\\\\r\\\\n\\\\r\\\\nPatients experiencing an overdose may present with bradycardia, cardiac failure, hypotension, and bronchospasm.[L7922,L7925] An overdose may be treated with atropine for bradycardia, digitalis and diuretics for cardiac failure, vasopressors for hypotension, and beta-2 stimulants for bronchospasms, as well as gastric lavage and hemodialysis.[L7922,L7925]', 'indication': 'Nadolol is indicated to treat angina pectoris and hypertension.[L7922] Another product formulated with [bendroflumethiazide] is indicated to treat hypertension.[L7925]', 'pharmacodynamics': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] It has a long duration of action as it is usually taken once daily and a wide therapeutic index as patients start at doses of 40mg daily but may be increased to doses as high as 240mg daily.[L7922,L7925] Patients taking nadolol should not aburptly stop taking it as this may lead to exacerbation of ischemic heart disease.[L7922,L7925]', 'mechanism of action': 'Although nadolol is described as a non selective beta blocker, it does not interact with beta 3 adrenal receptors.[A182402] Antagonism of beta-1 and beta-2 adrenoceptors in the heart inhibits cyclic AMP and its signalling pathway, decreasing the strength and speed of contractions as well as the speed of relaxation and conduction.[A34177] Antagonism of beta-2 adrenoceptors in the smooth muscle cells of the vasculature inhibits their relaxation, leading to an increase in peripheral vascular resistance and reducing the risk of severe hypotension.[A34177] The increase in peripheral vascular resistance may contribute to the decrease in insulin sensitivity associated with nadolol use.[A182441] Antagonism of beta-1 adrenoceptors in the juxtaglomerular apparatus of the kidney inhibits the release of renin, and therefore angiotensin II mediated vasoconstriction, aldosterone mediated water retention, and the release of epinephrine.[A34177] Antagonism of beta-2 adrenoceptors in the liver and skeletal muscle inhibits glycogenolysis, in the lungs prevents bronchodilation, and in the pancrease inhibits insulin release.[A34177]', 'metabolism': 'Nadolol is not metabolized by the liver in humans.[A182423,L7922,L7925]', 'descriptions': 'Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects.[A34177]\\\\r\\\\n\\\\r\\\\nNadolol was granted FDA approval on 10 December 1979.[L7922]'}]\\n    - Non-approved molecules (with similarity scores): [{'name': 'Duvoglustat', 'similarity score': 0.8663665652275085, 'approval groups': ['investigational'], 'average mass': 163.1717, 'half life': '', 'toxicity': 'ORL-RAT LD<sub>50</sub>: &gt; 5g/kg.\\\\r\\\\n', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.'}, {'name': 'Migalastat', 'similarity score': 0.8663665652275085, 'approval groups': ['approved', 'investigational'], 'average mass': 163.1717, 'half life': 'The mean elimination half-life (t1/2) of migalastat ranges from approximately 3 to 5 hours for a single oral dose of 150 mg.[L47057] For the dose of 123 mg, the mean elimination half-life was estimated to be 4 hours.[L47036]', 'toxicity': 'The most common adverse reactions reported with migalastat (\\u2265 10%) during the 6-month placebo-controlled, double-blind phase of its Study 1 clinical studies were headache, nasopharyngitis, urinary tract infection, nausea, and pyrexia [FDA Label, F1107].\\\\r\\\\n\\\\r\\\\nIn case of overdose, general medical care is recommended [FDA Label, F1107]. Headache and dizziness were the most common adverse reactions reported at doses of migalastat of up to 1250 mg and 2000 mg, respectively [FDA Label, F1107].', 'indication': 'Migalastat is approved by the FDA for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (GLA) variant based on in vitro assay data.[L47036] \\\\r\\\\n\\\\r\\\\nThis indication is approved under accelerated approval based on a reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.[L47036]\\\\r\\\\n\\\\r\\\\nMigalastat is also approved by the EMA and Health Canada to treat the same disease, although it is approved for both adults and adolescents aged 16 years and older in Europe.[L47057,L47087]', 'pharmacodynamics': 'In general, treatment in patients with migalastat in Phase 2 pharmacodynamic trials resulted in increases in endogenous alpha-galactosidase (alpha-Gal A) activity in white blood cells, as well as in skin and kidney for the majority of patients [FDA Label, F1107]. In patients with amenable galactosidase alpha gene (GLA) mutations, globotriaosylceramide (GL-3) levels tended to decrease in the urine and in the kidney interstitial capillaries.[L47057]\\\\r\\\\n\\\\r\\\\nIn an in vitro assay (HEK-293 assay), Human Embryonic Kidney (HEK-293) cell lines were transfected with specific GLA variants (mutations) which produced mutant alpha-Gal A proteins. In the transfected cells, amenability of the GLA variants was assessed after a 5-day incubation with 10 micromol/L migalastat. A GLA variant was categorized as amenable if the resultant mutant alpha-Gal A activity (measured in the cell lysates) met two criteria: 1) it showed a relative increase of at least 20% compared to the pre-treatment alpha-Gal A activity, and 2) it showed an absolute increase of at least 3% of the wild-type (normal) alpha-Gal activity. The in vitro assay did not evaluate the trafficking of the mutant alpha-Gal A proteins into the lysosome or the dissociation of migalastat from the mutant alpha-Gal A proteins within the lysosome. Also, the in vitro assay did not test whether a GLA variant causes Fabry disease or not.[L47036] ', 'mechanism of action': 'Fabry disease is a progressive X-linked lysosomal storage disorder that affects males and females [FDA Label, F1107]. Fabry disease-causing mutations occur in the galactosidase alpha (GLA) gene and result in a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A) that is required for glycosphingolipid substrate (GL-3 and lyso-Gb3) metabolism [FDA Label, F1107]. Reduced alpha-Gal A activity is, therefore, associated with the progressive accumulation of glycosphingolipid substrate in vulnerable organs and tissues, which ultimately leads to the morbidity and mortality associated with Fabry disease.[L47057]\\\\r\\\\n\\\\r\\\\nMigalastat is a pharmacological chaperone that reversibly binds to the active site of the alpha-galactosidase A (alpha-Gal A) protein (encoded by the galactosidase alpha gene, GLA), which is deficient in Fabry disease. This binding stabilizes alpha-Gal A allowing its trafficking from the endoplasmic reticulum into the lysosome where it exerts its action. In the lysosome, at a lower pH and at a higher concentration of relevant substrates, migalastat dissociates from alpha-Gal A allowing it to break down the glycosphingolipids globotriaosylceramide (GL-3) and globotriaosylsphingosine (lyso-Gb3). Certain GLA variants (mutations) causing Fabry disease result in the production of abnormally folded and less stable forms of the alpha-Gal A protein which, however, retain enzymatic activity. Those GLA variants, referred to as amenable variants, produce alpha-Gal A proteins that may be stabilized by migalastat thereby restoring their trafficking to lysosomes and their intralysosomal activity.[L47036] \\\\r\\\\n\\\\r\\\\nThe GLA mutations that are amenable and not amenable to treatment with migalastat are regularly maintained and updated on online sites that are readily accessible by healthcare providers.[L47036]   ', 'metabolism': 'Based upon in vivo data, migalastat is a substrate for uridine diphosphate glucuronosyltransferase (otherwise known as UGT or UDPGT), being a minor elimination pathway.[L47036]', 'descriptions': \\\"Fabry disease is a rare, progressive genetic disorder characterized by a defective GLA gene that causes a deficiency in the enzyme alpha-Galactosidase A (alpha-Gal A). This enzyme is responsible for breaking down glycosphingolipid substrate that, when deficient in patients with Fabry disease, builds up in the blood vessels, the kidneys, the nerves, the heart, and other organs.[L47036,L47057,L4274,L4278] In the U.S., it is estimated that more than 3,000 people are living with Fabry disease, and an estimated more than 50 percent of these diagnosed patients are currently untreated.[L4274]\\\\r\\\\n\\\\r\\\\nMigalastat (approved and sold under Amicus Therapeutics' brand name Galafold) is subsequently an oral pharmacological chaperone of alpha-Gal A for the treatment of Fabry disease in adults who have amenable GLA variants.[L47036,L47057,L4274,L4278] In these patients, migalastat works by stabilizing the body\\u2019s dysfunctional alpha-Gal A enzyme so that it can clear the accumulation of glycosphingolipid disease substrate.[L47036,L47057,L4274,L4278] Globally, it is estimated that approximately 35 to 50 percent of Fabry patients may have amenable GLA variants that are treatable with migalastat. [L4274]\\\\r\\\\n\\\\r\\\\nGiven the rarity of Fabry disease and the proportion of Fabry disease patients that could benefit from migalastat therapy, Amicus Therapeutics' brand name Galafold was approved using the Accelerated Approval pathway, under which the FDA may approve drugs for serious conditions where there is an unmet medical need and where a drug is shown to have certain effects that are reasonably likely to predict a clinical benefit to patients.[L47036,L47057,L4274,L4278] A further study is required to verify and describe the clinical benefits of Galafold, and the sponsor will be conducting a confirmatory clinical trial of Galafold in adults with Fabry disease.[L47036,L47057,L4274,L4278]\\\\r\\\\n\\\\r\\\\nAdditionally, Galafold was also granted Priority Review designation, under which the FDA\\u2019s goal is to take action on an application within six months of application filing where the agency determines that the drug if approved, would provide a significant improvement in treating, diagnosing or preventing a serious condition over available therapies.[L47036,L47057] Galafold also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.[L47036,L47057]\\\\r\\\\n\\\\r\\\\nAs of August 2018, migalastat under Amicus Therapeutics' brand name Galafold is currently approved in Australia, Canada, European Union, Israel, Japan, South Korea, Switzerland, and the United States.[L4274]\\\"}, {'name': None, 'similarity score': 0.8658441305160522, 'approval groups': None, 'average mass': None, 'half life': None, 'toxicity': None, 'indication': None, 'pharmacodynamics': None, 'mechanism of action': None, 'metabolism': None, 'descriptions': None}, {'name': 'Arbutin', 'similarity score': 0.8647643327713013, 'approval groups': ['approved'], 'average mass': 272.2512, 'half life': 'No pharmacokinetic data available. ', 'toxicity': 'In an acute oral toxicity study, the LD50-value for \\u03b2-arbutin is 9804 mg/kg bw for the mouse and 8715 mg/kg bw for the rat [F44]. Dermal LD50 value in rat and mouse was reported to be greater than 928 mg/kg bw, according to an acute dermal toxicity study [F44]. Extremely high doses may cause ringing in the ears, shortness of breath, convulsions, collapse, vomiting and delirium [F43]. Nausea and vomiting were seen individuals with sensitive stomachs following oral ingestion of 15 g of dried uva ursi leaves that contain arbutin [F43]. ', 'indication': 'Indicated for over-the-counter use for epidermal hyperpigmentation in various skin conditions, such as melasma, freckles, and senile lentigines. ', 'pharmacodynamics': 'At non-toxic concentrations, arbutin inhibited the activity of tyrosinase in cultured human keratinocytes, while having minimal effect on the expression of tyrosinase mRNA or the synthesis of the enzyme [A27248]. \\u03b1-Arbutin produced a concentration-dependent inhibition of melanin synthesis of human melanoma cells, HMV-II [A32939]. No inhibitory effect on HMV-II cell growth was seen at concentrations lower than 1.0 mM. At concentrations of 0.5 mM of arbutin, tyrosinase activity was reduced to 60% of that in non-treated cells [A32939]. The addition of arbutin blocked and inhibited \\u03b1-MSH-stimulated melanogenesis in B16 melanoma cells, brownish guinea pig, and human skin tissue [A32940]. In a pilot study of healthy male adults exposed to UV B irradiation, topical administration of arbutin inhibited UV-induced nuclear factor-kappaB activation in human keratinocytes [F43]. In mouse skin, arbutin counteracted oxidative stress induced by 12-O-tetradecanoylphorbol-13-acetate [F43].', 'mechanism of action': 'Arbutin is a hydroquinone glycoside, however the hydroquinone moiety is not solely responsible for the de-pigmentating actions of arbutin [A32942]. It acts as a competitive inhibitor of tyrosinase enzyme by acting on the L-tyrosine binding site to suppress melanogenesis and mediate its de-pigmenting actions on human skin [A27248]. Tyrosinase is an enzyme involved in the regulation of rate-limiting steps during the synthesis of melanin; it regulates the conversion of L-tyrosine into L-dopa, and subsequent conversion of L-dopa to L-dopaquinone [A27248]. Via inhibition of tyrosinase activity in a concentration-dependent manner, arbutin attenuates the production of melanin in melanocytes. While most studies suggest that arbutin has negligible effect on the tyrosinase mRNA expression, a study assessing the effect of arbutin on melanocyte differentiation inducement system using ES cells propose that arbutin may also downregulate the expression of tyrosinase in addition to its inhibitory action on the enzyme [A32938]. The contradictory findings across studies may be due to previous studies using terminally-differentiated melanocytes and melanoma cells [A32938]. ', 'metabolism': 'Arbutin is readily susceptible to hydrolysis in dilute acids to yield D-glucose and hydroquinone. It is expected that orally administered arbutin is easily hydrolyzed to free hydroquinone molecules by stomach acid [F43]. Hydroquinone is further metabolized into the main metabolites, hydroquinone glucuronide and hydroquinone sulfate [F43]. ', 'descriptions': 'Extracted from the dried leaves of bearberry plant in the genus _Arctostaphylos_ and other plants commonly in the _Ericaceae_ family, arbutin is a beta-D-glucopyranoside of [DB09526]. It is found in foods, over-the-counter drugs, and herbal dietary supplements [F43]. Most commonly, it is an active ingredient in skincare and cosmetic products as a skin-lightening agent for the prevention of melanin formation in various skin conditions that involve cutaneous hyperpigmentation or hyperactive melanocyte function [A27248]. It has also been used as an anti-infective for the urinary system as well as a diuretic [F43]. Arbutin is available in both natural and synthetic forms; it can be synthesized from acetobromglucose and [DB09526] [F43]. Arbutin is a competitive inhibitor of tyrosinase (E.C.1.14.18.1) in melanocytes [A27248], and the inhibition of melanin synthesis at non-toxic concentrations was observed _in vitro_. Arbutin was shown to be less cytotoxic to melanocytes in culture compared to [DB09526] [A32942].'}, {'name': 'Indole-3-carbinol', 'similarity score': 0.8617359399795532, 'approval groups': ['investigational'], 'average mass': 147.1739, 'half life': '', 'toxicity': '', 'indication': '', 'pharmacodynamics': '', 'mechanism of action': '', 'metabolism': '', 'descriptions': 'Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).'}]\\n    \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"think1\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\nOkay, let's start by looking at the data provided for Compound X. The first thing that jumps out is the molecular weight. It's over 2200 Daltons, which is way higher than the typical limit of 500 for small molecule drugs according to Lipinski's Rule of Five. That's a red flag right there. High molecular weight can affect absorption and permeability.\\n\\nThen there's the LogP value of -10.3. Lipinski's rule suggests LogP should be less than 5, but this is extremely negative. That might indicate high hydrophilicity, which could lead to poor membrane permeability. But wait, maybe this compound is a biologic? The molecular weight is more in line with peptides or proteins. But the user mentioned small molecules, so maybe not. Still, the LogP is way off.\\n\\nLooking at hydrogen bond donors and acceptors, both are 36. Lipinski's rules say H-bond donors should be \\u22645 and acceptors \\u226410. Veber's Rule also looks at polar surface area (TPSA) and rotatable bonds. The TPSA here is 947, which is extremely high. Usually, a TPSA under 140 \\u00c5\\u00b2 is considered good for oral bioavailability. This is way beyond that. Rotatable bonds are 59, which is way more than Veber's recommendation of \\u226410. All these factors suggest very poor oral bioavailability.\\n\\nThe approved similar molecules list has Bacitracin with a similarity score of 0.84. Bacitracin is a peptide antibiotic with a molecular weight around 1422, which is still high but lower than Compound X. It's approved for topical use, which makes sense because large molecules aren't absorbed systemically. The other approved molecules have high similarity scores but no data, so maybe they're also large or used topically.\\n\\nNon-approved molecules include Murepavadin and PL-3994, both investigational. Murepavadin is a cyclic peptide antibiotic, and PL-3994 is a natriuretic peptide receptor agonist. Their high molecular weights (1553 and 1875) suggest they might be administered via injection. The fact that they're still investigational could indicate challenges in development, possibly due to ADMET issues.\\n\\nADMET-wise, Compound X's size and polarity would lead to poor absorption if intended for oral use. It might require parenteral administration. Distribution could be limited due to high plasma protein binding, but without data, it's hard to say. Metabolism might be a problem if it's a peptide, as proteases could break it down quickly. Excretion could be via renal or biliary routes, but a high molecular weight might lead to accumulation if not properly cleared. Toxicity is a concern, especially nephrotoxicity seen in Bacitracin when used systemically.\\n\\nThe presence of 24 chiral centers complicates synthesis and increases the risk of off-target effects. High similarity to approved topical drugs might suggest Compound X could be used topically, but if systemic use is intended, the properties are unfavorable. The non-approved similar molecules being in trials might indicate that such compounds face regulatory hurdles, possibly due to toxicity or delivery challenges.\\n\\nIn summary, while Compound X is structurally similar to some approved drugs, its extreme molecular weight, LogP, TPSA, and rotatable bonds make it unlikely to meet drug-likeness criteria for systemic use. If it's intended for topical application, maybe, but even Bacitracin's approval is topical. The high similarity to non-approved molecules in trials suggests potential development challenges. Unless there's a specific delivery method or unique therapeutic niche, regulatory approval seems unlikely.\\n\",\n          \"\\nOkay, let me start by looking at the data provided for Compound X. The RDKit analysis gives me some key properties: Molecular Weight is 205.25, LogP is -1.14, TPSA is 89.79, Hydrogen Bond Donors and Acceptors are both 4, Rotatable Bonds are 6, and there are no chiral centers.\\n\\nFirst, I need to check the drug-likeness rules. Lipinski's Rule of Five says a molecule should have MW \\u2264500, which Compound X meets. LogP should be \\u22645, and here it's -1.14, so that's good. Hydrogen Bond Donors \\u22645 and Acceptors \\u226410; both are 4, so that's within limits. So, it passes Lipinski's rules.\\n\\nNext, Veber's Rule looks at TPSA and Rotatable Bonds. TPSA here is 89.79, which is under the 140 threshold. Rotatable Bonds are 6, which is just at the limit of \\u226410, so that's acceptable. So Veber's Rule is satisfied.\\n\\nGhose and others: The molecular weight is under 500, LogP is within the -0.4 to 5.6 range, so that's okay. The number of atoms is probably okay since the MW is low. So likely passes here too. PAINS and Brenk filters are for reactive or toxic groups. The approved similar molecules like Dexpanthenol and Miglustat don't have such issues, so maybe Compound X is okay, but without the actual structure, it's hard to say. But given the high similarity to approved drugs, it might not have PAINS issues.\\n\\nNow looking at the ADMET profiling. Absorption: LogP is low, which could mean good solubility but maybe poor permeability. TPSA is moderate, so maybe moderate absorption. Distribution: With a LogP of -1.14, it might have low plasma protein binding, leading to a higher volume of distribution. Metabolism: The similar approved drugs like Dexpanthenol are metabolized to active forms, but if Compound X is similar, maybe it's metabolized similarly. Excretion: If it's water-soluble, renal clearance might be primary. Toxicity: The approved similar drugs have low toxicity (e.g., Dexpanthenol's LD50 is high), so maybe Compound X is also low toxicity.\\n\\nLooking at the approved molecules: The top similar ones are Dexpanthenol (0.958), Miglustat (0.888), Glucosamine (0.886), and others. Dexpanthenol is a B vitamin derivative used for skin and intestinal issues, Miglustat is for Gaucher's, Glucosamine for joints. These are approved with good safety profiles. Their properties are similar to Compound X, which suggests that if Compound X is structurally similar, it might have similar ADMET and efficacy.\\n\\nNon-approved molecules: Duvoglustat (investigational), Migalastat (approved for Fabry), Arbutin (approved for skin), Indole-3-carbinol (investigational). Migalastat is approved but others are investigational. The high similarity to approved drugs like Migalastat and Arbutin (which is approved) might indicate that even though some are non-approved, Compound X's similarity to approved ones is a good sign.\\n\\nPossible red flags: The high number of rotatable bonds (6) might affect bioavailability, but since similar approved drugs also have similar features, maybe it's acceptable. The TPSA is moderate, which could affect permeability, but again, similar approved drugs have comparable values.\\n\\nConsidering all factors: Compound X meets drug-likeness rules, has ADMET profiles similar to approved drugs, and its closest analogs are approved with favorable toxicity and efficacy. The main concern would be if there's any structural alert not mentioned, but given the data, it's likely to have a good chance of approval.\\n\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"answer1\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\nAnalysis of Compound X's Drug Approval Potential\\n1. Drug-Likeness Rule Violations\\nCompound X exhibits severe deviations from standard drug-likeness criteria:\\n\\nMolecular Weight (2297 Da): Far exceeds Lipinski\\u2019s threshold (\\u2264500 Da) and even typical biologic thresholds (e.g., peptides like bacitracin are ~1400 Da). This suggests it is not a small molecule but likely a large peptide/polypeptide.\\n\\nLogP (-10.3): Extreme hydrophilicity, inconsistent with membrane permeability.\\n\\nHydrogen Bond Donors/Acceptors (36 each): Vastly exceeds Lipinski\\u2019s limits (\\u22645 donors, \\u226410 acceptors).\\n\\nTPSA (947 \\u00c5\\u00b2): Polar surface area is astronomically high (Veber\\u2019s Rule recommends \\u2264140 \\u00c5\\u00b2 for oral bioavailability).\\n\\nRotatable Bonds (59): Extreme flexibility (Veber\\u2019s Rule recommends \\u226410), suggesting poor metabolic stability.\\n\\nChiral Centers (24): Synthetic complexity and high risk of off-target interactions.\\n\\nConclusion: Compound X is not drug-like by small-molecule standards. It resembles a large peptide or biologic, which typically require parenteral administration and face distinct ADMET challenges.\\n\\n2. ADMET Profiling\\nAbsorption: Impossible via oral route due to size, polarity, and TPSA. Likely requires IV or topical administration.\\n\\nDistribution: High molecular weight and polarity limit tissue penetration; may bind plasma proteins excessively.\\n\\nMetabolism: Peptides are prone to proteolytic degradation; unclear metabolic stability.\\n\\nExcretion: Renal clearance unlikely due to size; potential for hepatic/biliary excretion.\\n\\nToxicity: High risk of nephrotoxicity (similar to bacitracin\\u2019s systemic toxicity) and immunogenicity (common with large peptides).\\n\\n3. Similarity to Approved/Non-Approved Molecules\\nApproved Molecules:\\n\\nThe only named analog, bacitracin (similarity score: 0.84), is a topical/veterinary antibiotic with nephrotoxicity upon systemic use. Its approval hinges on localized application.\\n\\nOther approved analogs (similarity scores: 0.95\\u20130.96) lack data but likely share bacitracin\\u2019s limitations (e.g., topical use).\\n\\nNon-Approved Molecules:\\n\\nMurepavadin (cyclic peptide antibiotic) and PL-3994 (peptide receptor agonist) are investigational, reflecting challenges in systemic delivery or toxicity.\\n\\nHigh similarity scores (0.79\\u20130.83) to non-approved molecules suggest Compound X shares traits linked to clinical attrition (e.g., poor PK/PD, toxicity).\\n\\n4. Regulatory Approval Prediction\\nCompound X is unlikely to gain approval for systemic use due to:\\n\\nNon-compliance with drug-likeness rules (extreme size, polarity, flexibility).\\n\\nHigh risk of toxicity (nephrotoxicity, immunogenicity).\\n\\nLack of oral bioavailability, necessitating invasive administration.\\n\\nSimilarity to non-approved molecules facing clinical hurdles.\\n\\nPotential niche: If designed for topical use (like bacitracin), approval is plausible but still challenging due to safety monitoring requirements.\\n\\nFinal Recommendation\\nReject Compound X as a systemic drug candidate. Prioritize structural optimization to reduce molecular weight, TPSA, and rotatable bonds. If pursuing topical/veterinary use, conduct rigorous nephrotoxicity and immunogenicity studies.\\n\",\n          \"\\nAnalysis of Compound X for Regulatory Approval Likelihood\\n\\n1. Drug-Likeness Assessment\\nLipinski\\u2019s Rule of Five\\n\\nMolecular Weight (205.25): Passes (\\u2264500).\\n\\nLogP (-1.14): Passes (\\u22645).\\n\\nH-bond Donors (4) / Acceptors (4): Passes (\\u22645/10).\\n\\nConclusion: No violations; excellent oral bioavailability potential.\\n\\nVeber\\u2019s Rule\\n\\nTPSA (89.79): Passes (\\u2264140 \\u00c5\\u00b2).\\n\\nRotatable Bonds (6): Passes (\\u226410).\\n\\nConclusion: Likely good oral absorption.\\n\\nGhose/PAINS/Brenk Filters\\n\\nNo structural alerts (e.g., reactive groups) inferred from similarity to approved drugs (e.g., Dexpanthenol, Miglustat).\\n\\n2. ADMET Profiling\\nAbsorption:\\n\\nLow LogP (-1.14) suggests high solubility but potential permeability challenges.\\n\\nModerate TPSA (89.79) may limit passive diffusion but aligns with approved analogs (e.g., Dexpanthenol: TPSA ~90).\\n\\nDistribution:\\n\\nLikely low plasma protein binding (due to low LogP), favoring tissue distribution.\\n\\nMetabolism:\\n\\nSimilar to Dexpanthenol (converted to pantothenic acid) or Miglustat (minimal hepatic metabolism). Low CYP450 interaction risk.\\n\\nExcretion:\\n\\nPredicted renal clearance due to hydrophilicity.\\n\\nToxicity:\\n\\nHigh LD50 values in analogs (e.g., Dexpanthenol: Mouse LD50 = 15 g/kg oral) suggest low acute toxicity.\\n\\nNo Ames test data, but structural similarity to non-mutagens reduces concern.\\n\\n3. Similarity to Approved/Non-Approved Molecules\\nApproved Analogs (High Similarity)\\nDexpanthenol (0.958): Approved for epithelial healing. Shares low LogP, moderate TPSA, and metabolism profile.\\n\\nMiglustat (0.888): Approved for Gaucher\\u2019s disease. Matches MW, rotatable bonds, and low toxicity.\\n\\nGlucosamine (0.886): Over-the-counter joint health. Aligns with solubility and safety trends.\\n\\nNon-Approved Analogs\\nMigalastat (0.866): Approved for Fabry disease (accelerated pathway). Suggests niche therapeutic potential.\\n\\nArbutin (0.865): Approved for hyperpigmentation. Supports safety in topical applications.\\n\\n4. Key Strengths\\nMeets all major drug-likeness rules.\\n\\nStructural and ADMET similarity to safe, approved drugs.\\n\\nLow toxicity risk based on analogs.\\n\\n5. Potential Risks\\nPermeability: Low LogP may limit passive absorption (needs formulation optimization).\\n\\nRotatable Bonds (6): Could affect bioavailability but aligns with approved drugs (e.g., Miglustat: 6 rotatable bonds).\\n\\nConclusion: Likely Approval\\nCompound X demonstrates strong alignment with approved drug profiles, favorable ADMET properties, and no critical structural alerts. Its similarity to Dexpanthenol and Miglustat\\u2014both with established safety/efficacy\\u2014supports regulatory approval, particularly for indications like epithelial repair or metabolic disorders. Mitigate permeability concerns via formulation (e.g., prodrug strategy) and validate in preclinical models.\\n\\nRecommendation: Proceed to IND-enabling studies.\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"2nd_prompt\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"But wait the true answer is Not Approved. think step by step and tell why\",\n          \"But wait the true answer is Approved. think step by step and tell why\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"think2\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"\\nOkay, so the user initially provided a detailed analysis of Compound X, considering various drug-likeness rules, ADMET profiles, and similarity to approved and non-approved drugs. The conclusion was a moderate likelihood of approval (~60%), but the user now states that the true answer is \\\"Approved.\\\" I need to figure out why that's the case, despite the initial concerns raised.\\n\\nFirst, I need to revisit the data. The compound's similarity to Atorvastatin is very high (0.85), which is a blockbuster drug. Atorvastatin itself has a LogP of around 4.3, and Compound X's LogP is 5.08. The initial analysis flagged LogP as a risk, but maybe the similarity to an approved drug with a slightly lower LogP isn't a deal-breaker. Also, Atorvastatin's success shows that some rule deviations are acceptable if the benefits outweigh the risks.\\n\\nLooking at the non-approved molecules, they have different targets (Ritobegron is a \\u03b23 agonist, Pavinetant is NK1 antagonist, etc.), which might mean their failure reasons aren't directly applicable to Compound X if it's a statin analog. The key here is therapeutic area and mechanism. Statins have a well-established pathway, so even with some ADMET issues, efficacy in lowering cholesterol might be sufficient for approval, especially if safety is manageable.\\n\\nThe user mentioned \\\"true answer is Approved,\\\" so I need to focus on why, despite the higher LogP and potential CYP3A4 metabolism, this compound could still get approved. Maybe the structural similarity to Atorvastatin is so strong that it's considered a derivative or a next-gen version with improved properties. Also, the initial analysis noted that Atorvastatin has a high plasma protein binding, which Compound X might share, but if it's effective, that's acceptable.\\n\\nAnother angle: the molecular weight is under 500, passes Lipinski's except LogP. But Lipinski's rules are more guidelines. The Veber's parameters are good (low rotatable bonds, TPSA), which suggests good bioavailability. Maybe the solubility issues are mitigated by formulation, like how Atorvastatin is formulated as a calcium salt to improve solubility.\\n\\nToxicity risks like hepatotoxicity are known for statins, but monitoring and dose adjustments can manage these in clinical use. The pharmacodynamics and mechanism are well-understood, which reduces development risk. Also, the non-approved similar drugs might have failed due to different reasons unrelated to Compound X's profile.\\n\\nIn conclusion, the high structural similarity to an approved drug with a proven track record, acceptable modifications within the statin class, manageable ADMET challenges through formulation or monitoring, and the established efficacy of HMG-CoA inhibitors likely outweigh the initial concerns. Therefore, despite higher LogP and CYP metabolism, the benefits make approval feasible.\",\n          \"\\nOkay, let's try to figure out why the compound X wasn't approved even though the initial analysis suggested it might be. First, I need to recall the data provided. The user mentioned that the model listed similar approved and non-approved molecules. The approved ones like Dexpanthenol, Miglustat, Glucosamine, and Nadolol had high similarity scores. The non-approved ones included Duvoglustat, Migalastat, Arbutin, and Indole-3-carbinol.\\n\\nThe initial analysis looked at drug-likeness rules (Lipinski, Veber) and ADMET properties, and everything seemed okay. Molecular weight, LogP, TPSA, rotatable bonds\\u2014all within acceptable ranges. Toxicity data from similar approved drugs suggested low acute toxicity. So why the rejection?\\n\\nHmm, maybe the answer lies in the specifics of the non-approved molecules. Let me check those again. Migalastat is mentioned as approved but under accelerated pathways, which sometimes means there's conditional approval pending further studies. Duvoglustat is investigational, so maybe it has issues. Arbutin is approved but for topical use, which is different from systemic administration. Indole-3-carbinol is investigational, possibly with unresolved safety issues.\\n\\nWait, the user said the true answer is \\\"Not Approved.\\\" So what's missing here? Maybe the ADMET profile isn't as good as thought. Let's re-examine the ADMET part. The compound has low LogP (-1.14), which is quite hydrophilic. High solubility is good, but too low LogP can mean poor membrane permeability, making oral bioavailability challenging. Even if similar approved drugs have low LogP, maybe this compound's combination of properties leads to poor absorption despite passing the rules.\\n\\nAnother angle: the similar non-approved drugs. If the compound is structurally closer to non-approved ones with issues, that's a red flag. For example, Migalastat's approval is under accelerated pathways with ongoing trials. If compound X's mechanism or metabolism mirrors a drug that later showed toxicity in confirmatory trials, that could be a problem.\\n\\nAlso, looking at the approved analogs: Dexpanthenol is used topically or as a supplement. Miglustat is for a rare disease (Gaucher) with specific indications. If compound X is intended for a broader use, the safety profile might not hold up. The high similarity to Dexpanthenol might not translate to efficacy in a different therapeutic area.\\n\\nToxicity data: The LD50 values from Dexpanthenol are high, but maybe compound X has off-target effects not captured in acute toxicity. Chronic toxicity or specific organ toxicity (like hepatotoxicity) could be a concern. The initial analysis didn't mention CYP interactions or detailed metabolism beyond what's in similar drugs. If compound X has unique metabolites that are toxic, that's a risk.\\n\\nPharmacodynamics and mechanism of action: If the approved analogs work through well-understood mechanisms but compound X's MoA is novel or less understood, regulators might be cautious. The non-approved analogs might have mechanisms that failed in clinical trials, and similarity to those could be a negative.\\n\\nAnother point: The presence of 4 hydrogen bond donors and acceptors. While within Lipinski's limits, this might lead to high polarity, affecting passive diffusion. Even if TPSA is under 140, the specific arrangement could hinder absorption.\\n\\nAlso, the rotatable bonds (6) are at the higher end of Veber's criteria. This might increase molecular flexibility, potentially leading to poor bioavailability or rapid metabolism. Approved drugs with similar counts might have optimized structures that compound X lacks.\\n\\nLooking at the non-approved list, Arbutin is approved but for topical use. If compound X is intended for systemic use, the safety profile from topical applications doesn't guarantee safety orally or intravenously. Similarly, Indole-3-carbinol is investigational, possibly due to insufficient efficacy or safety concerns.\\n\\nRegulatory agencies also look at therapeutic need. If compound X is similar to existing drugs but doesn't offer significant advantages (e.g., better efficacy, fewer side effects), approval might be denied. The market might already be saturated with similar molecules.\\n\\nLastly, maybe the model's similarity scores aren't the whole story. Structural similarity doesn't always translate to similar pharmacokinetics or dynamics. Subtle differences in the structure could lead to unexpected issues in clinical trials, like drug interactions or immune responses not seen in analogs.\\n\\nPutting it all together, despite passing initial drug-likeness and ADMET checks, compound X's high similarity to drugs with limited use (topical, rare diseases) or non-approved molecules, combined with potential bioavailability issues and lack of therapeutic innovation, likely led to its rejection.\\n\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"answer2\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\nRevised Analysis: Why Compound X Could Be Approved\\n1. Reassessing Drug-Likeness Assumptions\\nCompound X\\u2019s properties (MW = 2297 Da, LogP = -10.3, TPSA = 947 \\u00c5\\u00b2) defy small-molecule rules, but these criteria do not apply to biologics, peptides, or topical agents. Key insights:\\n\\nNatural product/peptide analogy: Bacitracin (MW ~1400 Da, approved for topical use) shares structural similarities (similarity score: 0.84). Like bacitracin, Compound X may be a polypeptide antibiotic or biologic optimized for localized action.\\n\\nRoute of administration: If designed for topical, ocular, or IV use, systemic absorption barriers (e.g., high TPSA, poor permeability) become irrelevant.\\n\\n2. Context-Specific ADMET Profiling\\nAbsorption/Distribution:\\n\\nTopical use: High molecular weight and polarity prevent systemic absorption, reducing toxicity risks (e.g., bacitracin\\u2019s nephrotoxicity only occurs with intramuscular use).\\n\\nIV administration: Bypasses absorption challenges; large biologics (e.g., antibodies, peptides) routinely use this route.\\n\\nMetabolism/Excretion: Peptides are often metabolized into non-toxic fragments, and renal/hepatic clearance may not be critical for localized agents.\\n\\nToxicity: If Compound X avoids systemic exposure (e.g., topical formulation), nephrotoxicity and immunogenicity risks are mitigated.\\n\\n3. Similarity to Approved Molecules\\nBacitracin\\u2019s approval precedent: Despite violating small-molecule rules, bacitracin is FDA-approved for localized infections due to:\\n\\nProven efficacy in topical formulations.\\n\\nManageable safety profile when not administered systemically.\\n\\nHigh similarity to unnamed approved analogs (scores: 0.95\\u20130.96): Likely indicates shared traits with other topical antibiotics or biologics that bypass traditional drug-likeness requirements.\\n\\n4. Non-Approved Molecules: Lessons from Development\\nMurepavadin (cyclic peptide antibiotic) and PL-3994 (peptide agonist) are investigational, showing that peptides with optimized stability/targeting can advance clinically.\\n\\nCompound X\\u2019s structural similarity to these molecules suggests potential for engineering (e.g., cyclization, PEGylation) to enhance stability or reduce toxicity.\\n\\n5. Regulatory Flexibility for Niche Applications\\nApproval could hinge on:\\n\\nUnmet medical need: If Compound X treats a resistant infection or rare disease, regulators may tolerate suboptimal ADMET.\\n\\nLocalized delivery: Topical/IV formulations avoid systemic toxicity.\\n\\nNatural product lineage: Bacitracin and other polypeptides have historical approval despite complexity.\\n\\nRevised Approval Rationale\\nCompound X is likely approved for a specialized use case, such as:\\n\\nTopical antibiotic (e.g., skin/eye infections) where high molecular weight and polarity are advantageous.\\n\\nParenteral biologic for a niche indication (e.g., resistant infections), leveraging peptide-specific targeting.\\n\\nKey drivers of approval:\\n\\nDemonstrated efficacy in localized settings.\\n\\nAcceptable safety profile for the intended route.\\n\\nStructural similarity to bacitracin and other approved polypeptides.\\n\\nFinal Conclusion\\nCompound X is approved because it operates outside small-molecule paradigms, likely as a topical or parenteral peptide/biologic. Its success reflects:\\n\\nContext-specific ADMET optimization (e.g., avoiding systemic exposure).\\n\\nRegulatory acceptance of complex molecules for niche applications.\\n\\nPrecedents set by bacitracin and similar agents.\\n\\nThis case underscores the importance of route-specific development and regulatory flexibility for non-traditional drug modalities.\\n\",\n          \"\\n1. Critical Drug-Likeness and ADMET Red Flags\\nLipinski/VEBER Rule Limitations\\nLow LogP (-1.14): Extremely hydrophilic, suggesting poor membrane permeability despite good solubility. While Lipinski\\u2019s rules are met, passive absorption for systemic delivery may fail (e.g., analogs like Dexpanthenol are used topically or in niche indications, not orally).\\n\\nHigh Rotatable Bonds (6): At the upper limit of Veber\\u2019s criteria, increasing metabolic instability and reducing bioavailability compared to optimized drugs like Miglustat.\\n\\nADMET Weaknesses\\nAbsorption: Low LogP and moderate TPSA (89.79) indicate poor oral bioavailability. Approved analogs (e.g., Dexpanthenol) bypass this via non-oral routes (injection/topical).\\n\\nToxicity Gaps:\\n\\nNo Ames test data for mutagenicity. Structural similarity to non-mutagens is not definitive.\\n\\nChronic toxicity risks (e.g., hepatotoxicity) are unaddressed. Non-approved analogs like Duvoglustat/Indole-3-carbinol highlight unresolved safety concerns.\\n\\n2. Structural Similarity to High-Risk Analogs\\nNon-Approved Molecules\\nMigalastat (0.866 similarity): Approved under accelerated pathways with ongoing confirmatory trials. Compound X\\u2019s similarity raises questions about long-term safety validation.\\n\\nArbutin (0.865 similarity): Approved only for topical use. Systemic administration of Compound X may inherit unstudied risks (e.g., hydroquinone release).\\n\\nDuvoglustat/Indole-3-carbinol: Investigational status implies efficacy/safety failures in trials (e.g., anti-HIV activity abandoned due to toxicity).\\n\\nApproved Molecules with Niche Use\\nDexpanthenol: Topical/epithelial use only. Systemic efficacy unproven.\\n\\nMiglustat: Targets rare diseases (Gaucher/Niemann-Pick). Broad indications for Compound X may require stricter safety thresholds.\\n\\n3. Lack of Therapeutic Differentiation\\nMechanistic Redundancy: Overlaps with existing drugs (e.g., Glucosamine for joint health) without novel targets or improved efficacy.\\n\\nNo Market Need: Similar to Nadolol (beta-blocker), which is no longer first-line due to newer selective agents.\\n\\n4. Hidden Metabolic/Toxicological Risks\\nMetabolism: Unlike Miglustat (minimal hepatic metabolism), Compound X\\u2019s undefined metabolic pathway risks toxic metabolite formation.\\n\\nCYP450 Interactions: No data on enzyme inhibition/induction, critical for chronic use.\\n\\nConclusion: Key Reasons for Rejection\\nPoor Oral Bioavailability: Hydrophilicity and rotatable bonds limit systemic absorption.\\n\\nStructural Links to Non-Approved/High-Risk Drugs: Migalastat\\u2019s conditional approval and Arbutin\\u2019s topical-only use signal unaddressed risks.\\n\\nLack of Therapeutic Innovation: Redundant mechanism without safety/efficacy advantages.\\n\\nIncomplete Toxicity Profile: Missing mutagenicity and chronic toxicity data.\\n\\nFinal Verdict: Regulatory agencies prioritize risk-benefit balance. Compound X\\u2019s similarity to niche-use drugs, unresolved ADMET gaps, and lack of differentiation outweigh its drug-like properties. Not Approved.\\n\\nRecommendation: Redesign for improved permeability (e.g., prodrug) or pursue topical indications with rigorous chronic toxicity studies.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"3rd_prompt\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"\\n    write your thinking in the following format\\n    {\\\"status(Approved/NonApproved)\\\": Not Approved,\\n    \\\"score(0=notapproved to 10=approved): \\\"\\n    \\\"reason_to_be_approved\\\":\\n    \\\"reason_to_be_notapproved\\\"   }\\n    \",\n          \"\\n    write your thinking in the following format\\n    {\\\"status(Approved/NonApproved)\\\": Approved,\\n    \\\"score(0=notapproved to 10=approved): \\\"\\n    \\\"reason_to_be_approved\\\":\\n    \\\"reason_to_be_notapproved\\\"   }\\n    \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"think3\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\nOkay, let's tackle this. The user wants the answer in a specific JSON format, and they mentioned that the true answer is \\\"Approved.\\\" So I need to reconcile the initial analysis which leaned towards NonApproved with the fact that the correct answer is Approved.\\n\\nFirst, I'll recall the compound's properties: extremely high molecular weight, very low LogP, massive TPSA, lots of H-bond donors/acceptors, and many rotatable bonds. Initially, these all scream \\\"not drug-like\\\" for a small molecule. But the user says it's approved. So maybe it's not a small molecule but a biologic or peptide.\\n\\nLooking at the similar approved drug, Bacitracin. It's a large peptide antibiotic used topically. The high similarity score here suggests Compound X might be similar. Bacitracin's approval is for topical use, avoiding systemic issues. So Compound X could be approved for a similar route\\u2014topical, maybe IV if it's a biologic.\\n\\nThe reasons for approval would hinge on route of administration. If it's topical, the ADMET issues like poor absorption don't matter. Also, if it's a biologic, different rules apply. The precedents like Bacitracin and maybe other biologics show that large molecules can be approved if they're used appropriately.\\n\\nBut why the high similarity to non-approved molecules? The non-approved ones like Murepavadin and PL-3994 are investigational. Maybe they're still in trials, or have different targets. But Compound X's approval could be based on better efficacy or safety in a specific context.\\n\\nSo the score should reflect that it's approved, but with caveats. Maybe a 7, since it's approved for a specific use but might have limitations. The reasons to approve are the similarity to Bacitracin and topical use. The reasons to not approve would be all the drug-likeness issues if it were a systemic small molecule.\\n\\nNeed to structure this into the JSON format as specified. Make sure to include both reasons and the score. Also, check that the keys are correct and the values are concise.\\n\\n\\n\",\n          \"\\nAlright, the user wants me to format the previous analysis into a specific JSON structure. Let me start by recalling the conclusion from the last response: Compound X was deemed Not Approved.\\n\\nFirst, I need to assign a score. The original analysis mentioned strengths like meeting drug-likeness rules and similarity to approved drugs, but significant weaknesses in bioavailability and toxicity. Considering the balance, a score around 3.5/10 seems appropriate\\u2014low but not the absolute lowest.\\n\\nFor \\\"reason_to_be_approved\\\", I should list the positives: adherence to Lipinski's and Veber's rules, similarity to safe approved drugs like Dexpanthenol, and low acute toxicity. These are valid points that could support approval under certain conditions.\\n\\nNow, \\\"reason_to_be_notapproved\\\" requires detailing the critical flaws. Poor oral bioavailability due to low LogP and high rotatable bonds is a key issue. Structural similarity to non-approved or topically used drugs like Arbutin and Migalastat (with their own risks) raises red flags. Lack of data on chronic toxicity and CYP interactions, plus no therapeutic innovation compared to existing drugs, are major hurdles. The market need isn't addressed, making approval unlikely.\\n\\nI need to ensure the JSON syntax is correct, with proper commas and quotes. Also, the score should be a float. Let me double-check each key and value to match the required format.\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"anwer3\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"\\n{\\n    \\\"status(Approved/NonApproved)\\\": \\\"Approved\\\",\\n    \\\"score(0=notapproved to 10=approved)\\\": 7,\\n    \\\"reason_to_be_approved\\\": \\n        \\\"Compound X is structurally analogous to bacitracin (similarity score: 0.84), an FDA-approved polypeptide antibiotic for topical use. Its extreme hydrophilicity, high molecular weight (2297 Da), and large TPSA align with biologics/peptides optimized for localized action (e.g., topical, IV). Approval is feasible if developed for non-systemic routes (e.g., topical infections, niche IV biologics) where traditional drug-likeness rules are irrelevant. Precedents like bacitracin and similarity to unnamed approved analogs (scores: 0.95\\u20130.96) suggest regulatory flexibility for specialized applications.\\\",\\n    \\\"reason_to_be_notapproved\\\": \\n        \\\"Violates all small-molecule drug-likeness rules (MW >500, LogP <0, TPSA >>140 \\u00c5\\u00b2, 36 HBD/HBA). Systemic use would fail due to poor absorption, nephrotoxicity risks (like bacitracin\\u2019s intramuscular toxicity), and metabolic instability. High similarity to non-approved molecules (e.g., murepavadin, PL-3994) reflects clinical attrition risks for large peptides.\\\"\\n}\\n\",\n          \"\\n{\\n    \\\"status(Approved/NonApproved)\\\": \\\"Not Approved\\\",\\n    \\\"score(0=notapproved to 10=approved)\\\": 3.5,\\n    \\\"reason_to_be_approved\\\": \\\"Compound X meets key drug-likeness rules (Lipinski/Veber), aligns structurally with safe approved drugs (e.g., Dexpanthenol, Miglustat), and shows low acute toxicity in analogs.\\\",\\n    \\\"reason_to_be_notapproved\\\": \\\"1. **Poor oral bioavailability**: Extremely low LogP (-1.14) and high rotatable bonds (6) limit systemic absorption. 2. **Structural similarity to non-approved/topical drugs**: Migalastat (accelerated approval with unresolved safety) and Arbutin (topical-only use) suggest unaddressed systemic risks. 3. **Incomplete toxicity profile**: No Ames test or chronic toxicity data. 4. **No therapeutic differentiation**: Overlaps with existing drugs (e.g., Glucosamine) without novel mechanisms. 5. **Metabolic uncertainty**: Undefined CYP450 interactions and potential toxic metabolites.\\\"\\n}\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 133
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "## 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"
      ],
      "metadata": {
        "id": "PEpf4SPO95_t"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import AutoTokenizer,AutoModelForCausalLM,BitsAndBytesConfig,TrainingArguments\n",
        "from peft import LoraConfig, prepare_model_for_kbit_training, get_peft_model\n",
        "import torch\n",
        "\n",
        "tokenizer = AutoTokenizer.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9P4c5xgjmpkY",
        "outputId": "8e568805-a980-42e7-d8f5-c60cb8da587d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/huggingface_hub/utils/_auth.py:94: UserWarning: \n",
            "The secret `HF_TOKEN` does not exist in your Colab secrets.\n",
            "To authenticate with the Hugging Face Hub, create a token in your settings tab (https://huggingface.co/settings/tokens), set it as secret in your Google Colab and restart your session.\n",
            "You will be able to reuse this secret in all of your notebooks.\n",
            "Please note that authentication is recommended but still optional to access public models or datasets.\n",
            "  warnings.warn(\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "df_sft_sft = pd.read_csv(\"/content/drive/MyDrive/Papers/Original_Papers/Llm_drug_prediction/Code/reasoning_data_api/just_for_sft.csv\")\n",
        "\n",
        "df_sft_sft_100 = pd.concat(100*[df_sft_sft], axis=0, ignore_index=True)\n",
        "\n",
        "dset = Dataset.from_pandas(df_sft_sft_100)\n",
        "\n",
        "def get_tokenize(dset):\n",
        "    return tokenizer(dset[\"sft_input\"] , padding=\"max_length\" , truncation=True  )\n",
        "\n",
        "\n",
        "dset2train = dset.map(get_tokenize)\n",
        "def get_sft_prompt(input , thinking , answer):\n",
        "    return f\"\"\"<｜begin▁of▁sentence｜><｜User｜>{input}<think>{thinking}</think><｜Assistant｜>{answer}<｜end▁of▁sentence｜><｜Assistant｜>\"\"\"\n",
        "\n",
        "\n",
        "# df_sft[\"sft_input\"] = df_sft.apply(lambda row : get_sft_prompt(row[\"1st_prompt\"] ,f\"\"\"{row[\"think1\"]} \\n{row[\"answer1\"]} \\n but wait lets analysis again \\n{row[\"think2\"]}\\n {row[\"answer2\"]}\"\"\"  , row[\"anwer3\"]) , axis = 1)\n",
        "# Load model directly\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 49,
          "referenced_widgets": [
            "35b5bde01867489c8639f5425b1fc4e3",
            "5325c46ce1114a9cadbdff3b4eba8e1e",
            "5b01d8d6dae3439a906b41d3c63a9dda",
            "c838a44d2e6141029d293f10728d80b2",
            "e75317ba160e4d11b89e5036e74f9ebc",
            "e64799106bcd4f95bf501f0fd9952613",
            "9aa62d20e5094f57ba1561467c5cfaee",
            "91922e731f5c40aea16148b5ac39ddbe",
            "26eeb5890c6c4ba8a94269a8f62f93c7",
            "afc5f4e29900417690658eaeadfefe2e",
            "d9640a5d0b374019bc01b9e2746e6148"
          ]
        },
        "id": "OnnmTpcihMX0",
        "outputId": "72406e5f-d8d9-4d18-ee77-e448d267b4c1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Map:   0%|          | 0/500 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "35b5bde01867489c8639f5425b1fc4e3"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer.model_max_length"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "yqmcQHsehFgn",
        "outputId": "7fa34477-d2bc-40bf-94ed-fe57a2be6ae4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "16384"
            ]
          },
          "metadata": {},
          "execution_count": 4
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "ZVYL6v3tiaYu"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "model = AutoModelForCausalLM.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\", # this is not working I shoud replace it with 7b\"deepseek-ai/DeepSeek-R1-Distill-Qwen-14B\"\"meta-llama/Llama-3.1-8B-Instruct\"\n",
        "                                             device_map=\"auto\",  # Automatically places layers on available devices\n",
        "                                             torch_dtype=torch.bfloat16,\n",
        "                                             )"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 227,
          "referenced_widgets": [
            "2a84afa083e247458ded7d2d1b7bbdcf",
            "ba555c6279824533a9e06a94f753e3bc",
            "e80a0d27beb043f3be8e28e24440588d",
            "2ccce53cd2b84bc1b164a9483ca22fd8",
            "4e251e3805204980a4315bb75b51d7ea",
            "240edf9d11b644b99a33c1a1a37400dd",
            "f3045f7bd48e49ff8abbeba93edeea25",
            "da99aea7d2d34da8934a9022eebb9346",
            "704391c96bf4490fa5b0ff1efd3d1bd2",
            "24ea06865d1f4188ac6ea27d762d50e6",
            "896a7c0d2c1c40c8b0d85cef8b4ae7e2",
            "aea11a88ca164d38bd41624afa3f3263",
            "63842a5c138c4441a3b29632e8fca09d",
            "33b4f57a8ca1403e8e38d106746e90db",
            "3032ac75f07045c6a2360f63b9eec81e",
            "c1b456fdef87425b82c5d3fc845cf9e1",
            "7090ca9d99aa468fb4f0191c2b14b09d",
            "4161a240d070484b8ad55fd01535c0e9",
            "0c154d9110a947c7932ef15ff6e3380f",
            "2c7180ab842a4562842f3ebc15ed9932",
            "d7eab4416e5c4b4e80c537cf5f47311a",
            "12a9a010972d4f798270ad33d6b89c5b",
            "696cbe32be89465ba8525cdadcd519d7",
            "4264deb7410545bcbada15928ccd2979",
            "c5cc128a103b4c73b604004b3e878d52",
            "528ab88045d24fe896b39c59f495e06e",
            "9e00166a77ba4845b5e75aaddc31d2e5",
            "13a18e4da18f4dcb8829e2ffde114b9b",
            "4a22ea9829aa40dd91e9645846127d43",
            "2891a90c5c824bf3af4d846dccf9b376",
            "205d6207593343b68ec7bd50df745d1a",
            "292a2f9a6f854dfaa5545d9d9414ee20",
            "3f7db5e9b68f4374ac63658b4f2bdd24",
            "79dc28185a3543899b36417ceb2aa521",
            "b82e58e83ac645c795040a872ff4e513",
            "a000327b45d440208867b22c155f7da1",
            "190ca58635d1441ca1af375a61a645e5",
            "daf8b09d093447b7a911050c37bae72f",
            "3c639b0da59d442788c75ad720969d4f",
            "afb50bc5bd9d4f86b841f08b09fda31d",
            "7430ff654ba44fe98f5d48a6fc72e7e1",
            "8e4f07611cfa417cbd69db378d08db7c",
            "ec01598cbe574538ae67b9eec4cb01f3",
            "edf144e7a6a2406883589a498d1bb0ce",
            "50e3faccc8b142a69844c15bc3376037",
            "1d5f86564d014171a0522f4b81ec57e6",
            "13906a1d284a4afea9785397d69ee445",
            "439e1db0102747d5a686d53afee4c51c",
            "b96f7ef3dfc745418f86a67c5915fdba",
            "784ef22c55494cc89cdb715ec5d0ce55",
            "4c8a48a893e644d9889b15f8e88833a6",
            "f7bd3222e17e47d98343d7adc2445b01",
            "cc83e26f390b4f84b8e2d51a28a43e0b",
            "fa8ebcfcd7ce4935a5c63518758d69c6",
            "3f8f167c54cd4463a03106cf6dd43483",
            "37a2dbbd1033466fb59a791414c00ecd",
            "d6ef039d40ef404baabd218a35c59f47",
            "89f435bc17de4b8c94633a59d08b2618",
            "1dfe47ee12374719be9de93fd0f563ac",
            "856bc0c76f774db6b0942c5dbddd6c6d",
            "6f7fa182ce3f4fbcb6211a3e666b3233",
            "697022776aaa4d2eb2a22a8bba95c378",
            "b7b1f28efa6c465aa535261828bbab2a",
            "f9e2a5f74104435582ebfb8d449f1d48",
            "53509d36683f4cb19e59ed79888a9e8b",
            "5e8bbb13d7be40be8e43613e67e0763e"
          ]
        },
        "id": "dpQieNW8j6BF",
        "outputId": "430548aa-7256-4dc1-8496-a8ba0719864d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model.safetensors.index.json:   0%|          | 0.00/24.2k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2a84afa083e247458ded7d2d1b7bbdcf"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Fetching 2 files:   0%|          | 0/2 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "aea11a88ca164d38bd41624afa3f3263"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model-00001-of-000002.safetensors:   0%|          | 0.00/8.67G [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "696cbe32be89465ba8525cdadcd519d7"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "model-00002-of-000002.safetensors:   0%|          | 0.00/7.39G [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "79dc28185a3543899b36417ceb2aa521"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Loading checkpoint shards:   0%|          | 0/2 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "50e3faccc8b142a69844c15bc3376037"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "generation_config.json:   0%|          | 0.00/181 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "37a2dbbd1033466fb59a791414c00ecd"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "WARNING:accelerate.big_modeling:Some parameters are on the meta device because they were offloaded to the cpu and disk.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "model"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "iqTe_lFej-Xj",
        "outputId": "8e1915b6-6619-445d-af32-7b782e52229c"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "LlamaForCausalLM(\n",
              "  (model): LlamaModel(\n",
              "    (embed_tokens): Embedding(128256, 4096)\n",
              "    (layers): ModuleList(\n",
              "      (0-31): 32 x LlamaDecoderLayer(\n",
              "        (self_attn): LlamaAttention(\n",
              "          (q_proj): Linear(in_features=4096, out_features=4096, bias=False)\n",
              "          (k_proj): Linear(in_features=4096, out_features=1024, bias=False)\n",
              "          (v_proj): Linear(in_features=4096, out_features=1024, bias=False)\n",
              "          (o_proj): Linear(in_features=4096, out_features=4096, bias=False)\n",
              "        )\n",
              "        (mlp): LlamaMLP(\n",
              "          (gate_proj): Linear(in_features=4096, out_features=14336, bias=False)\n",
              "          (up_proj): Linear(in_features=4096, out_features=14336, bias=False)\n",
              "          (down_proj): Linear(in_features=14336, out_features=4096, bias=False)\n",
              "          (act_fn): SiLU()\n",
              "        )\n",
              "        (input_layernorm): LlamaRMSNorm((4096,), eps=1e-05)\n",
              "        (post_attention_layernorm): LlamaRMSNorm((4096,), eps=1e-05)\n",
              "      )\n",
              "    )\n",
              "    (norm): LlamaRMSNorm((4096,), eps=1e-05)\n",
              "    (rotary_emb): LlamaRotaryEmbedding()\n",
              "  )\n",
              "  (lm_head): Linear(in_features=4096, out_features=128256, bias=False)\n",
              ")"
            ]
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import AutoConfig\n",
        "\n",
        "config = AutoConfig.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\")\n",
        "print(config.max_position_embeddings)  # This gives the context length"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "iUjNB_e7j-DB",
        "outputId": "36604d6b-f710-4976-841e-95c993e7da74"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "131072\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from huggingface_hub import notebook_login\n",
        "notebook_login()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 17,
          "referenced_widgets": [
            "661cb7bf9bfc4d60aa2541ab95987edc",
            "6471f8f988bd4c5f8cc8b7760656ea9d",
            "9cf16c240b294d8e8bda2a08b45983ff",
            "27f6a38ab5854760930c6b8ee8bf2e2b",
            "d6c8682406a3488ba5cd8ae27d737646",
            "a922c6a00c0f4caba23767e692dd0f6c",
            "1b4147371e374df2bbe7db60d00d9a9c",
            "ea066d5b756f4e8cb75c82706a19728f",
            "0050a0acdf68464aad55725ccd7e5d50",
            "113e2a63308b4edd8c71645546d0c650",
            "c1f8b768a6ac4272844dc6d58c40a1d6",
            "de18b40d5ff4406589d6f26702b1731f",
            "390967cb1bbc477a9847698f8bdb7c04",
            "1f1e89a488f542f7bb462552be6b56a7",
            "171ea308278b4031b909e32ada0b06ac",
            "6853b9387d7c4c1f9428487b4cdadb50",
            "6a45caee4dab458090af818d0f16294e",
            "df10fdb6a9c34233b8fec13f1d8ff0a7",
            "49d30b301bc643d2b73636c2ebbee8f1",
            "10e70edc06e246e09e8b509a0ee8938c"
          ]
        },
        "id": "FL3xCDVct4s-",
        "outputId": "f56ed8b8-440b-4b00-a049-a99d5df1f015"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "VBox(children=(HTML(value='<center> <img\\nsrc=https://huggingface.co/front/assets/huggingface_logo-noborder.sv…"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "661cb7bf9bfc4d60aa2541ab95987edc"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer = AutoTokenizer.from_pretrained(\"meta-llama/Llama-3.1-8B-Instruct\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 113,
          "referenced_widgets": [
            "6c7633f034a5427bbb8fb99906376135",
            "ecdad2813c1a485a8a8eb757f568231d",
            "8169b570a6ca49d3b13446cf2473d41e",
            "a99c7ca0406e423385a2ba2bfa8af4c4",
            "5dd0bef7e6ef48ae9764e1c4b5c0d937",
            "5fe94338137c46c287f0290ced244b4c",
            "af0fce60b48944149976a6eca2558958",
            "73bdac672adf4dcf939f7ca5d5b77737",
            "b37ab3da6d2c4c0c9072ce4d181e7a60",
            "f8b062c5e47d447fa388c07b8e9d3ee4",
            "10e40d4309504b25bc03ddaa740fea17",
            "efb8bbaaafc44c33970334123551dc29",
            "3c738bc6bd51486fa14b2e64636c9b9a",
            "af506c5aaa304a79b43c049f23eb53d6",
            "3a6eeb5790434081b3a2c72142126e17",
            "58115e023a6349b885ae57184a27f444",
            "75b987bcb29640caa59ba7573702f68e",
            "ff8855c78c71404283a75188ad69e071",
            "06953861ec2b4bacb96b0e35e0a57f0b",
            "5a4ef5d74b45449eaff3768b54f40445",
            "b9d1d5afc56d44448fc43f9e044fad19",
            "44c024bdacb443ca82ad02436cf39ade",
            "836719a5d51f492a8d35000ab621cfaa",
            "d925231868bb4d83addd6517d0c78838",
            "25b42175fd1c459ca700ad139428621b",
            "bd8f8b41121a4662b41011eb51824de9",
            "40c237fd1b5a43918dd091fae7c5a3c0",
            "0e044a12ca854d5ea18a3412a2320a17",
            "6c10a282b52b476ab5bc4353219659a2",
            "8c6b366bf74840ce8ebb2162524d40b4",
            "4211fc6bcc5f4d6ab4d0c977e1ed0e0e",
            "2f829651500448979b2329105bea146c",
            "79a2c838447d42b98c47f063ee9b2e78"
          ]
        },
        "id": "FEigt-Hlpvph",
        "outputId": "661dc985-9dc4-49c2-b064-7c66b8ba9ec4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/55.4k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "6c7633f034a5427bbb8fb99906376135"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/9.09M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "efb8bbaaafc44c33970334123551dc29"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "special_tokens_map.json:   0%|          | 0.00/296 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "836719a5d51f492a8d35000ab621cfaa"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "message = [\n",
        "    {\"role\":\"system\",\"content\":\"you are a helpful assistant\"},\n",
        "    {\"role\": \"user\", \"content\":\"hi what is yourname? jsekhgflkja;`qwhbufgln qwbgl;uq b\"},\n",
        "    {\"role\":\"assistant\",\"content\":\" foul \" }\n",
        "]\n",
        "tokenized = tokenizer.apply_chat_template(message, tokenize=True, return_tensors=\"pt\")\n",
        "\n",
        "tokenized"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "B3xqtpRzpS9M",
        "outputId": "5b177514-47a0-4864-eb84-927752899e59"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "tensor([[128000, 128006,   9125, 128007,    271,  38766,   1303,  33025,   2696,\n",
              "             25,   6790,    220,   2366,     18,    198,  15724,   2696,     25,\n",
              "            220,   1627,  10263,    220,   2366,     19,    271,   9514,    527,\n",
              "            264,  11190,  18328, 128009, 128006,    882, 128007,    271,   6151,\n",
              "           1148,    374,    701,    609,     30,    503,    325,  31764,     70,\n",
              "           1517,     74,   5697,     26,     63,     80,   1336,   6034,     70,\n",
              "           2312,   2874,  20824,   6200,     26,     84,     80,    293, 128009,\n",
              "         128006,  78191, 128007,    271,     69,  11206, 128009]])"
            ]
          },
          "metadata": {},
          "execution_count": 49
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer.decode(tokenized[0])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 72
        },
        "id": "e6kpNzKirpJd",
        "outputId": "b320bb05-f681-4e8d-ef1b-02da9398a4d3"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'<|begin_of_text|><|start_header_id|>system<|end_header_id|>\\n\\nCutting Knowledge Date: December 2023\\nToday Date: 26 Jul 2024\\n\\nyou are a helpful assistant<|eot_id|><|start_header_id|>user<|end_header_id|>\\n\\nhi what is yourname? jsekhgflkja;`qwhbufgln qwbgl;uq b<|eot_id|><|start_header_id|>assistant<|end_header_id|>\\n\\nfoul<|eot_id|>'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 50
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "bnb_config = BitsAndBytesConfig(\n",
        "    load_in_4bit=True,\n",
        "    bnb_4bit_quant_type=\"nf4\",\n",
        "    bnb_4bit_compute_dtype=torch.bfloat16,\n",
        "    bnb_4bit_use_double_quant=True,\n",
        ")\n",
        "\n",
        "\n",
        "model = AutoModelForCausalLM.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\", # this is not working I shoud replace it with 7b\"deepseek-ai/DeepSeek-R1-Distill-Qwen-14B\"\"meta-llama/Llama-3.1-8B-Instruct\"\n",
        "                                             quantization_config=bnb_config,\n",
        "                                             device_map=\"auto\",  # Automatically places layers on available devices\n",
        "                                             torch_dtype=torch.bfloat16,\n",
        "                                            #  attn_implementation=\"flash_attention_2\"\n",
        "                                             ) #\"manycore-research/SpatialLM-Llama-1B\"\"deepseek-ai/DeepSeek-R1\"\n",
        "\n",
        "model = prepare_model_for_kbit_training(model)\n",
        "\n",
        "peft_config = LoraConfig(\n",
        "    r=8,  # Rank of the low-rank matrices\n",
        "    lora_alpha=16,  # Scaling factor\n",
        "    target_modules=[\"q_proj\", \"k_proj\", \"v_proj\", \"o_proj\", \"down_proj\" , \"up_proj\" , \"gate_proj\"],  # Modules to apply LoRA to\n",
        "    lora_dropout=0.05,\n",
        "    bias=\"none\",\n",
        "    task_type=\"CAUSAL_LM\",\n",
        ")\n",
        "\n",
        "# 6. Wrap model with LoRA\n",
        "model = get_peft_model(model, peft_config)\n",
        "\n",
        "# [len(tokenizer.tokenize(i)) for i in df_sft[\"sft_input\"]]\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 438
        },
        "id": "1gpIdoN-ADKw",
        "outputId": "731e1e79-5f25-4914-8ff7-9379028ad5dd"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "error",
          "ename": "RuntimeError",
          "evalue": "Failed to import transformers.integrations.bitsandbytes because of the following error (look up to see its traceback):\n0 active drivers ([]). There should only be one.",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/utils/import_utils.py\u001b[0m in \u001b[0;36m_get_module\u001b[0;34m(self, module_name)\u001b[0m\n\u001b[1;32m   1967\u001b[0m         \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1968\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mimportlib\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mimport_module\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\".\"\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mmodule_name\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__name__\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1969\u001b[0m         \u001b[0;32mexcept\u001b[0m \u001b[0mException\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0me\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/__init__.py\u001b[0m in \u001b[0;36mimport_module\u001b[0;34m(name, package)\u001b[0m\n\u001b[1;32m    125\u001b[0m             \u001b[0mlevel\u001b[0m \u001b[0;34m+=\u001b[0m \u001b[0;36m1\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 126\u001b[0;31m     \u001b[0;32mreturn\u001b[0m \u001b[0m_bootstrap\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_gcd_import\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mname\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mlevel\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mpackage\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlevel\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    127\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap.py\u001b[0m in \u001b[0;36m_gcd_import\u001b[0;34m(name, package, level)\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap.py\u001b[0m in \u001b[0;36m_find_and_load\u001b[0;34m(name, import_)\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap.py\u001b[0m in \u001b[0;36m_find_and_load_unlocked\u001b[0;34m(name, import_)\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap.py\u001b[0m in \u001b[0;36m_load_unlocked\u001b[0;34m(spec)\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap_external.py\u001b[0m in \u001b[0;36mexec_module\u001b[0;34m(self, module)\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap.py\u001b[0m in \u001b[0;36m_call_with_frames_removed\u001b[0;34m(f, *args, **kwds)\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/integrations/bitsandbytes.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m     20\u001b[0m \u001b[0;32mif\u001b[0m \u001b[0mis_bitsandbytes_available\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 21\u001b[0;31m     \u001b[0;32mimport\u001b[0m \u001b[0mbitsandbytes\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0mbnb\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     22\u001b[0m     \u001b[0;32mimport\u001b[0m \u001b[0mtorch\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/bitsandbytes/__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m     14\u001b[0m )\n\u001b[0;32m---> 15\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0mnn\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mmodules\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     16\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0moptim\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0madam\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/bitsandbytes/nn/__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m     20\u001b[0m )\n\u001b[0;32m---> 21\u001b[0;31m from .triton_based_modules import (\n\u001b[0m\u001b[1;32m     22\u001b[0m     \u001b[0mStandardLinear\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/bitsandbytes/nn/triton_based_modules.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 6\u001b[0;31m \u001b[0;32mfrom\u001b[0m \u001b[0mbitsandbytes\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtriton\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdequantize_rowwise\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mdequantize_rowwise\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      7\u001b[0m from bitsandbytes.triton.int8_matmul_mixed_dequantize import (\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/bitsandbytes/triton/dequantize_rowwise.py\u001b[0m in \u001b[0;36m<module>\u001b[0;34m\u001b[0m\n\u001b[1;32m     17\u001b[0m     \u001b[0;31m# TODO: autotune this better.\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 18\u001b[0;31m     @triton.autotune(\n\u001b[0m\u001b[1;32m     19\u001b[0m         configs=[\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/triton/runtime/autotuner.py\u001b[0m in \u001b[0;36mdecorator\u001b[0;34m(fn)\u001b[0m\n\u001b[1;32m    367\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mdecorator\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mfn\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 368\u001b[0;31m         return Autotuner(fn, fn.arg_names, configs, key, reset_to_zero, restore_value, pre_hook=pre_hook,\n\u001b[0m\u001b[1;32m    369\u001b[0m                          \u001b[0mpost_hook\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mpost_hook\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mprune_configs_by\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mprune_configs_by\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mwarmup\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mwarmup\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mrep\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mrep\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/triton/runtime/autotuner.py\u001b[0m in \u001b[0;36m__init__\u001b[0;34m(self, fn, arg_names, configs, key, reset_to_zero, restore_value, pre_hook, post_hook, prune_configs_by, warmup, rep, use_cuda_graph, do_bench)\u001b[0m\n\u001b[1;32m    129\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mdo_bench\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 130\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdo_bench\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mdriver\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mactive\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget_benchmarker\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    131\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/triton/runtime/driver.py\u001b[0m in \u001b[0;36m__getattr__\u001b[0;34m(self, name)\u001b[0m\n\u001b[1;32m     22\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0m__getattr__\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 23\u001b[0;31m         \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_initialize_obj\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     24\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mgetattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_obj\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/triton/runtime/driver.py\u001b[0m in \u001b[0;36m_initialize_obj\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m     19\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_obj\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 20\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_obj\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_init_fn\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     21\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/triton/runtime/driver.py\u001b[0m in \u001b[0;36m_create_driver\u001b[0;34m()\u001b[0m\n\u001b[1;32m      7\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0mlen\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mactives\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m!=\u001b[0m \u001b[0;36m1\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 8\u001b[0;31m         \u001b[0;32mraise\u001b[0m \u001b[0mRuntimeError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34mf\"{len(actives)} active drivers ({actives}). There should only be one.\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      9\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0mactives\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mRuntimeError\u001b[0m: 0 active drivers ([]). There should only be one.",
            "\nThe above exception was the direct cause of the following exception:\n",
            "\u001b[0;31mRuntimeError\u001b[0m                              Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-20-74207dc6315e>\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      7\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      8\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 9\u001b[0;31m model = AutoModelForCausalLM.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\", # this is not working I shoud replace it with 7b\"deepseek-ai/DeepSeek-R1-Distill-Qwen-14B\"\"meta-llama/Llama-3.1-8B-Instruct\"\n\u001b[0m\u001b[1;32m     10\u001b[0m                                              \u001b[0mquantization_config\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mbnb_config\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     11\u001b[0m                                              \u001b[0mdevice_map\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"auto\"\u001b[0m\u001b[0;34m,\u001b[0m  \u001b[0;31m# Automatically places layers on available devices\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/models/auto/auto_factory.py\u001b[0m in \u001b[0;36mfrom_pretrained\u001b[0;34m(cls, pretrained_model_name_or_path, *model_args, **kwargs)\u001b[0m\n\u001b[1;32m    571\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mtype\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mconfig\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mcls\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_model_mapping\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mkeys\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    572\u001b[0m             \u001b[0mmodel_class\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0m_get_model_class\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mconfig\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcls\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_model_mapping\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 573\u001b[0;31m             return model_class.from_pretrained(\n\u001b[0m\u001b[1;32m    574\u001b[0m                 \u001b[0mpretrained_model_name_or_path\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m*\u001b[0m\u001b[0mmodel_args\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mconfig\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mconfig\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mhub_kwargs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    575\u001b[0m             )\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/modeling_utils.py\u001b[0m in \u001b[0;36m_wrapper\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    270\u001b[0m         \u001b[0mold_dtype\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtorch\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mget_default_dtype\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    271\u001b[0m         \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 272\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    273\u001b[0m         \u001b[0;32mfinally\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    274\u001b[0m             \u001b[0mtorch\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mset_default_dtype\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mold_dtype\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/modeling_utils.py\u001b[0m in \u001b[0;36mfrom_pretrained\u001b[0;34m(cls, pretrained_model_name_or_path, config, cache_dir, ignore_mismatched_sizes, force_download, local_files_only, token, revision, use_safetensors, weights_only, *model_args, **kwargs)\u001b[0m\n\u001b[1;32m   4290\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   4291\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mhf_quantizer\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 4292\u001b[0;31m             hf_quantizer.validate_environment(\n\u001b[0m\u001b[1;32m   4293\u001b[0m                 \u001b[0mtorch_dtype\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mtorch_dtype\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   4294\u001b[0m                 \u001b[0mfrom_tf\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mfrom_tf\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/quantizers/quantizer_bnb_4bit.py\u001b[0m in \u001b[0;36mvalidate_environment\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m     78\u001b[0m             )\n\u001b[1;32m     79\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 80\u001b[0;31m         \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mintegrations\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mvalidate_bnb_backend_availability\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     81\u001b[0m         \u001b[0;32mfrom\u001b[0m \u001b[0;34m.\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mutils\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mis_bitsandbytes_multi_backend_available\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     82\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/lib/python3.11/importlib/_bootstrap.py\u001b[0m in \u001b[0;36m_handle_fromlist\u001b[0;34m(module, fromlist, import_, recursive)\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/utils/import_utils.py\u001b[0m in \u001b[0;36m__getattr__\u001b[0;34m(self, name)\u001b[0m\n\u001b[1;32m   1954\u001b[0m             \u001b[0mvalue\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mPlaceholder\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1955\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mname\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_class_to_module\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mkeys\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1956\u001b[0;31m             \u001b[0mmodule\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_get_module\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_class_to_module\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mname\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1957\u001b[0m             \u001b[0mvalue\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgetattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mmodule\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1958\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mname\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_modules\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/utils/import_utils.py\u001b[0m in \u001b[0;36m_get_module\u001b[0;34m(self, module_name)\u001b[0m\n\u001b[1;32m   1968\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mimportlib\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mimport_module\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\".\"\u001b[0m \u001b[0;34m+\u001b[0m \u001b[0mmodule_name\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__name__\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1969\u001b[0m         \u001b[0;32mexcept\u001b[0m \u001b[0mException\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0me\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1970\u001b[0;31m             raise RuntimeError(\n\u001b[0m\u001b[1;32m   1971\u001b[0m                 \u001b[0;34mf\"Failed to import {self.__name__}.{module_name} because of the following error (look up to see its\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1972\u001b[0m                 \u001b[0;34mf\" traceback):\\n{e}\"\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mRuntimeError\u001b[0m: Failed to import transformers.integrations.bitsandbytes because of the following error (look up to see its traceback):\n0 active drivers ([]). There should only be one."
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install -q torch ninja packaging\n",
        "!pip install -q flash-attn --no-build-isolation"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "EdonnFLqEWm8",
        "outputId": "dc2f7454-cef6-4c53-d531-645fcb4065a0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m422.8/422.8 kB\u001b[0m \u001b[31m10.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.0/6.0 MB\u001b[0m \u001b[31m50.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Building wheel for flash-attn (setup.py) ... \u001b[?25l\u001b[?25hdone\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install -q  accelerate"
      ],
      "metadata": {
        "id": "Da_8QW_DE-aD"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "# df_sft_sft = df_sft[[\"sft_input\"]]\n",
        "# df_sft_sft.to_csv(\"/content/drive/MyDrive/Papers/Original_Papers/Llm_drug_prediction/Code/reasoning_data_api/just_for_sft.csv\", index = False)\n",
        "offload_dir = \"./offload\"\n",
        "training_args = SFTConfig(\n",
        "    output_dir=\"/tmp\",                  # Directory for output files\n",
        "    num_train_epochs=1,                # Number of training epochs\n",
        "    per_device_train_batch_size=2,     # Batch size per device\n",
        "    gradient_accumulation_steps=1,     # Number of updates steps to accumulate\n",
        "    learning_rate=2e-4,                # Learning rate\n",
        "    weight_decay=0.01,                 # Weight decay\n",
        "    logging_dir=\"./logs\",              # Directory for logs\n",
        "    logging_steps=1,                  # Log every X steps\n",
        "    save_steps=500,                    # Save checkpoint every X steps\n",
        "    save_total_limit=2,                # Max number of checkpoints to keep\n",
        "    # evaluation_strategy=\"steps\",       # Evaluate every X steps\n",
        "    # eval_steps=100,                    # Evaluation steps\n",
        "    fp16=True,                         # Use mixed precision training\n",
        "    warmup_steps=500,                  # Number of warmup steps\n",
        "    optim=\"paged_adamw_8bit\",\n",
        "    lr_scheduler_type=\"cosine\",\n",
        "    report_to = \"none\",\n",
        "    torch_compile =True,\n",
        "    gradient_checkpointing= True,\n",
        "    # use_flash_attention_2=True,\n",
        "    # low_cpu_mem_usage=True  ,\n",
        "    # torch_dtype=\"auto\",  # Automatically uses bf16/fp16 if supported\n",
        "    # device_map=\"auto\",\n",
        ")\n",
        "\n",
        "trainer = SFTTrainer(\n",
        "    model = model ,\n",
        "    train_dataset=dset2train,\n",
        "    args=training_args,\n",
        ")\n",
        "trainer.train()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 931,
          "referenced_widgets": [
            "25d40f625dbe4f978a02a6b2a7210ae5",
            "6b365cc4096544d3b9bbd6f9c614597d",
            "afd072d3dd184979b0ac9263ff9eee53",
            "3d87856ef0cc4c1299855a1cd3c14c1b",
            "5b3c33a919bf42adb78a9f221fbe2df2",
            "f097c078eecc4c7195646b5feb4ff144",
            "2079ba12f15d468ca36b789f948e0764",
            "60d863e06e1d47a9b4e28d9d3506a8e2",
            "10987c118565476f89e9980d1f55758d",
            "d0cb6eaaa6234bee85e6161e1ba01627",
            "810fc824c86a479cba21530bf71f1147"
          ]
        },
        "id": "GMtfWRDU-qr3",
        "outputId": "9dd082cb-42bc-4054-f602-c330f6ce0cb7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "The speedups for torchdynamo mostly come with GPU Ampere or higher and which is not detected here.\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Truncating train dataset:   0%|          | 0/500 [00:00<?, ? examples/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "25d40f625dbe4f978a02a6b2a7210ae5"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "No label_names provided for model class `PeftModelForCausalLM`. Since `PeftModel` hides base models input arguments, if label_names is not given, label_names can't be set automatically within `Trainer`. Note that empty label_names list will be used instead.\n",
            "`use_cache=True` is incompatible with gradient checkpointing. Setting `use_cache=False`.\n",
            "W0326 10:54:59.310000 6752 torch/_inductor/utils.py:1137] [14/0] Not enough SMs to use max_autotune_gemm mode\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<IPython.core.display.HTML object>"
            ],
            "text/html": [
              "\n",
              "    <div>\n",
              "      \n",
              "      <progress value='14' max='250' style='width:300px; height:20px; vertical-align: middle;'></progress>\n",
              "      [ 14/250 01:31 < 30:03, 0.13 it/s, Epoch 0.05/1]\n",
              "    </div>\n",
              "    <table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              " <tr style=\"text-align: left;\">\n",
              "      <th>Step</th>\n",
              "      <th>Training Loss</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <td>1</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>2</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>3</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>4</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>5</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>6</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>7</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>8</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>9</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>10</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>11</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <td>12</td>\n",
              "      <td>0.000000</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table><p>"
            ]
          },
          "metadata": {}
        },
        {
          "output_type": "error",
          "ename": "KeyboardInterrupt",
          "evalue": "",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-11-b9094d6df920>\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     33\u001b[0m     \u001b[0margs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mtraining_args\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     34\u001b[0m )\n\u001b[0;32m---> 35\u001b[0;31m \u001b[0mtrainer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtrain\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/trainer.py\u001b[0m in \u001b[0;36mtrain\u001b[0;34m(self, resume_from_checkpoint, trial, ignore_keys_for_eval, **kwargs)\u001b[0m\n\u001b[1;32m   2243\u001b[0m                 \u001b[0mhf_hub_utils\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0menable_progress_bars\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2244\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2245\u001b[0;31m             return inner_training_loop(\n\u001b[0m\u001b[1;32m   2246\u001b[0m                 \u001b[0margs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2247\u001b[0m                 \u001b[0mresume_from_checkpoint\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mresume_from_checkpoint\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/trainer.py\u001b[0m in \u001b[0;36m_inner_training_loop\u001b[0;34m(self, batch_size, args, resume_from_checkpoint, trial, ignore_keys_for_eval)\u001b[0m\n\u001b[1;32m   2554\u001b[0m                     )\n\u001b[1;32m   2555\u001b[0m                     \u001b[0;32mwith\u001b[0m \u001b[0mcontext\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2556\u001b[0;31m                         \u001b[0mtr_loss_step\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mtraining_step\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mmodel\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0minputs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mnum_items_in_batch\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   2557\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2558\u001b[0m                     if (\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/trainer.py\u001b[0m in \u001b[0;36mtraining_step\u001b[0;34m(***failed resolving arguments***)\u001b[0m\n\u001b[1;32m   3762\u001b[0m                 \u001b[0mkwargs\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m\"scale_wrt_gas\"\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mFalse\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   3763\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 3764\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0maccelerator\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbackward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mloss\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   3765\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   3766\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mloss\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdetach\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/accelerate/accelerator.py\u001b[0m in \u001b[0;36mbackward\u001b[0;34m(self, loss, **kwargs)\u001b[0m\n\u001b[1;32m   2353\u001b[0m             \u001b[0;32mreturn\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2354\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mscaler\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2355\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mscaler\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mscale\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mloss\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbackward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   2356\u001b[0m         \u001b[0;32melif\u001b[0m \u001b[0mlearning_rate\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32mNone\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mhas_lomo_optimizer\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2357\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mlomo_backward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mloss\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlearning_rate\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/_tensor.py\u001b[0m in \u001b[0;36mbackward\u001b[0;34m(self, gradient, retain_graph, create_graph, inputs)\u001b[0m\n\u001b[1;32m    624\u001b[0m                 \u001b[0minputs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0minputs\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    625\u001b[0m             )\n\u001b[0;32m--> 626\u001b[0;31m         torch.autograd.backward(\n\u001b[0m\u001b[1;32m    627\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mgradient\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mretain_graph\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcreate_graph\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0minputs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0minputs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    628\u001b[0m         )\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/autograd/__init__.py\u001b[0m in \u001b[0;36mbackward\u001b[0;34m(tensors, grad_tensors, retain_graph, create_graph, grad_variables, inputs)\u001b[0m\n\u001b[1;32m    345\u001b[0m     \u001b[0;31m# some Python versions print out the first line of a multi-line function\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    346\u001b[0m     \u001b[0;31m# calls in the traceback and some print out the last line\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 347\u001b[0;31m     _engine_run_backward(\n\u001b[0m\u001b[1;32m    348\u001b[0m         \u001b[0mtensors\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    349\u001b[0m         \u001b[0mgrad_tensors_\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/autograd/graph.py\u001b[0m in \u001b[0;36m_engine_run_backward\u001b[0;34m(t_outputs, *args, **kwargs)\u001b[0m\n\u001b[1;32m    821\u001b[0m         \u001b[0munregister_hooks\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0m_register_logging_hooks_on_whole_graph\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mt_outputs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    822\u001b[0m     \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 823\u001b[0;31m         return Variable._execution_engine.run_backward(  # Calls into the C++ engine to run the backward pass\n\u001b[0m\u001b[1;32m    824\u001b[0m             \u001b[0mt_outputs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    825\u001b[0m         )  # Calls into the C++ engine to run the backward pass\n",
            "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Load model directly\n",
        "from transformers import AutoTokenizer, AutoModelForCausalLM\n",
        "\n",
        "tokenizer = AutoTokenizer.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\")\n",
        "# model = AutoModelForCausalLM.from_pretrained(\"deepseek-ai/DeepSeek-R1-Distill-Llama-8B\")"
      ],
      "metadata": {
        "id": "C7v2-73L-Rzk",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 211,
          "referenced_widgets": [
            "465a1294db034eb29cf73c72600b9781",
            "708a852b7e4a45fdb2435cd8d1219a40",
            "5a9388bf0f3c4fb8a42f8b7a8142e51f",
            "bddb529520b64c7a8f331106e96c2d27",
            "a4322f2a7c86424fb1be469ff68f359c",
            "cfaef5a62425448dad9a2094fc98c0e9",
            "b1be7fcb8387492480b95c759e841e23",
            "813057db43a84b5b9c0575cab0d28eec",
            "ec873db6f387427487595da5dd8ba974",
            "3e61f59ff6f24310b15a60c38f280d04",
            "e65abbed4c8e4e7cac1618bc04e812ee",
            "617476bf14964a2aa5038a93bad4c005",
            "34cbf956ac154db3b0a340c193970439",
            "89ef2cc0d69041e1992d834e21315cb3",
            "d4fe78d67ef14b5281836c52d37b69b5",
            "f21d2c1ad118433abaa6545b4056db0d",
            "dbb3e11968e74432a00ced93059266ba",
            "bf830e67a85b48fe991dc361c8c4a870",
            "e2d0e29e1854422baf5e7acb9c5b4023",
            "7f923d649c1b4e92b5a6500c6d2906a5",
            "779567d439844215b0ad30b4ea4876b9",
            "345adf6aad1445798d5a4822d7357b7a"
          ]
        },
        "outputId": "2d30c83f-d03b-4421-989e-bbde2ccc225e"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/huggingface_hub/utils/_auth.py:94: UserWarning: \n",
            "The secret `HF_TOKEN` does not exist in your Colab secrets.\n",
            "To authenticate with the Hugging Face Hub, create a token in your settings tab (https://huggingface.co/settings/tokens), set it as secret in your Google Colab and restart your session.\n",
            "You will be able to reuse this secret in all of your notebooks.\n",
            "Please note that authentication is recommended but still optional to access public models or datasets.\n",
            "  warnings.warn(\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/3.07k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "465a1294db034eb29cf73c72600b9781"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/9.08M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "617476bf14964a2aa5038a93bad4c005"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer.model_max_length"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_AiyNicTV94R",
        "outputId": "7cbf122d-1706-48b5-8e00-f7f189d3e930"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "16384"
            ]
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from huggingface_hub import notebook_login\n",
        "notebook_login()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 17,
          "referenced_widgets": [
            "99738d8077ac43ea9449a59ef57eeb96",
            "ea4ea81e41164c0b8b011112f0d9645f",
            "fbf2ce06dc2d4783a9ab23fd97af8cd7",
            "4b07613e1a5a42bbba45d110a10b794e",
            "af4e498cc0b043d6aa1bb5a991a878f8",
            "e2c3c16960f64da894f9c4e6a67ae356",
            "6ea9b405f77347229e8629de41db2b30",
            "ab7efa9867c846be9f9e14cb74cf5b42",
            "afefde691db246e48d2a4fbb5e8f9b3a",
            "2059fd91052b43fda01efa132d0a0445",
            "1f7d2f21a57045999b54937ca1c06efc",
            "edb87c184ebc4219ae45a9b3110431ed",
            "942f9ca9ec714026a8b1847d050b1a5e",
            "e2554819d2984ec1b327c11b4b45456c",
            "4f5ecfd0462c433f86f669882955c3cc",
            "f16734c4ae1d4c5b98695524e1c357df",
            "b6394b08100744f3be37f1695f1d1aa1",
            "f0cb1a56992542eb8728432a19b90bc6",
            "d689c0414fe04ec191e93b0444409e0e",
            "e4046926828e48e3adfac6869ad7aa92"
          ]
        },
        "id": "zTnCQaK4Wipc",
        "outputId": "fbd41aac-0da4-45fa-d8e1-64971404a3db"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "VBox(children=(HTML(value='<center> <img\\nsrc=https://huggingface.co/front/assets/huggingface_logo-noborder.sv…"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "99738d8077ac43ea9449a59ef57eeb96"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "tokenizer2 = AutoTokenizer.from_pretrained(\"meta-llama/Llama-3.1-8B-Instruct\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 113,
          "referenced_widgets": [
            "4d12ca37e8de428eb4156703563ff051",
            "403705c60380480b8d563e3fa6a2d842",
            "cc53cde2c26c4ae1a9def1bcdf3e58a6",
            "b99f44b1b60940819924cfa590930296",
            "ed34293e647b4217a6c7bb904a47ec1b",
            "5f5d5b48352346148b4225effe923fdb",
            "16081339a40047ebbda048f1936c48d1",
            "cf5051ec2ea940ab98194717546797e0",
            "5d98c32ae5074111aeecc92e53521e76",
            "5d9e28713d4b4fe9ab4dd33d4a13450e",
            "782735b0036f4b78914061828fd3cefc",
            "2de9c53fe58243169cf9be6772a7c6fa",
            "3865fa4ea8744cf892881e742f814aea",
            "bcf3f4b17cf141f38126759392c7a7ea",
            "4750ae15951248898961a7a98303aa1b",
            "344df6c9224d4def9fbc5fa93d3c164d",
            "56994727030c4222aeb9a13e36bfe08d",
            "5aa2785937b74b029c98790ebd2fcb9e",
            "e0b4952ea6e3460aa6748703caf5271d",
            "ba0b6512b3084666a18d3a1f2eea981d",
            "d30ff64e6a09419382c8ec50ea8aa45b",
            "d4a583f692ad4093aa343a94e37a3f27",
            "e107a4f43f5c4cda8efced1143475f53",
            "c7126aacc5714f549241261ace73a52c",
            "39801b0a1fc4404a99e04e33e6b96441",
            "21a5335c6ee7480ab8e62e5b802a2c9f",
            "d1bb7c4029ce486caaee91dc8fc76abe",
            "f7b4db4ec93642f5ac08c3ff20576cc1",
            "1c31d8ef3e1041219965a4971c71c4a5",
            "e0697b2a547849b3a4d300e93adbfc05",
            "3c80e807f8d9409ebbb908ca4b7d25cc",
            "d1e23316a5bc4e8796f7b8291a6424d4",
            "c7f364f8e192477e8ef54c3e1166866a"
          ]
        },
        "id": "yNcY0OoUV-2z",
        "outputId": "f7f12537-52c9-4923-804c-0c353b3e6d73"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/55.4k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "4d12ca37e8de428eb4156703563ff051"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/9.09M [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2de9c53fe58243169cf9be6772a7c6fa"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "special_tokens_map.json:   0%|          | 0.00/296 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e107a4f43f5c4cda8efced1143475f53"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer2.model_max_length"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "cqOFjkyfWe8E",
        "outputId": "aa1aad60-453b-4217-99d3-d2abe7d68c1d"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "131072"
            ]
          },
          "metadata": {},
          "execution_count": 8
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "5BWI8A5eZsMy"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}